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I V 
Two Chinamen, behind them a third, 
Are carved in lapis lazuli, 
Over themflies a long-legged bird, 
A symbol of longevity; 
The third, doubtless a sen ;ing-man, 
Carries a 111usical instrument. 
Every discoloration of the stone, 
Every accidental crack or dent, 
Seems a water-course or an avalanche, 
Or lofty slope ll'here it still snows, 
Though doubtless plum or cherry-branch 
Sweetens the lillie ha(f-wav house 
Those Chinamen climb towards, and I 
Delight to imagine them seated there; 
There, on the mountain and the sky, 
On all the tragic scene they stare. 
One asks f or moumjit! melodies; 
Accomplishedfingers begin to play. 
Their eyes mid many wrinkles, their eyes. 
Their ancient, glitte ring eyes, are gay. 
-From Lapi s Lazuli 
by William Butle r Yeats 
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Abstract 
With the advent o f well -de fined ruthenium o lefin meta thesis catal ysts th at are 
hi ghl y ac ti ve and stabl e to a variety of functional groups, the synthes is of complex 
o rganic molecules and polymers is now possible ; thi s is rev iewed in C hapte r 1. The 
majority of the rest of this thes is describes the application of these cata lys ts towards the 
synthesis of novel polyme rs that may be useful in bi o log ica l applications and 
in vesti gations into their efficacy. 
A me th od was deve loped to produce polye the rs by metathes is, and thi s is 
described in C hapte rs 2 and 3. An un saturated 12-crow n-4 ana log was made by 
template-direc ted ring-c losing metathes is (RC M ) and utili zed as a monomer for the 
synthes is of unsaturated polyethers by ring-opening metathesis polymerization (ROMP). 
The yie lds were high and a range of mo lecul a r weig hts was accessib le. In a s imilar 
manner. substituted po lyethers wi th vari ous backbones were synthesized : po lymers with 
benzo g roups a lo ng the backbone and various concentratio ns of amino ac ids were 
prepared . The results from in vilro toxic ity tests of the un substi tuted po lyethers are 
considered. 
T he conditi ons necessary to synthesize polynorbornenes w ith pe ndent bioactive 
pcptidcs were explo red as illustrated in C hapter 4. Firs t, the polymeri zation of various 
norbornenyl monomers s ubstituted w ith g lyc ine, a lanine or penta(e thyle ne g lycol) is 
descri bed. Then , the syntheses of polymers substituted with peptides GRGD and SRN, 
X 
components of a cell binding domain of fibronectin, using newly developed ruthenium 
initiators are di scussed. 
In Chapter 5, the syntheses of homopolymers and a copolymer containing 
GRGDS and PHSRN , the more acti ve forms of the peptidcs, arc described . The ability of 
the polymers to inhi bit human dermal fibroblast cell adhesion to f ibronectin was assayed 
using an in l'itro competiti ve inhibition assay, and the results are discussed. I t was 
discovered that the copoly mer substituted with both G RGDS and PHSRN peptides was 
more acti ve than both the G RGDS-containi ng homopolymer and the GRGDS free 
peptide. 
Hi storically , one of the drawbacks to using metathes is is the removal of the 
residual ruthen ium at the completion of the reacti on. Chapter 6 describes a method 
where the water soluble tri s(hydroxymethyl)phosphine is utili zed to fac ilitate the removal 
of rc idual ruthenium from RCM reaction products. 
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Chapter 1 
General Introduction to Olefin Metathesis 
And Its Application to Bioactive Materials 
2 
Part 1. Olefin Metathesis 
Genera l Aspects. Olefin metathesi s i s a transi tion metal catalyzed reaction in 
wh ich the groups of two substi tuted alkenes are transposed (Scheme 1). 1 Since thi s 
method is a catalytic way to both break and form C-C double bonds, it has developed into 
a powerful tool for organic molecu le and po lymer synthesis. 
catal yst + 
Scheme 1. General o lefin metathesis reacti on w ith unsymmetri cal l y substituted 
o le fins. 
The mechanism of o lefin metathesis, ori ginall y proposed by Chauvin et al.,2 was 
shown to proceed through a metallacyc lobutane intermediate (Scheme 2). A 
[2+2]cyc loaddition between an o lefin and a transition metal-carbene complex forms the 
intermediate. C leavage of the metall acyclobutane can occur in a producti ve fashion to 
form a new metal-carbene and o lefin or in a nonproduct i ve fashion to revert back to the 
ori gi nal starting material s. Each step in the reaction i s reversib le, and the reaction i s 




Scheme 2. Chauvin mechanism of o lefin metathesis. 
3 
The po tential of metathes is in o rganic synthes is was great ly inc reased by the 
advent of sing le compone nt catal ysts. 1·' Because these well -defined complexes react in a 
control led and consiste nt fashion , the ir activities and le ve ls o f func ti o nal group to lerance 
can be studied. As a result, the cata lyst performance has been attenuated by a ltering the 
metal or ligand sphere , leading to the de ve lopment of increas in g ly mo re active and 
to lerant catalysts. M a ny of the modern catalysts (representatives shown in Figure 1) are 
well suited for the synthes is of com plex o rganic mo lecules and po lymers. 
A 
RQ ...... z~ 
RO,.-
R. R. Schrock 
I \ 
Cy-N N- Cy 
~H 
Cl' ~ Ph 
Cy-N N- Cy 
\ I 
W. A. Herrmann 
M = Mo, W 
OR = OCMe3 
OCMe2CF3 
OCMe(CF3)2 (1) 
Cy3P { I ... CI .•• H c c 
R(~ R = Ph (2), H Ph2 
Cl ' I R 
PCy3 
R. H. Grubbs 
{\ 
Mes-N~N-Mes 
~H { R = Ph (3), CHC(CH3)2 (4) 
Cl ' R 
PCy3 
R. H. Grubbs 
Figure 1. Representative single-component , metathesis-acti ve cata lysts. 
T he molybdenum and tungste n catal ys ts, particu larl y 1, deve loped by Schrock 
and coworke rs (Figure I ), are hi g hl y ac ti ve and able to affec t a variety of 
tran sformations.~ However, the viability of these catalysts has been limited by their 
4 
ex treme sensiti vity to oxygen , water , and severa l common func tiona l groups. suc h as 
a ldehydes and alcoho ls . Thi s lim itat ion has restric ted the application of these compo unds 
to certain substrates and necessitated the use of rigorous ly purifi ed solven\s and starting 
material s. 
Metathesi s cata lys ts that are to lerant of both po lar and protic fun cti o na l groups 
were first di scovered by G rubbs and coworkers, w hen the first ruthe nium bi sphosphine 
catal ys ts were deve loped (Fig ure 1 ).5 S ince the n , a number of ruthe nium -based 
complexes have been synthesized that offer synthe ti c advantages over the mo lybdenum 
and tungsten a lkylidenes. 6·7 For example, 2 was found to be selecti ve for o lefins in the 
presence of a w ide varie ty of functional g roups, inc luding alcohols and aldehydes.6 
These rutheni um alkylidenes are a lso stabl e to man y impurities including air, proti c 
so lvents, and water. In fac t , cata lyst 2 affects polymerizations in water unde r emul sion 
co ndi tions us ing a surfac tant. 8 By altering the pho p hine ligands o n 2 to be water 
so lubl e, the cata lyst is active in pure water o r methanol. 9 The o nly drawback of these 
bi sphosph ine cata lysts is that they display lower ac ti vity compared to the molybdenum 
catal yst 1, and they are not particularly stable to primary or secondary amines. 
It was di scovered by He rrmann ,10 Grubbs, 11 and o lan 12 that the ac tivity of 
ruthen ium cata lysts cou ld be inc reased by substituting o ne o r both of the phosphines w ith 
basic N-heterocyc lic carbene li gands. When the substitution was made wi th one 2,3-
dih ydroimidazo lyi dine li gand by G rubbs and coworkers, 13 the resulting catal yst , 3 , was 
found to be more acti ve than the molybdenum-based c ata lyst 1 . 1J Th is ac tivity was 
coup led w ith hi gh stab ility and functional g ro up to le rance demonstrated by the o ther 
ruthe nium-based m e tathesis cata lysts. Thi s recent breakthroug h has a llowed fo r the 
5 
synthesis of materials previously inaccessible and for the reduction in catalyst loadings , 
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Scheme 3. Metathes is processes: A) ring-c losing metathesis; B) c ross metathesis; C) 
ring-open ing metathesis po lymeri zation ; D) acyc lic diene metathesis polyme rization. 
Metathesis catalysts have been employed to synthesize small molecules, natural 
products, and pol y mers . These have been accomplished us ing the reactions shown in 
Scheme 3. Organic mo lecules have been synthesized by ring-c losing metathesis (RCM) 
and cross metathesis (CM), while po lymers have been synthesized us ing ring-ope ning 
metathes is pol ymeri zation (ROMP) and acycli c diene metathes is po lymeri zation 
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(ADMET). These processes are inteJTelated, and the particular pathway is determined by 
the olef in structure and reaction conditions. 
Ring-Opening Metathesis Polymerization. Many o lefin metathesi s catal ys ts 
initiate the ROMP of cyc lic o lefin s to y ield pol y(olefins) (Scheme 3C). 1a.Jb. 16 ROMP is 
dri ven enthalpi cally by the release of ring-strain in the monomer. Highly strained 
monomers, such as norbornenes, cyc lobutenes, and barrelenes (Figure 4 , A-C), have been 
successfully polymerized using metal alky lidenes. Many metathesis catalysts wi ll also 
affect the po lymeri zati on of less-strained o lefins, such as cyclooctene, cyc lopentene and 
cyclooctadiene (Figure 4 , 0 -F). H owever, cyclohexene (Figure 4, G) will not pol ymerize 
under equilibrium conditions. 17 Since ROMP is an equilibrium process, depending on the 
monomer and conditions used. depoly meri zati on can also occur, w here the growing chai n 
" back-bites" to form cyc lic o l efin s . ~.' · 1 8 
D 00 0 0 
A B c D E F G 
Figure 2 . Cyc lic Olefins: A) norbornene, B) ban·elene, C) cyc lobutene, D) cyclooctene, 
E) cyc looctadiene, F) cyc lopentene, and G) cyc lohexene. 
Compared to other types of polymerization s meth ods, ROMP has several 
advantages. 3b. J(,,, Many o f the metathesis catal ysts already described initiate the li v ing 
polymerization o f strained cyc lic o lefins. A liv ing po ly meri zation proceeds in the 
absence of chain termination and can be used to synthesi ze polymers w ith predictable 
molecu lar weights and na1Tow polydispersities. 1? In orne cases, the architecture can also 
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be controlled, and block copolymers have been synthesi zed.20 The synthesis of random 
copolymers is straightforward, because unlike other polymerization methods, generall y 
the monomer incorporati on is dependent only on the concentration in the feed . In 
addition, the synthesi s of pol ymers with well-defined end groups (telechelic polymers) 
has been accomplished.21 Polymers have even been polymerized off of surfaces."" 
M any of the monomers shown in Figure 2 can be deriviti zed and polymeri zed by 
metal alk y l idenes to form f unc ti onalized materia ls for a variety of purposes. 
Functionalized cyclooctenes have been pol ymerized and hydrogenated to make perfectl y 
linear, f uncti onalized pol yethy lene."' Conducting pol ymers24 and polymers wi th 
photo luminescence properties 25 have been made. Po ly mers for use i n li ght emitting 
diodes (L EDs)26 and those that are liquid-crystalline27 have also been synthesi zed by 
ROMP. 
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Figure 3. Polymers substituted wi th sugars and penicillins synthesized by ROMP. 
With the advent o f metathe is catal ys ts that react preferenti all y w ith o lefins over 
many other functional groups and are ac ti ve in water , the ROMP of monomers w ith 
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bio logicall y relevant units has been reali zed. Only a fevv of the polymers, however, have 
been characteri zed for their bio logica l acti vity. Po lymers w ith pendent sugars have been 
synthesi zed28 and used to explore protein-saccharide interactions (Figure 3).28c-e Kiessling 
and coworkers found th at the po lymers were much m ore ac ti ve th an the monomers at 
inhibi tin g ce ll agglutination. Thi s was thought to be due to multi valent interacti ons 
between the sacchar ide-substituted polymers and the ce ll surface proteins. Polymers 
substi tuted w ith nuc leotide ba es2'l and amino acid esters' 0 have been synthes ized using 
ru theni um and molybdenum metathesis complexes as initiators. In addition. polymers 
wi th pendent drugs such as penicillins (Figure 3)' 1 and vancomycins32 have been made. 
In the latter study, the po lymers were found to have significantl y increased (8 to 60 fo ld) 
ant ibacteria l acti vities against resistant strains of bacteria compared to the vancomycin-
deri ved monomer, agam potentiall y due to mul tivalent i nteracti ons provided by the 
po lymer scaffo ld. 
Ring-Closing Metathesis. Ring-c los ing metathesis is a relati vely new react ion 
compared to ROMP.1b.JJ U nli ke ROMP, RCM of an a,w-diene to form a cyc lic o lefin is 
enthalpicall y disfavored; the reacti on i s entropicall y dri ven by the rel ease o f a volatile 
small molecule such as ethy lene. The formation of the ring i s limited by the relati ve ring 
strain of the product. Because of its usefulness and versatility, thi s reacti on has been 
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Scheme 4. RCM of fun cti onali zed cx,w -d ie ne to form 5-7 membered rings. 
In 1992 , Grubbs a nd coworkers de m o nstrated that RC M was a viable way to 
synthes ize 5-7 me m bered rings w ith vari o us func tio na lity in hi g h y ie lds (Sc he me 4).3J 
Severa l years la te r, it was s hown that 8-me mbered rings could be synthesized , provided 
that the die ne substrate conta ined a s te ric constraint to restric t the conformatio n to o ne 
favorable for ring-c losure.35 Since the n , a large numbe r o f compo unds synthesized by 
RCM have been re po rted.36 A mo ng the ma ny examples, tri - or te trasubstituted cyc lic 
alkencs:17 b icyc lic di aza compounds,38 c hro me nes ,39 and bicyc lic ~- l ac tamsJO have been 
made. RC M has been exte nded to inc lude ta nde m reac ti ons in w hic h multi -cyc li zat ion 
can occur by a ttac h ing me tathesis re lays s uc h as ace ty le nes o r cyc lic olefin s.J1 An 
exampl e o f thi s s trategy w he re a o ne s te p tri cyc li zati o n w as accompli shed us in g 
acety lene re lays, is shown in Sche me 5.J1c 
0 0" 
cata lyst 
Scheme 5. Tande m o ne s tep tricyc li zati o n R CM reactio n. 
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Man y la rge-s ized ring syste ms ha ve been synthes ized in a hi g hl y effi c ient 
manner, whe the r the s ubstrates contain ri goro us conformationa l constraints or not. 
H yd rogen bondin g between a min o ac ids has been exp lo ited to synthes ize 
conformationa ll y-stabilized cyc lic [3-turn analogs (Figure 4) , .. ~ a-helices,43 and peptide-
based nano tubes . .j.j RCM in the presence of a metal template accomp lished the synthesis 
of [2]catenanes in hi gh yie lds ... 5 Ste ric constraints built into the substrates provided a 
bridged cali x[4]arene .. 6 and the tricyc lic core of roseophilin ... 7 T he synthesis of large 
macrocycles, such as cyc lic lactones .. 8 and crown e thers, .. 9 was accomp li shed in good 
yie lds in the absence of any steri c constraint by s low addition techn iques. 
Me ~Me 0 Me Me~N 
N H 0 
~/o HN 0 
BocN ···· ... , )---{ 
,,,,,,~/ OBn 
Figure 4. Peptide [3-turn covalentl y stabilized by RCM. 
The sy ntheti c importance of RCM ts de monstrated in the number of natural 
products that have recently been reported where ring-closi ng was the key step. For 
example. small molecules such as fronta lin50 to complex , biologica ll y active epoth ilio ne 
A and its derivatives51 have been synthesized where RC M was the key step. 
Cross Metathesis and Acyclic Diene Metathesis Polymerization. The cross 
metathes is process resemb les RC M thermodynam ica ll y in that the reaction is driven 
e ntropic all y by the evaporat ive loss of a small molecu le suc h as e th y le ne. 1b.JJc 
II 
Historicall y, the prac tical use of thi s reaction has been hampered due to poor selecti vities 
for the desired produc ts. 33c For the C M of two terminal olefins, one desired he te rodimeric 
produc t and two undesired homodimers are obtained (Scheme 6A). Despite thi s, cross 
metathes is has been used to successfull y sy nthes ize compound s in good yields, 1b.oJc 
inc luding dimers of the immunosuppressant FK 506.52 Recent ly, by us ing symmetric 
di subs tituted o lefin s as coupling agents (Sc he me 6B), the yie lds of the des ired 
heterodimeric produc ts were sign ificantl y increased.53 
A) R ;=c., 
[M] I R1 R2 
\ + \ desired product 
R1 R2 
;=c., + ;=c., 
R1 R1 R2 R2 
undesired homodimers 
B) R 
[M] I ;='<-, 
\ + ;=c., R1 R2 
R1 R2 R2 
desired product 
Scheme 6. C ross metathesis : A) Two terminal o lefins cross to form the desired 
heterodimer and the undesired ho modi mers. B) A termina l o lefin c rossed with a 
symmetric di substituted olefin yie lds the desired heterodimer product. 
ADMET provides a means to synthesize unsaturated polymers from linear a ,w-
dienes.1h It is c lose ly re lated to C M and has a s imilar thermodynamic profile. The 
reaction is typicall y carri ed out in neat mo nomer unde r vacuum, where the removal of a 
vo latile compound, such as ethy lene , d rives the re action. Since it is a step-growth 
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pol ymerization , where very hi gh convers ions are necessary to o btain good yields. '9 thi s 
me thod typicall y suffers from low con vers io ns and produces a numbe r of undesirable 
s ide-products . l t has, however, been used success full y e mployed to produce perfectly 
branched and linear poly(et hy le ne),54 et hy lene/C055 and ethy le ne/v in y l alcoh o l56 
copolymers, po ly(ethers),57 po ly(aceta ls),58 and hi g hl y conjugated pol y mers such as 
pol y(phenylvin ylenes)s,59 among other examples. '" To date, however, ADMET has not 
been deve loped as exte ns ively as ROMP. 
Part 2. Manipulation of Biological Response Through the Incorporation of 
Poly(ethylene glycol) and Arg-Gly-Asp into Synthetic Materials 
The cont ro l of bio logica l response thro ugh ra ti onal macromo lecular design is a 
key issue in many biomateria l appli cati ons. For example, minimal bio logical response to 
a mate rial may be desired in a spec ific application . To this end, man y researc he rs have 
incorpo rated pol y(eth ylene g lycol) (PEG) into mate rial s to limit biological adhesions.60 
A lterna ti ve ly, a specific response may be desired and obtai ned by incorpo ra t ion of a 
bioacti ve compound, such a the peptide arg inine-glyc ine-aspartic ac id (Arg-Gl y-Asp, 
RGD ). into a mate rial. Much work in this area has foc used o n the modification of 
existing material s through the covalent attachment of bioactive moie ties. 
Poly(ethylene glycol) as a Biomaterial. PEG (Figure 5) is a flexible polye ther 
that has a number of unique properti es. 60·61 It is so lubl e in most organic so lvents and 
water and has a large exc lusion volume in water. lt is nontoxic , weakly immunogenic , 
and hos pitab le to bio logica l ma te ri a ls . It is even F DA approved fo r in te rna l 
consumpti o n. As a solubl e pol ymer, PEG has many applications .60 '61 When lin ked to 
13 
molecules or proteins, it solubli zes the m, he lps move the m across cell membranes , and 
reduces the rate of c learance through the kidney.60·61 Because of these prope rties, it has 
been wi del y used in the biomedical and bioengineering communities. 
HOr0~0H 
Figure 5. Pol y(ethylene g lycol). PEG. 
Because PEG resists prote in absorption ,62 as an insoluble mate ri a l it is useful for a 
vari ety of applications. Absorbed o n a surface or cross- linked as a ge l, it rende rs the 
material protei n rejecting and is dubbed " nonfouling." PEG and various copolymers of 
PEG arc utili zed as protein-rejec ting mate rial s for impla nts and as barrier material s 
during the wound healing rcsponse .60·6 t.63 A notable example of the latter is the 
applica tion of PEG-based hydrogels for use in polymeric e ndo lumina l ge l paving 
applicat io ns w here resorbable hydrogels are ex tre me ly effect ive at preventing post-
angioplas ty adhesio ns in animal mode ls.M B y covalentl y attac hing a bound peptide to 
PEG-based material s, the material can be rendered se lecti ve ly adhes ive to certa in cell 
types, w hile remaining res istant to protein absorption .65 In this m anner, the wound 
healing response may be manipulated and contro lled. Thi s has been accompli shed by 
attaching short bioactive peptides. such as RGD, to PEG hydrogel s66 o r o li go(ethy le ne 
g lycol) self-assembled mon olayer surfaces,67 amo ng o the r examp les. 60·6 t.65 Ongoi ng work 
inc ludes the deve lo pme nt of functiona lized PEGs o r P EG-conta inin g pol y mers and 
material s for use in various applicati o ns as a soluble or insoluble materia l. 
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Incorporating A rg-G iy-Asp to Elicit a Biologica l Response. Many 
ex tracellul ar m atri x proteins bi nd to ce ll surface integrin s th rough the sho rt peptide 
sequence RGD .68·69 In fac t, RGD a lo ne has been shown to pro mote cell adhesion .70 Since 
ce ll attac hme nt mediated by integrin -prote in inte rac t ions influe nces ce ll s urvival, 
d iffere ntiat io n, and mi grat io n , thi s sequence has been ta rgeted to study integrin func tion 
and p rovide treatments fo r di seases. 71 For example , fibro nectin and RG D containi ng 
peptides have been shown to have ant i-metastatic ac ti vity a nd thus may have good 
prospects as drugs for tumor therapy. 7~ 
A ltho ug h the RGD peptide is effecti ve in certain applicati o ns , its therapeut ic 
pote ntial is low. One reason fo r thi s is th at the affin ity of the pe ptide to ce llu lar integrins 
is s ignificantly lower (> 1000 times lower) than the pro te ins fro m w hich it is de ri ved. 68b 
Thi s is partl y due to the presence of syne rg istic s ites o n the protei ns that enhance RGD-
integ ri n b inding. For example , in fibronectin the seq uence Pro-H is-Ser-Arg- Asn 
(PHSR ) , whi ch is o n the same side of the pro te in 30-40 A from RG D (Figure 6) ,73 acts 
synergistically with RG D .74 Interesting ly , PHSR N acts in syne rgy o nl y w hen cova lent ly 
attac hed in prox imity to RG D .74 A ltho ugh most bi om ate ri a ls o nl y contain RGD and no t 
the PHS R N seque nce, efforts have been m ade to synthes ize RGD mimics th at have 
enhanced ac ti vities. A second reason for the low therapeuti c potential is because RGD, 
as a small peptide, has a have ha lf- life in vivo of onl y a few m inutes. 75 As a result , efforts 
have been made to synthesize non -peptide RG D m imics and materia ls that contai n th is 
o ligopeptide seque nce to increase the life times in vivo. 
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RGD 
Figure 6. Ribbon diagram of the seventh through the tenth (RGD-containing) type 
III repeats of human fibronectin. The cell-binding RGD loop and i ts synergy site, 
PHSRN, are on the same side o f the protein . This structure was obtained from the 
Protein Data Bank; see reference 73. 
Efforts have been made to increase the therapeutic potential of the RGD peptide. 
The activities have been increased by cyclizing the peptides,75'76 altering the flanking 
groups,76 and synthesizing nonpeptide mimetics.76 The o-forms of the amino acids and 
nonpeptide mimetics also have increased lifetimes in vivo.76•77 Since linking a peptide to 
a polymer can also increase lifetimes in vivo, polymers substituted wi th RGD have been 
synthesized.77•78 The presentation o f many RGDs on one molecule may lead to 
multivalent interactions and increased activities.79 Polypeptides wi th RGD repeats80 and a 
synthetic polymer with RGD units l inked to a poly(carboxyethylmethacrylamide) 
backbone8 1 have been reported and shown to have an increased therapeutic potentials to 
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inte rfere with cance r me tastas is compared to the free peptide. Ongoing research has 
foc used on c rea tin g sy nthetic mate rial s w ith inc reased lifet imes , activiti es, and 
selectivities. 
Thesis Research 
With the ad vent of well -defined ruthe nium me tathesis catal ysts that a re hi g hl y 
active and stable to a varie ty of func ti o nal groups, the synthesis of biologicall y relevant 
organi c molecules and pol yme rs is now poss ible. The majority of thi s thes is describes 
the appli cati o n of 2-4 towards the synthesis of nove l po lymers that may be useful in 
biological applications. Po lymers with pol yether and pol ynorborne ne backbones that are 
substituted with peptides have been synthesized . The e fficacy of some of these pol ymers 
for bio logical applicati o ns is addressed . 
A nove l me thod to pre pare po lyethe rs by metathesis is described in C hapter 2. 
A n unsaturated analog of 12-crown-4 tha t was made by te mplate -directed RCM was 
utilized as a monomer fo r the synthesis o f un saturated po lyethers by ROMP (Scheme 7). 
In contrast to previous syntheses of polyethers by metathesis,57 the y ie lds were high and a 
range of molec ul ar weig hts was accessible. The unsaturated pol ymer could be contac ted 
w ith 2 unde r RCM conditions to quantitati vely regene rate the unsaturated crown e the r 
monomer. Hydrogenation of the un saturated po lymer yielded the saturated pol ye ther. 
Since the pol yethers were water soluble and contained PEG units, the tox ic iti es were 
investigated by in vitro cyto tox ic ity tests. T hey were found to have s imilar toxici ties as 




Scheme 7. S ynthesis of pol yethe rs by ROMP of an unsaturated c rown ether. 
The first synthesis of substituted po lyethers by o lefin me tathesis is described in 
Chapter 3. Template-direc ted RC M yie lded unsaturated benzo-crown ethe rs and a benzo-
c row n e the r with a pendent phe ny la lanine meth y l este r. T hese mo no mers were 
homopolymeri zed and copo lymeri zed w ith the 12-crown-4 ana log to fo rm pol ymers with 
different backbones and amino acid concentratio ns (Figure 7). General ly, peptides are 
attac hed to the e nds of a polyether chain, and the refore the concentratio n of peptide per 
polymer c hain is low.60"61 With thi s technique, the peptide is substituted alon g the 
backbone and the concentration was de termined simpl y by the initi al concentrati on in the 
feed. As a demonstration, polymers subst ituted wi th the bioactive sequence RGD were 
made. 
Figure 7. Po lyethers wi th diffe rent backbones and concentratio ns of phenyla lanine. 
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The synthesis of pol ynorbornenes w ith pendent amino ac ids is described 1n 
C hapter 4. Various norbo rne ny l monome rs subs titute d with g lyc ine , alanine or 
penta(ethylene g lycol) were polymerized using 2 as a catalyst and compared in terms of 
monomer and polymer yield, reaction time, and molecular weight di stribution. Polyme rs 
wi th GRGDS and SRN, components of an integrin-cell binding domain of fibronectin, 
were a lso made . Since, catalyst 2 is unstable to amines,' 4 the highly active ruthenium 
catalysts 3 and 4 were necessary to synthes ize polymers contai ning high concentrations 
of the o li gopeptides. Using these catalysts , homopol ymers substituted with bi oacti ve 
seque nces and copo ly mers a lso substituted with penta(ethylene glyco l) (Figure 8) were 





Figure 8. Copol ymer substituted with GRGD, SRN, and penta(ethy lene g lycol). 
The biological activity of po ly mers with bioactive peptides is described in 
C hapter 5 . Homopo lymers and a copo lymer containing GRGDS and PHSRN, the more 
active forms of the peptides , were synthesized. The ability of the po lymers to compete 
w ith fibronectin for human dermal fibrob last cell binding was assayed us ing an in viTro 
competiti ve inhibition assay. The homopo lymer w ith many pendent GRGDS peptides 
19 
was s ignificantl y m ore active at in hibiting cell binding to fibronectin than was the free 
peptide, presumably due to multivalent interactions. 79 The copolymer substituted w ith 
both GRGDS and PHSRN was m o re pote nt than both the GRGDS-containing 
homopolymer and the free peptide, demo nstrating that synthe ti c polymers that inhibit 
cellul ar adhesion to fibronect in are now accessible thro ugh ROMP. 
Hi storicall y, o ne of the drawbacks to using o lefin metathesis is the removal of the 
residual ruthenium at the comple tio n of the reactio n. Residual metal can pose problems, 
such as o lefin isomerizatio n during di s tillation of the product, decompos itio n over time , 
and increased toxicity of the final m ate ri a l. Chapter 6 describes a me thod where the 
water soluble tri s(hydroxy methyl)phosphine li gand is utili zed to faci litate the removal of 
res idual ruthenium from o lefin metathesis products. Several s imp le procedures are 
described and compared for the puri f ication of the RCM prod uct of diethyl 
dial ly lmalonate. It was found that fo r an aqueous extracti on, o nl y 10 equ ivalents of the 
phosphine (based on ruthenium) were necessary to remove most of the metal. Thi s 
method was a lso appli ed to the synthesis of unsaturated crown ethers to circumvent the 
typica ll y time-consuming purification procedures of these RCM products. 
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Chapter 2 
The Synthesis of Polyethers Using a Tandem Approach: 
Template-Directed Ring-Closing Metathesis Followed by Ring-
Opening Metathesis Polymerization+ 
30 
Abstract 
Th is c hapte r desc ribes the sy nthes is of pol yethers by a tandem approach of 
template-direc ted ring-c losing metathesis (RC M ) fo llowed by ring-opening me tathes is 
polymerization (ROMP) us ing RuC I2(=CHPh )(PCy3) 2 (1 ) as an in itiato r. Template-
directed RC M is a process which utili zes non-covalent inte ract ions between a di ene and 
an appropriate templ ate to e nhance the RC M of the subs tra te devoid of othe r 
conformational constra ints. Template-directed RCM was fo und to be an exce ll ent 
synthe tic protocol fo r the sy nthesis of unsatura ted crow n e the rs in hi g h yie lds with 
se lecti ve ly for the cis o lefin s. ROMP of these crown ethers produces un saturated 
polyethe rs with different mo lec ular weights (M" from l 0 ,900 to 206,300) depending on 
the initial monomer to cata lyst ratios. Hydrogenation of these polyme rs proceeded 
quantitative ly to y ie ld the saturated po lyethe rs. T e mplate-directed depol ymerizat ion of 
un saturated po lyether to complete ly regenerate the pare nt crown e ther is a lso descri bed. 
Results from in vitro cytotoxic ity tests are di scussed wh ich suggest that the pol yethe rs are 
nontoxic to at least a concentration of 1 wt. % and have a limited she lf li fe. 
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Introduction 
Polyethers a re of comme rc ial importance in areas such as po lyurethane synthesis, 
lu bricants , cosmeti cs, and e lastomers. 1 A notabl e exampl e i po ly(ethylene gl ycol ) 
(PEG) which has been wide ly used in the bioeng ineerin g and bio medi ca l communities 
due to its wate r solubilit y, low tox ic ity, and pro te in resistant prope rties ." PEG has been 
attached to surfaces and to mo lecu les such as proteins, enzy mes, and small -molec ule 
pharmaceuticals to impart stability and biocompatibility to these materi a ls.2·' Since PEGs 
are not commerc iall y available between molecular wei ghts o f 20 ,000 to 200 ,000 ,.~ a new 
versatile route to synthesize wate r so luble po lyethers of vari o us mo lecul a r weights, th at 
can readil y adapted to make func ti onalized pol yethers, is desirab le. Thi s chapter focuses 
on suc h a route where wate r-solubl e po lyethe rs w ith PEG segme nts are synthesized by 
ring-opening metathesis po lymeri zati on (ROMP) using RuC I2(=CHPh)(PCy3) 2 (1 )
5 as an 
ini ti ato r. 
Few examples or the synthesis o f po lyethe rs by o le fin metathes is po lymerizatio n 
have been publi shed. Wagener el a/ . reported the synthesis o f po lyethers having the 
s truc ture [ -C H2=CH-(CH2 ) 11-0 -(CHz) 11 - ] by acyc li c di e ne me tathes is po ly me ri zati on 
(AOMET ) using a tungsten or mo lybdenum catal yst.6 The po lymerizati on o f cx,w-dienes, 
d i-4-pente ny l e the r (n=3) and di -5- hexeny l e the r (n=4) resulted in h igh yie lds of 
polymers with moderate mo lec ul ar weights. However, these po lyethe rs do no t contain 
P EG units (whi c h are necessary to impart wate r so lubilit y to the po lyme rs) . The 
ADMET o f e th ylene g lycol di a ll y l e the r was descri bed , but thi s gave onl y oligomers. 
They a lso reported the ROMP o f 2 ,5-dihydrofuran to g ive a po ly mer with hi gh molecular 
weight ; however, the y ie lds were low (-33% ).6b A n a lte rna ti ve approac h described in 
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this chapte r was undertaken to produce polyethers in hi g h y ie lds from unsaturated crown 
ether monomers. 
Template-Directed RCM to Synthesize Unsaturated Crown Ether Monomers 
Grubbs and coworkers reported the first demonstration of template-directed ring-
closing metathesis (RCM), were non-cova lent interacti o ns between a diene and an 
appropriate template were utili zed to e nhance the RCM of linear dienes devoid of other 
conformational constraints."" lt was determined that the yie lds of c rown ethers derived 
from linear pol yethers coul d be signi ficantl y increased when an appropriate metal io n 
"templ ate" was used to preorgani ze the substra te a nd promote th e des ired 
macrocyc li zati on."" For example , 12-crown-4 is a known io nophore fo r Li+ (Scheme 1).7 
A na logously, it was anticipated that the preorganization of a linear cx., w-diene 2 about a 
complementary me ta l ion would provide the conformation a l res tri c tion s required to 
enhance RC M and form the 12-crown-4 analog 3 in hi gh yields (Sc heme 2)."" 
+ 
12-crown-4 






I ,,~CI ,,,H 
Ru~ 




(M=Li+, Na+, or K+) 
3 (n= 1) 
5 (n=2) 
Scheme 2. S ynthes is of unsaturated crown ethe rs by te mplate-directed RC M. 
By thi s approach, c rown e thers 3 and 5 were synthesized (Scheme 2) ; these are 
s imilar to known ionophores 12-crown-4 and 15-crown-5 , respective ly. The findin gs are 
summari zed in Table I . Noting the pre ferential binding of Li+ by 12-crown-4, it was 
an ti ci pated from the structural similarities between 3 and 12-crown-4 that the RCM of 2 
would afford the hi ghest y ie ld of 3 when Li+ is used as the templ ate. As anticipated, a 
> 95% y ie ld of th e cis ring-closed product was obta ined when the RC M of 2 was 
performed with Li C I04. For the 17-me mbered ring, 5, the RC M was e nhanced by bo th 
LiCI04 and NaCI04 de mo nstra ting that both Li+ and Na+ ions are capable of res tric ting 
the diene to a conformation favorin g RCM. In general, it was ev ident that the ions which 
func tion best as te mplates to g ive the hi ghest yield of ring-c losed product a lso favored the 
formation of the cis isomer. Thi s trend implies that the cis isomer allows the macrocycle 
to adopt a confo tmati on whi ch be t accommodates the template ion. As predic ted. yields 
of the ri ng-c losed product were much lower in the absence of a comple me ntary templ ate. 
34 
Table 1. Template-directed Ring Closing Metathesis of 2 and 4.a 
substrate M+ yieldb cis : trans ratio 
2 none 39% 38 : 62 
u + > 95 (85)% 100: 0 
Na+ 42% 62 : 38 
K+ 36% 36:64 
4 none 57% 26:74 
u + 89% 61 : 39 
Na+ 90% 68:32 
K+ 64% 25:75 
a[Substrate]=0.02M in CH2CI2rrHF, MCIO,Jsubstrate=5/1, 5 mol% 1. 
bYields determ ined from 1 H NMR ana lysis of the c rude reaction mixture. 
Bracket denontes isolated yie ld. 
The cis i somer of an unsaturated, 12-crown-4 analog (3 ) was formed in hi gh 
yie lds utiliz ing thi s approach . After the react ion , all ionic spec ies were removed by a 
sing le aqueous ex trac ti on . In thi s chapter , the ROMP of 3 to form water-soluble, 
unsaturated pol yethers containing PEG units i s described. ADMET as a route to the 
polyethers was al so explored. Template-directed depoly meri zation o f the unsaturated 
po lyether to reform the crown ether monomer i s discussed . Final l y, results from 
toxicological investi gations of the ethers are described. 
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Results and Discussion 
Polymer Synthesis and Characterization. B y ole fin metathesis, polymers are 
synthesized by two pa th ways: ROMP and ADMET. Since the ADMET of 2 and the 
ROMP of 3 shou ld both resul t in the desired water-soluble po lye the r 6 (See Scheme 3), 
the strengths and li mitati ons o f both routes were explo red. 
(~o.._/'-o~) 
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1 Template-Directed RCM 
3 
Scheme 3. Metathesis routes to the synthesis of polyethers wi th PEG segments. 
Since ADMET is the most strai ghtforward route to 6, thi s avenue was explored 
first. Subjecting 2 to standard ADMET conditions (5 mole % 1, neat, 15 mton) at 50 OC 
(Sche me 4) yie lded re lati vel y low molec ular weight pol ymer and oligomers (total yie ld of 
95%) w ith a !raw; to c is rati o o f 6.3/1 as de tected by 'H NMR spectroscopy. The 
po lym e r had a numbe r-a ve raged mo lecular we ig ht (Mn ) o f 11 ,200 (re lative to 
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polystyrene standards) with a broad molecular weight di stribution (polydi spe rsity index , 
PDI) of 3.4. These results vvere not s urpri s ing s ince ADMET is a step-growth 
polymerization route, whi ch usually leads to low molec ular weight polymers unless high 
conversions are achieved. 




1 (5 mol%), so ·c 
6 
Scheme 4 . Synthesis of po lyethers by AD MET. 
ROMP, which is a chain growth po lymeri zation route, was then explored for the 
synthesis o f 6. In a typical polymerization , complex 1 in CH2Cl2 was added to a via l 
containing 3 (Scheme 5). The solutions were stilTed for 4 hours and e thyl vin yl ether was 
added to terminate the reacti ons, as the resulting meta l spec ies is me tathesis inactive. 
The polymers were iso lated by prec ipitation into e the r chilled to 0 OC. The pol ymers 
were a ll viscous o il s a t room tempe rature. 
The ROMP of 3 with an initi a l monomer to catal yst ra tio ([M]/[C]) o f I 0011 gave 
polymer 6 in quantitati ve yie ld, as de termined by 'H NMR spec troscopy of the c rude 
reaction mi xture (78% isolated yield). The trans to c is rati o of the iso lated product was 
4.111 by ' H NMR spectroscopy. The Mn dete rmined by ge l permeation chromatography 
(GPC) was 65 ,900 and the PDI was 1.96 (Table 2). The g lass transition tempe rature 
(Tg) of thi s polymer at -59.0 OC was obtained by di ffe rential scanning calorimetry (DSC). 
37 
n 
Scheme 5. Synthesis o f pol yethers by ROMP. 
A wide range of pol ymer molecular weights was accessible by this methodology. 
The molecular weight of poly mers produced by li ving ROMP of strained monomers can 
be readily controlled by the initial monomer to catalys t rati o ([M]/[C]). A lthough the 
monomers described here do not polymeri ze in a li vi ng fashion, since the ini tiator 
remain s acti ve throughout the reacti on, the molar mass should be proporti onal to the 
[M]/ [C] rati o. 
Table 2. Results for pol ymerizati on of 3 with 
various I MIl l C j.a 
[M]/[C] yieldb Mn x1o-4c PDJC trans/cisb 
25 >95% 1.09 1.50 5.4 
100 >95% 6.59 1.96 4.1 
1000 83% 9.12 2.29 3.1 
3000 78% 15.5 1.83 2.6 
4000 71% 20.6 1.73 2.4 
a[3)=1.2M in CH2CI2 , 25 ·c, 4 h . bDetermined 
from 1H NMR spectra. co etermined by GPC, 
polystyrene calibration. 
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To test thi s, the po lymerization of 3 with mono mer to catalys t rati os between 25/l 
and 4000/l was pe rfo rmed and the results are shown in Table 2. The mo lec ul ar weights 
d id increase as the [M]/[C] was increased to yield po ly mers w ith M n·s be tween I 0 ,900 
and 206.300. POI values were all be tween 1.7 and 2.3. As the catalys t loading was 
decreased, the pol yme r yie lds (dete rmined by 1H NMR spectroscopy) decreased from > 
95% ([M]/[C] = 25/ l ) to 7 1 o/o ([M]/ [C] = 4000/ l ). 
A t a low loading of 1, the po lymerizati on o f 3 sometimes resulted in very low 
yields of 6 . Inspection of the c rude reac ti on mi xtures in these cases revealed the presence 
or a sma ll amount (< 5% ) of a viny l ethe r species suggesting that isomeri zati on of an a ll y l 
ethe r (from monomer and/or po lymer) to a vinyl e ther had occurred . It is known that the 
reacti o n o f 1 with a viny l ethe r fo rm s the me tathesis- inac ti ve RuCI 2(=CHOR)(PCy3h 
com plex.5h In fac t, as prev io us ly indi cated . ethy l vi nyl e the r is frequentl y used to 
termi na te me tathesi s reac tions catal yzed by 1. The iso me ri zati on and subseq uent 
termi nation of 1 (Equation I) could the refore compete with po lyme ri zation resulting in 
low yie lds of 6 . Occurrence of thi s on a small scale would be more proble matic w hen 
using low concentrations of catalyst. 
allyl ether vinyl ether 
To study thi s poss ib ili ty , 3 was po lyme ri zed in C D, C I, and the pro pagating 
a lky lide ne of 1 was monito red by 1H MR spectroscopy. In the cases w here low yields 
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were obtained, a peak at 14.45 ppm was observed in the 1H NMR spectrum in addition to 
the desired a-H a lkylidene resonance at 19. 19 ppm. The propagating carbene resonance 
dec reased in intensity as the peak at 14.45 ppm increased in inte nsity until no propagating 
carbene was observed.8 The peak at 14.45 ppm compares very c lose ly to the a-H peak of 
RuC I/ =CHOCH 2C H 3)(PCy3h at 14.51 ppm obtained by the reaction o f 1 with e thyl vinyl 
e the r in CD2CI2 . Thi s supports the hypothes is that isomeri zation to a vinyl ether and 
subsequent termination of 1 was occurrin g in these cases. The reason for th is 
isomerization is not yet understood, a lthough it is probably related to ruthenium hydride 
impurities in the catalyst.9 However, thi s detrimenta l reac tion was not problema tic unless 
very low concentrations o f 1 (hi gh [M]/ [C]) and impure cata lyst were used. 
0a~o~o~o~ 
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M etathesis yie lds pol yethers with unsaturated backbones, and in order to obtain 
saturated backbones, the polymers must be hydroge nate d. First thi s was atte mpted by 
subjecting 6 to hydrogen in the presence of palladium o n carbon , w hi ch resulted in 
quantitative hydrogenati on . However, it was apparent by 1H MR that a s ignifi cant 
amount of chain sc iss io n had al so occurred . Quantitative hydrogenation of 6 us ing 
C rabtree 's catalys t,10 however. gave the desi red saturated polyether (7 ) in 66% isolated 
y ield. o chain scission produc ts were apparent in the 1H NMR spectrum. The T g of the 
resulting po lymer was s li ghtl y lower than 6 (-65 OC versus - 59.0 OC respectivel y). 
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Depolymerization. One key feature of olefin metathesis is that , unlike other 
carbon-carbon bond forming reactions, the reversible formation and breaking of a carbon-
carbon double bonds a llows the thermodynamic product distribution to be a tta ined. This 
concept, w ith respect to template-directed RCM , implies that unproductive coupling (i.e., 
" mistakes" w hich do not result in the desired product) can be "corrected" to yie ld the 
desired product if the template effect is a significant driving force. It is a lso known that 
w hen dilute soluti o ns of polymers obtai ned via ROMP are reac ted with an o lefin 
metathesis catalyst, an equilibrium concentration of cyc li c monomers is re-establi shed. ' ' 
In an attempt to exploit these processes, the reactio ns between polymer 6 and catalyst 1 in 
the presence and absence of Li + were undertaken. It was antic ipated that the te mplate-
directed " backbiting" of 6 should y ie ld macrocyc le 3 . In the absence of a template, 
"backbiting" should result in a complex mixture of macrocyc les of various ring s izes and 
linear o ligomers. 
0.02 M, 50 "C 
Scheme 6. Depo lymerization of polye ther 6 to reform 3 (cis). 
Performing the lithium ion-templated degradation of 6 under the same RCM 
conditi o ns e mployed in the convers ion of 2 to 3 resulted in a nearly quantitative 
conversion of 6 to the cis isomer of 3 (83 % isolated yie ld) (Sc heme 6). Polymer 
degradation in the absence of aLi+ template gave only -20% combined yield of both cis 
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and trans 3, the remainder consisted of low mo lecul ar weight polymer (Mn = 9.000) and 
o li gomers. In addition to demonstrating the concept of template-directed backbiting , thi s 
resu lt also illustrates the concept that if " mi stakes" (i.e. , ADMET dimers) are formed 
during the template-directed RCM of 2 , they can in principle be converted to 3 via thi s 
process . 
Toxicity of Polyether 6. PEG is a nontoxic po ly mer that is FDA approved for 
human consumption .2·3 Since the pol yethers synthesized from 3 contain PEG segments. 
the toxicity of 6 was in vestigated and compared to PEG. 
A quantitative in vitro cytotoxicity test12 of 6 (M,- 69,000) was undertaken using 
normal human dermal fibrob last ( HDF) ce ll s . HDF cell s were harvested usin g 
trypsin/EDT A, suspended in serum-supple mented media, and seeded into 24-well ti ssue 
c ulture po lys tyre ne (TC PS) plates at a de ns ity of 35,700 ce ll s/em". The ce lls were 
allowed to spread for 24 hours. at w hich time the medi a was re moved . Fresh medi a and 
sterilized solutions of 6 or PEG in HBSS of vari ous concentrations were added to the 
well s. The cel ls were incubated with the pol ymers fo r 24 ho urs before the polymer 
solutio ns were removed . The well s were the n washed with HBSS , and the amounts of 
live ce ll s were dete1mined us ing a li ve/dead assay. 
Both calcein AM and e thidium homodimer were added to the well s to a llow 
different iati on between the li ve and dead cell s. Under fluorescein excitati o n opti ca l 
filters , live cell s fluoresce blue/green (A= 485 nm) due to es terase activation of calcein 
AM. The nuc lei of dead cell s fluoresce red (A= 530 nm), as ethidium ho modimer passes 
th rough the compro mised membranes o f the dead cell s o nl y. B ecause the exc itati on 
wavelengths are resolved for these two compounds, the number of li ve and dead cell s in 
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each well can be counted. The average percent of live cells for 6 was compared to the 



























Figure 1. Percent live HDF cells incubated with increasing concentrations of 6 or 
PEG. All values are an average o f 2 wells. PEG is the average of wells containing 
PEG molecular weight of 20K and 1 OOK. 
The results (Figure 1) indicate that polymer 6 has similar toxici ty to PEG up to 
0. 1 wt.% (0.5 mM based on the repeat units) polymer. However, at 1 wt.% (5 mM based 
on the repeat units), 6 was toxic to the cells while PEG was not. The polymer in this 
study was synthesized using 0. 1 equivalents ([M]/ [C]= 100) of 1, and ruthenium is known 
to be toxic.13 Although it was possible that the polymer itself was toxic, it was thought 
that residual ruthenium contained in the polymer was causing the response. To test this, 
6 was synthesized using a lower concentration of catalyst (0.001 equivalents of 1) and the 
toxicity of the resulting polymer was studied. 
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Figure 2. Number of live HDF cells per well incubated with various concentrations 
of 6, RuCI3, and PEG. The values are x 10
3 cells and are an average of 3 wells. The 
RuCI 3 concentration was 79.2 ~Min PBS buffer. 
Polymer 6 was synthesized using a 1000/1 initial monomer to catalyst ratio. The 
amount of ruthenium in a 1 wt.% solution of 6 was quantified by ICP-MS. It was found 
by comparing to ruthenium standards that after purification, a 1 wt.% solution of 6 
contained 79.2 ~M of residual ruthenium. As a control, the toxicity of a 79.2 ~M 
solution of RuCI3
14 was assessed along with 1 x 10·5 to 1 wt.% solutions of 6 and 1 wt.% 
solutions of PEGs using the same method described above. Because all of the cells 
appeared alive when observed by phase contrast microscopy and were adhered normally 
with several focal contacts, the cells were enzymatically removed from the surface and 
counted by an automatic cell counter. The results showed (Figure 2) that the polymer 
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synthesized with a lower catalyst loading (lMl/[C]= I 00011 versus 10011 ) was nontoxic 
to the HDF cell s to at least at 1 wt. %. The concentration of ruthenium in the 1 wt.% 
solution was also nontoxic . From these results it appeared that toxicity was decreased 
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Figure 3. Percent live HDF cells incubated with increasing solutions of 6, RuCI3, and 
PEG in PBS that have been aged over one month. The values are an average of 3 
wells. The RuCI3 concentration was 79.2 J!M in PBS buffer. 
However, when the tests were repeated for the solutions kept at room temperature 
for over a month, a different result was obtained. It was found that a l wt.% solution of 6 
([M]/[C]=lOOO) was now toxic to the HDF cells (Figure 3). The cells were still alive 
after being subjected to the RuC13 (79.2 J!M) solution that was stored for over a month, 
suggesting that the ruthenium was not causing the toxic affect. The same results were 
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obtained if the so lutions were made the day of the experi me nt fro m bulk polymer that 
was kept at room temperature fo r over a month . Thi indicates that 6 has a li mited shelf 
li fe both in soluti on o r in the bulk , and that over time, the polymer degrades into toxic 
s ide-products. Various autooxidatio n reacti o ns can be envi s ioned that would resu lt in 
toxic degradati on products. The she lf life of the mate rial s may be increased by 
hydrogenat ing the double bonds, as described above. A lte rnative ly, the pol ymer may be 
in ve tigated for applications w he re low concentrations or short therapeutic time periods 
are needed. Also, the re are many nonbio logical applications for these polyethers. 1" 
Summary 
Wate r-solubl e polyethers were synthesized us ing a tandem approach in volvi ng 
temp late-d irected RCM fo ll owed by ROMP. ROMP of an unsaturated analog of 12-
c rown-4 synthesized by templated directed RC M , yielded polymers contain ing PEG and 
butenediol units. B y altering the catalyst loadings, the po lymer was synthesized in a wide 
range or molecular weights. ADMET was no t as effecti ve and resulted in low molec ular 
we ig ht o li gomers and pol ymers. Templ ate-directed depolymeri zati o n of the unsaturated 
polyethers quantitatively reformed the starting crown ether monomer. Toxicity testing of 
the polymers showed that the materials are nontoxi c up to I wt. % when made with a low 
catalyst loading. although the un saturated polymer has a lim ited she lf life. 
Experimental Section 
Materials. All y l bromide, sodium hydride , lithium perchlorate, ethyl vin yl ether, 
and ruthenium standards was purchased from Aldrich and used as received. Triethylene 
-+6 
g lycol and ethylene gl ycol were purchased from Aldri ch and dried over 4 A molecular 
sieves (Linde) . C rabtree's cata lyst was purchased from Stre m Che mical s and used as 
received . Dry tetrahydro furan (THF) and methylene chlo ride (CH2Cl2) were rigorously 
degassed and passed through purifi cation columns.15 All o the r solvents were purchased 
fro m EM Science and used as received. Trypsin/EDT A w as purchased from Sigma. 
Dul becco 's modified eag le medium (DMEM) and o ther c e ll cu lture reagents were 
purc hased fro m GIBCO and used as received. The sterile flas ks and plates were 
purc hased from Becton Dic kin son Labware. All other sterile c ulture material s were 
purc hased from Falcon. The human derma l fibroblast neo natal ce lls isolated from 
foreskin ti ssue from a s ing le male donor were purchased from C lonetics. The li ve/dead 
kit was obtained from Mo lecular Probes. 
Techniques. Unless o therwise noted , all operations were canied out under a dry 
nitrogen or argon atmosphere . Dry box operations were performed in a nitrogen-filled 
Vacuum Atmospheres dry box. Column c hromatog raphy was performed using s ili ca gel 
60 (230-400 mesh) fro m EM science. 'H NMR (300. 1 MHz) and 13C NMR (75.49 MHz) 
spec tra were recorded on a Ge neral Electric QE-300 spectro meter. 1 H NMR (399.65 
MH z) spectra to monitor poly me ri zations were taken on a JEOL GX-400 spectro meter. 
Chemical shi fts are reported downfield from tetramethy lsilane (TMS). Po lymer 'H MR 
spectra we re o btained usin g a pul se de lay o f 60 sec. Infrared spectroscopy was 
perfo rmed on a Pe rkin El mer Paragon 1000 FT-IR spectro mete r using a thin film of 
sam ple cast o n a NaC l pl a te. Hi gh-resolution mass spectra were pro vided by the 
So uthern Ca liforni a Mass Spectrometry Fac il ity (Uni versity o f C alifornia , Rivers ide). 
Ge l permeation chromatographs were obtained with CH 2C l2 as the e luent (flow rate o f 1 
47 
mL/min) us ing an HPLC system equipped w ith an Altex mode l 11 OA pump, a Rheodyne 
model 7 125 injector w ith a I 00 ~tL injectio n loop. two American Po lymer Standards I 0 
micron mi xed bed columns, and a Knaue r diffe renti a l refrac to mete r. The mo lec ul ar 
vveig hts and polydi spe rs ities were reported versus monodispersed polystyrene standards. 
Differentia l scann ing calorimetry was measured on a Perkin-Elmer DSC-7. The results 
are given for the second heating using a scan rate o f 20 OC/min . for a ll cases. All ce ll 
manip ulation s were perfo rmed in a verti cal laminar fl ow hood. Ph ase contrast 
microscopy was perfo rmed on an Ol y mpus C K 2 , I OOx mag nifi catio n. Fluo rescence 
microscopy was performed on a Zeiss Microscope using 485 and 530 nm opti cal filte rs. 
Inducti ve-coupled mass spectrometry data was obtained on an E lan 5000A . T he samples 
were weighed on a microbalance and diluted in 1% nitric ac id. Results for Ru isotopes 
99, 101 , and 102 were obtained and compared to standards. 
Monom er Synthesis 
Synthesis of trie thylene glycol dia lly l e ther (2). To a room temperature, st irred 
so luti on of a lly l bromide (4 mL, 46.2 mmo l) and sodium hydride ( 1.35 g, 56.3 mmo l) in 
dry T HF ( I 25 mL) was added, over a period of I h, a soluti on o f t riethylene g lycol (3.0 
mL, 22.5 mmo l) in T HF (25 mL). The reaction was a llowed to stir at roo m temperature 
for a tota l of 12 h. THF was re moved in vacuo, and the c rude product was taken up in 
ether and extracted wi th water 3 times. The ether layer was separated, dried over MgS0 4 , 
a nd the so lvent removed in vacuo. T he crude product was purifi ed by column 
c hromatography (ether e luent) to afford 3.52 g (70 %) of 2 as a colorless oil. 'H NMR 
(CDCI3) 8 5.82-5.95 (m, 2H). 5. 13-5.28 (m, 4H), 3.98-4.01 (m, 4H), 3.56-3.66 (m, 12 H). 
48 
uc NMR (CD CI 3) 8 134.65 , 11 6.99, 72. 12, 70.52, 69.30. IR: 3072, 2864, 1462. 1420, 
1348 . 129 1, 1249, 11 09, 995 , 9 17 . HR MS (CI) calcd fo r (MH t 23 1.1 596, fou nd 
23 1. I 596. 
Synthesis of 1,4 ,7,10 tetraoxa-cyclotetradec-12-ene (3). THF (59 mL) was 
added to 2 (3 g, 13.0 mmo l) and LiCIO~ (6.9 1 g, 65.2 mmo l) and the soluti on stirred for 
30 min o r until a ll solids had di sso lved. [Precawion should be used when handling 
perclilorate salts due to the explosive nature of these compounds; a blast shield should be 
used at all times.] Dry C H2Cl2 (580 mL) was added to the flask followed by a sol ution 
of 1 (537 mg, 0.652 mmo l) in C H2Cl2 ( I 0 mL). The mi xture was heated to 40 OC for 90 
min before cooling to room tempe rature , adding- I mL of ethy l vin yl ether and stirring 
for an additional 30 min . The so luti on was extracted with a minimal amount of water to 
remove the lithium, the organic layer was dried over MgSO~ , and the solvent was 
removed in vacuo. The residue was subjec ted to chromatography (ether e luent) to yie ld 3 
as a brown liquid in 74-99 % yield. 1H MR (CDCI3) 8 5.75-5.78 (m, 2), 4 .29-4 .30 (m, 
4H), 3.64-3.72 (m. 12 H ). 13C NMR (75 MHz, CDC I3) 129.80, 71.77 , 70 .2 1, 66.77. 
HRMS: calcd: 203. 1284 (m+H+) , obsd. 203. 1290 (m+H+). 
Polymer Synthesis 
Experimental procedures and data not rep011ed within the text are reported below. 
ADMET of 2. In a round bottom, 3.6 mg of 1 (0.0044 mmol ) in a minimal 
amount of C H2Cl2 wa added to 20 mg (0.087 mmol) of 2. The flask was evacuated to 15 
mtorr and the mi xture was heated in an oil bath a t 50 OC for 3 h. Ethyl vi ny l e ther (0.1 
mL) was added and the mi xture stirred for 30 min. The e thyl vi ny l ether was removed 
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under vac uum and the 1H NMR spectrum of the crude reaction mixture taken . The 
polymer was isolated by precipitation into co ld ethe r, collected by centri fugation , and 
dried under vac uum. Analytica l data, except fo r the GPC results, of the isolated polymer 
were ident ical to that obtai ned for 6 (vide infra). 
ROMP of 3 with various [M)/[C) (6). In a nitrogen-filled dry box, a solution of 
complex 1 in CH2C l2 (to g ive a fin a l monomer conce ntration of 1.2 M) was added to 3 
and the reaction mi xture was stirred at room temperature for 4 h. T he [M]/[C) was varied 
between 25 and 4000. T he polymerizations were terminated by ethy l vinyl e ther and the 
so luti ons stined for an additional 15-30 min. The polymers were prec ipitated into cold 
ether, stirred for 15 min , subjected to centrifugati on, washed with co ld ether (3x), and 
dried under vacuum. 1H NMR (CDCI3) 8 5.78-5.81 & 5.70-5.73 (trans & cis, both m, 
2H), 4.08-4.09 & 4.00-4.02 (trans & cis , both m, 4H), 3.56-3.66 (m, l 2H). IR: 3570, 
2864, 1457, 1353, 1296, 1249, II 14, 979, 88 1, 855 cm·1• 
Hydrogenation of 6 (7 ). The hydrogenat ion of 6 was undertaken using 
Crabtree's catalyst (2.5 mol % ) according to literature procedure. 16 1H NMR (CDCI 3) 
8 3.54-3.63 (m , 12H), 3.43-3.46 (m , 4 H), 1.59- 1.63 (m, 4H). IR: 3926, 2866 , 1479, 
1449, 135 1, 1297 , 1247 , 111 5,844 cm·1• 
Templated-Depolymerization of 6. The same procedure as for the synthesis of 3 
was fo llowed, w ith 75 mg (0.37 mmol) of polymer 6 as the substrate. 1 H NMR 
spectroscopic analysis of the crude showed a quantitative conversion of pol ymer 6 to 
macrocyc le 3 . T he crude was di ssolved in CH2CI2 and washed several times w ith 
deionized water. The organic layer was concentrated under vacuum and purified by silica 
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co lumn chromatography (EtOAc) to afford 62 mg (83%) of 3 . Analytical data for the 
product was identical to those reported fo r 3 above. 
Cell Culture 
Cell Maintenance. HDF cell s were maintained in DMEM supple mented with 
10 % fe ta l bovine serum , 400 U/mL penic illin , and 400 mg/mL s treptomycin in an 
incubator at 37 OC and 4.9% C02 . Subculturing was accompli shed by rinsing the cells 
with HEPES buffered saline solutio n (HBSS), enzy matically removing them from the 
surface with trypsin/EDT A, and neutralizi ng the tryps in wi th supplemented DMEM. The 
cells were suspended in DMEM and added to 25 cm2 flasks. 
Toxicity Test. HDF cells of passage 4-7 were harvested with trypsi n/EDTA, 
seeded onto 24 we ll TCPS p lates, and incubated for 24 h after which time the media was 
w ithdrawn. Fresh supplemented DMEM and polymer solutions in HBSS that had been 
steri le fi ltered through 0.2 jlm fi lte rs were placed into the wells. The cells were 
incubated for another 24 h before the polymer solut ions were removed. The well s were 
washed w ith HBSS buffer and aspirated to assure complete re moval of the medium and 
polymer. The morphology was observed under phase contrast mi croscopy. The cells 
were then counted by one of the assays described below. 
Simple Cell Counting Assay. If all the cells appeared normal and were adhered 
with several focal contacts (not rounded), the fo llowing s imple cell counting assay was 
undertaken. The cells were removed using trypsin/ETDA and the number of cells per 
we ll counted by a automatic cell counter. 
Live/Dead Counting Assay. If some of the cells were ro unded and appeared 
dead, the fo llowing counting assay was undertaken . A solution containing 2 jlM calcein 
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AM and 4 11M e thidium homodimcr in HBSS was freshly prepared and kept in the dark 
until use. 100 J..!L of the live/dead so lution was added to each well, and the plates were 
incubated for 10 min in the dark. T he cell s were viewed usi ng fluore scence microscopy. 
For each view, the cel ls were counted first with the 485 nm fil ter fo llowed by the 530 nm 
fi lter. A cell was deemed li ve if it was colored g reen/blue w hen viewed through the 485 
nm fi lte r and dead if the nuc le us was stained red w he n viewed thro ugh the 530 nm filter. 
At least 3 views per we ll were counted. The pe rcent live ce lls was determined by 
dividing the total number of live cells by the number of li ve and dead cell s. 
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Chapter 3 
Synthesis of Peptide-Substituted Poly ethers by Ring-Opening 
Metathesis Polymerization of Unsaturated Crown Ethers+ 
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Abstract 
Polyethers of various backbones and pendent peptides were synthesized by a 
tandem approach of ring-c losing metathesis (RCM) followed by ring-opening metathesis 
polymerizati on (ROMP) using RuC I2(=CHPh)(PCy_,h (1 ) as an initiator. An 
unsubstituted benzocrown ether and a benzocrown ether substituted w ith a phenylalanine 
methyl ester were synthesized in good yields using a lithium ion as a templ ate and 1 as a 
catalyst by RCM. From the pheny lalanine methy l ester crown ether. crowns substituted 
wi th a phenylalanine carboxylic acid and a arginine-glycine-aspartic acid (RGD) peptide 
were made. ROMP of the unsaturated crown ethers formed the respective polyether 
homopolymers. The copo lymerizat ion of these monomers with an unsaturated analog of 
12-crown-4 formed copolymers, w here the compositi ons cotTesponded to the feed ratios 
of the monomers. In thi s way, po lyethers of various backbones and concentrati ons of 
ami no acids were synthesized. 
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Introduction 
There are a number of applications, such as drug delivery, 1 w here having 
polycthers functionali zed along the backbone is desirable; yet the number of synthetic 
methods to produce such polymers arc few. T ypicall y, modification i s at one or both 
ends of the pol ymer, limiting the attachment sites for a linear po ly mer to two. 
Po ly(oxya lky lene )s such as poly(cpichlorohydrin) have been synthesized and 
subsequently modified with a number of functional groups. 2 H owever, since reactions 
on a polymer chain can prove difficult and may not result in quantitative conversions, it 
i s advantageous to polymeri ze functionali zed monomers. In Chapter 2, the synthesis of 
unfunctionalized polyethers by a tandem approach of template-directed RCM followed 
by ROMP was described. Thi s chapter di scusses the synthesi s of polyethers with 
different backbones and pendent amino acids using this approach. 
As was described in Chapter I , ruthenium alkyl idenc 13 i table in the presence 
of many functional groups and is active in many so lvents including water.J Due to the 
development of thi s catal yst and others, the ROMP of monomers w ith biologically 
rel evant units has been recently undertaken. As described in Chapter I , polymers w ith 
pendent sugars have been synthesized5 and used to exp lore protein -saccharide 
interacti ons. 5"·d Additionally, pol ymers substituted with nucleotide bases/; antibiotics,7 
and amino acid esters8 have been prepared using ruthenium and molybdenum complexes. 
These examples have been based on polynorbornene and poly(7-oxanorbornene) 
backbones. H owever, polyethcr backbones may ha ve advantages compared to 
polynorbornenes, since polycthcrs are flexible and water soluble. If the polyethers 
contain poly(ethylene g lycol) (PEG) segments, they may also be biocompatible and 
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nontoxic. Thi s chapter describes the synthesis of polyethers wi th PEG units substituted 
with peptides. Polymers w ith pendent pheny lalani ne (Phe, F) and the cell-binding protein 
fragment described in Chapter I . arginine-g lycine-asparti c acid (Arg-G iy-Asp, RGD), 
were synthesized. 
Results and Discussion 
Monomer Synthesis. The synthesis of functionali zed cx,w -diene precursors for 
RCM from tartaric ac id or serine was not successful: however, the dienes were readil y 
prepared from catechol deri vati ves. The synthes is of l ,2-bi s-(2-allyloxy-ethyoxy)-
benzene (4 ) and I ,2-bi s-(2-ally loxy-ethyoxy)-benzene substituted w ith a pendent 
pheny lalanine meth y l ester (5) were undertaken as shown in Scheme I . Phenyla lan ine 
methyl ester hydrochloride salt was coupled to 3,4-dihydroxyhydrocinnamic acid using 
standard peptide coupling procedures employing HOBT and DCC in C H 2Cl2 to give 2 in 
75% y ield (Scheme I A ). Ethylene glyco l w as treated with all y l bromide and base to 
form the eth y lene glycol monoall y l ether ; the alcohol was subsequentl y converted to a 
tosy l group to gi ve 3 (38% overall yield) (Scheme I 8). Reacti on of 3 with catechol or 2 
in the pre ence of potassium carbonate in DMF gave 4 (6 1% y ield) and 5 (72% yield), 
respectively (Scheme I C). The synthesis of the unfuncti onalized diene, 6 , was 









1. KOH, AllyiBr 
~0~0Tos 
2 . p-TosCI, Et3N, 
DMAP, CH2CI2 
85-90 ·c 
3 (38% overall) 
4 , R = H (61 %) 
5 , R = CH2CH2CONHCH(CH2Ph)COOCH3 (72%) 
Scheme 1. Synthes is o f unsubstitutcd and phen ylal anine substituted a,w-dienes. 
Template-directed RCM using a lithium ion (LiC I O.~) as a template and complex I 
as a cata lyst was undertaken to form the unsaturated crown e the rs (Sche mes 2 and 3). 
First. the unfunctionali zed c rown e ther 7 was synthesized from 6 (Scheme 2) as described 
in C hapte r 2. 9 It was demonstrated that the lithium io n prco rganized the diene for RC M , 
g ivin g hig h y ie lds and se lecti vity for the cis isomer ( 10011 c isllrans). In a s imil ar 
ma nner, 4 was con verted to 8 in quantitati ve yield as dete rmined by 1H NMR 
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spectroscopy (Sc he me 3): howe ver, the iso lated y ie lds were muc h lower (50-63% ). 
Template-directed RCM of 5 afforded 9 in 7 1% isola ted y ield. In both cases, the cis 
isomer was formed preferentia ll y (94/6 cisllrans). 
7 
Scheme 2. Synthesis of unfuncti ona lized c rown ether by te mplate-directed RCM. 
1 (5 mol%), LiCI04 
4 or 5 8: R=H 
9: R=CH2CH2CO-Phe-OCH3 
Scheme 3. Synthesis of unsubstituted and pheny lalanine substituted c rown e thers by 
template-direc ted RCM. 
It was described in C hapte r 2 that the synthesis of 7 in the absence of a lithium 
10 11 (a ll other condition s the same) favored the lrans isomer (38/62 cisl!rans) and the 
yie ld obta ined was much lower (39% yie ld). 9 The te mplating effect of the lithium ion in 
thi s reaction was furthe r confirmed w hen the synthesis of 8 or 9 was performed w itho ut a 
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lithium ion and monito red by 1H MR spectroscopy. The overall y ields of the c rude 
mixtures obtained from the 1H NMR spectrum were lower than the RC M performed in 
the presence of a lithium ion (73% for 8 and 60% for 9 ). In both cases, the trans isomers 
(armed predominatel y w ith a cis/trans ratio o f 35/65 fo r 8 and 46/54 for 9. 
In RCM , an equilibrium exists between the rin g-c losed and the r ing-opened 
spec ies.9 · 10 The template effect, coupled with running the reaction under conditions of 
high dilution, fa vored the ring-closed product over the ring-ope ned produc t in these 
examples.9 Thi s was de monstrated in both the syntheses of 7 and 8 where onl y the ring-
c losed product was observed at the e nd of the reaction . However, in the synthesis of 9 , a 
linear oligomer was de tec ted in the c rude reaction product by 1H NMR spectroscopy. 
Even upon rigorous purificati o n o f the substrate , thi s o li gomer pers isted as I -5% of the 
final product. 
The yie ld of the c rown product over o ligomer side products was the greatest when 
the substiwe nt (R, Sc heme 3) of the diene substrate was CH ~CH ~- Phe-OCH3 (5 ). For 
example, w hen R = COOH. COOC H3, or CH 2COOCH,, the desi red RC M product yie lds 
were less than 32%, and signifi cant amounts o f both linear and cyc li c o li gomers were 
detec ted in the c rude reaction mixtures by 1H NMR spectroscopy. This was true whether 
a lithium ion was present in the reaction mixture o r not. It was observed by 1 H MR 
spectroscopy that the subs trates were not templa ted by the lithium io n.11 For the 
substituted produc ts. e ithe r the spacer, bu lk of the phenylalanine, or both were necessary 








Scheme 4. Generati on of pheny lalanine carboxyli c acid monomer. 
In order to obtain the crown ether w ith a pendent phenylalanine carboxyl ic ac id, 
the saponification o f 9 was carried out (Scheme 4). Reacti on of 9 w ith hydroxide base 
gave 10. The linear oligomers in the starting material were removed during product 
isolation to af ford 10 in 75% yield. 
H2 N-R(Pbf)-G-D(t-Bu)2 
10 15 
Scheme 5. Synthesis of an RGD-containing crown ether monomer. 
From 10, the RGD containing crown ether was made (Scheme 5) . The R(Pbf)-G -
D(1-Bu)2 peptide was synthesized by standard so lution-phase FMOC chemistry ,
12 and 
then coupled to 10 wi th DCC and HOBT to afford 15 in 66% y ield. The protected 
monomer w as readily soluble in organic solvents such as CH 2C I2 . 
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Polymer Synthesis and Characterization . The ho mopol ymeri zation of 7 to 
form the unfunc tionali zed po lyether 11 (Sche me 6) was desc ribed in Chapter 2. In th is 
chapter, the sy nthesis of function a li zed po lyethers is desc ribe d. In a typical 
polymerization , compl ex 1 in CH2Cl 2 was added to a v ial containing mono mer o r a 
mixture of monomers. The soluti ons were stirTed for 4-5 hours and ethyl viny l e ther was 
added to terminate the reactions. T he polymers were isolated by prec ipitation into ether 
chi lled to 0 oC. Ma ny of the pol ymers were s lightly solub le in ether, and thus the isolated 
yie lds were decreased by thi s purifi cation process. 1' T he po lymers gene ra ll y were 
viscous o il s or sticky solids at room te mperature. 
T he homopolymerizati on of 8 and copol ymerizations of 7 and 8 were undertaken 
(Scheme 6) and the results are given in T able l . The homopo lymeri zati on of 8 gave a 
54% isolated yie ld of polymer 12e with aM" of 16 ,300 and polydispersity index (POI) of 
1.57. T hermal analysis by DSC indi cated that po lymer 12e possessed both a g lass 
trans ition (Tg = -7.9 OC) and a melt ing point (T
111 
= 8.0 OC). Copoly mers 12a-d were 
synthes ized in good yie lds between 48% and 68% . T he Tg of copolymers 12a-d vari ed 
between those of the two homopolymers (11 = -59.0 OC and 12e = -7.9 OC). However, the 
c rys talli zation of the copolymers was inhibited by th e incorpo ration of 7 , and only 
copolymer 12d conta ining 80% of 8 exhibited a me lting point (Tm = 6.6 OC). The POI' s 
and lrans to c is rat ios were all s im ilar and ranged from 1.57- 1.84 a nd 2.6-3.0/l, 
respectively. 
An important component of a copoly meri zat ion reaction is the final concentrati on 
of the monomers in th e po lymer (copo lymer compos ition ) re lative to the ini tial 
concentrati ons of the monomers (feed composition ). 14 A des irab le characteri stic for the 
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copolymers in thi s research was that the incorporatio n into the copol ymer of the two 
monomers be dependent on the feed composition . ln thi s way, the copol y mer 
compos ition (and pende nt groups) could be c hanged b y s imply a ltering the initial 
monomer concentrations. Thi s was the case as demonstrated by the resu lts for 12a-d; for 
each copolymer the concentration of 8 incorporated was the same as that in the feed. 
+ 
7 
8, 9 , or 10 
n 0 : R = H (12a-d), 
CH2CH2CO-Phe-OCH3 (13a-d), or 
CH2CH2CO-Phe-OH (14) 














































































































































































































































































































































































The polymer yields decreased w ith increasing amounts o f 8 (Table \ ) . Tne 'H 
MR spectra of the crude reaction mixtures quenched after 5 hours indicated the 
presence of both polymer and unreacted 7 and 8 (residual monomers were in the same 
rati o as ini tial ly). When the homopolymerization of 8 was carried out for 23 hours, the 
'H N MR spectrum of the crude reaction mixture indicated a > 95 % y ield of 12e 
(compared to a 58% y ield after 5 hours). Thi s result indicates that higher yields for these 
polymers may be obtained by using longer polymeri zati on times. 
The homo- and copol ymerizati ons o f 9 and 7 were conducted (Scheme 6) and the 
results are gi ven in Table 2. The homopolymerization of 9 using a [M]/ [C ] of 50/l gave 
13e in 79% isolated yield with a molecular weight o f 3,460 and POI of 2.00. The GPC 
trace contained a sli ght low-molecular weight shoulder. The copolymeri zations with 
vari ous concentrations of 9 in the feed gave pol ymers 13a-d in good y ields. Analogous 

































































































































































































































































































































































































































































































Similar co po ly mer 13e, the molecular weight distributi ons for the copoly mers 
were all broad, and the GPC traces of 13b-d exhibited either a high or low molecul ar 
'"eight houlder . Copo lymer 13b had the broadest molecular weight distributi on and 
largest shoulder as shown by the G PC trace in Figure J a. A s di scussed earli er , 9 
contai ned a small amount of a linear oligomer w hich could have caused chain transfer 
reactions during ROMP.15 After only 5 hours o f reaction time the polymeri zati ons would 
not have reached eq ui librium, leaving some long chains and some short chains.15 ' 16 
T ypicall y ROMP chain transfer reacti ons proceed for hours to days before reaching 




15 min. 20 min. 
Figure 1. G PC traces for polymers 13b and 13f: a) M onomers polymeri zed for 5 
hour w ith [M]/ [C ]= l OO (13b); b) Polymer (13b) subj ected to [repeat unit]/ [C]=25 for 
I week; c) M onomers polymeri zed for J week w ith [M]/ [CJ=25 (13f) . 
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With the additi on of fresh cata lyst to the pol ymers and longer reac tion times, the 
chain s could equil ibra te to narrower molecular weight distribut ions due to bac k-biting 
a lo ng the polyme r c hain .15· 16" To in ves tigate thi s, cata lys t 1 ([repeat unit]/[C]=25) 18 and 
isolated pol ymers 13a-e were reacted for 1 week . The compositions of the pol ymers did 
not c hange. However, the res ults g iven in Table 2 demons trate that the mo lec ular 
we ig hts lowered and most s igni ficantl y , the POls narrowed and mo lecular we ig ht 
distributions were monomodal. This change was most marked fo r polymer 13b where 
the POl went from 4. 10 wi th a high molec ul ar weight shoulde r to 2. 18 and mono modal 
(Fig ure I a, b). Addit ionally, the trans to cis ratios of eac h of the pol ymers increased 
(Table 2) . Thi s de m o nstrates that the pol y me rs were eq uilibrat in g to the 
thermodynamicall y more stable product. There was no di scernible change in the trans to 
cis ratios for the po lymers stined in solution in the absence of cata lyst. 
In princ iple , the same nanowing effect shou ld occur for the pol ymerization of 7 
and 9 at long reac tion times. To tes t this , 9 (25 % in feed) and 7 were subjected to 
complex 1 ([M]/ [C] = 25) for 1 week. The resulting polymer (13f) contained 24 mol % 
of 9 . A lso, the pol ymer had a monomodal GPC trace with a molecular weight of 12,300 
and a POI of 2.32. The GPC trace compared very c losely to that obtai ned for 13b after 
reacting the pol ymer w ith 1 fo r 1 week (Figure 1 b, c). These results indicate that long 
po lymerization times are necessary for the copol y meri zation of 7 and 9 to obtain 
polymers with monomodal molecul ar weight di stributions. 
The homopo lymerization of 10 was attempted, but y ie lded an intractable mi xture 
due to the low solubility of the mate rial formed. The copolymeri zations of 10 and 7 were 
performed employing 1 with a [M]/[C] of 5011 (Scheme 6). The po ly meri zati on of 10 (8 
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mol % in feed) w ith 7 y ielded polymer 14 w ith -5% of 10 incorporated into the polymer, 
a M il of 6,990 and PDI of 2.04 in 95% y ield. A ttempts at incorporating larger amounts of 
10 resulted in oligomers and poly mers o f l imited so lubility. H owever. the copolymer 
made had a monomodal molecular wei ght distributi on, w hich i s consistent with the fact 
that no linear oli gomers were present in thi s monomer. 
7 + 15 
16 
Scheme 7. Synthesis of a polyether containing the bioacti ve RGD sequence. 
Polymers Containing RGD. The homopolymerization o f 15 resulted in < 5% of 
polymer . Thi s may be due to the rapid degradation of 1 in the presence o f the monomer 
w hich contains many amines, since I is not stable in the presence o f secondary amines. 19 
T he homo- or copo lymeri zat ion of an unprotected RGD containing crown ether was 
unsuccess ful , presumabl y for the same reason. H owever , the copo ly merizati on of the 
protected RGD peptide monomer 15 w ith 7 (Scheme 7) to form 16 w as accompli shed in 
661h isolated y ield. The result ing po lymer contained 15 mol% RGD, w hich is sl ightl y 
higher th an the I 0 mol% in the feed. The M il w as 3,970 (with a slight low molecular 
weight shoulder), the PDf was 1.98, and the trans to cis rati o w as 4.8/ I . 
It is know n that very low concentrati ons, on the order o f 5 pmol/cm~, of RGD 
containing peptides promote cell adhes i on. ~0 Although the homopo ly merization of 15 
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was unsuccessful , copolymer 16, which contains 15 mol% RGD, was synthesized. This 
amount of RGD peptide is significant and could promote cell adhesion when the polymer 
is absorbed on a surface or cross- linked to form a ge l. The preparation of 15 
demonstrates the feasibility o f synthesizing polyether backbone po lymers by ROMP that 
contain bioacti ve peptide substituents. 
Summary 
Polyethers w ith different backbones and pendent peptides were prepared using a 
tandem approach in volving template-directed RCM followed by ROMP. A benzocrown 
ether and a benzocrown ether w ith a pendent pheny lalanine methyl ester were 
synthesized in high y ields wi th se lecti vity for the cis i somer using a lithium ion as a 
template for RCM. Crow n ethers containing pheny lalanine carboxylic acid and the 
bioactive sequence RGD were also made. Various pol yether backbones were produced 
by copolymeri zing different rati os or the benzocrown ether and an unsaturated analog or 
12-crown-4. Exce llent correlation between the initial monomer concentrations and final 
pol y mer compositions was observed. In a similar manner , poly mers with penden t 
pheny lalanine methy l esters and phenylalanine carboxy lic acids were made. In the case 
of the pheny lalanine methyl ester pol ymers, long polymerization times were necessary to 
obtain polymers wi th monomodal molecular weight di stributions. Finall y, the synthesis 
of a protected-RGD containing polyether, wi th 15 mol % of RGD, was described. 
7 1 
Experimental Section 
Materials. Allyl bromide, sodium hyd ride, 4-dimethylaminopyridine (DMAP), 
p-to luenesulfonyl ch loride, triethylamine (Et3N), catecho l, lithium pe rch lorate (LiCIO_.), 
e(ny! vinyl ether, and 1,3-dicyclohexylcarbodiimide (DCC) were purc hased from Aldrich 
a nd used as received . Triethylene g lycol and ethy le ne g lyco l were purchased from 
A ldri ch and dried over 4 A molecular sieves (Linde). 3,4-Dihydroxyhydrocinnamic acid 
was purchased from Aldrich and dried under vac uum at 30 mtorr for 24 h. L-
Pheny lalanine methyl ester hydrochloride and 1-hydroxybenzotri azole (HOBT) were 
purchased from Sig ma and used as recei ved . Anhydrous potass ium c arbonate (K 2C03 ) 
and potassium hydroxi de were purchased from Mallinckrodt and used as received. 
Crabtree's catalyst was purchased from Strem Chemi cals and used as received. T he 
FMOC-protec ted peptides were purchased from Novabiochem and used as received . Dry 
tetrahydrofuran (THF) and methy le ne c hloride (CH 2CI:J were rigorously degassed and 
passed through purificati on co lumns? N,N-Dime thy lformamide (D.MF) was di stilled 
from MgSO_. and stored over 4 A mo lec ular sieves (Linde). All other solvents were 
purchased from EM Science and used as received . 
Techniques. Un less otherwise noted, all operations were carried out under a dry 
nitrogen or argon atmosphere. Dry box operati ons were performed in a nitrogen-filled 
Vacuum Atmospheres dry box. Column chromatography was performed using silica gel 
60 (230-400 mesh) from EM science. 1H NMR (300. 1 MHz) and 13C NMR (75.49 MHz) 
spectra were recorded on a General E lec tric QE-300 spectrometer. 1 H NMR (399 .65 
MHz) spectra to mo nitor polymerizations were taken on a JEOL GX-400 spectro me ter. 
C hemical shifts are reponed downfield from tetramethyls il ane (TMS). Pol ymer 1H NMR 
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spectra were obtained us ing a pulse delay of 60 sec. Infrared spec troscopy was 
performed on a Pe rkin E lmer Paragon 1000 FT-IR spectrometer using a thin film of 
sample cast on a NaC I plate. Hi g h-reso lution mass spectra were provided b y the 
Southern Californ ia M ass S pectrometry Fac ility (Univers ity of Califo rnia, Ri vers ide). 
Gel permeation chromatographs were obtained with CH~CI ~ as the eluent (flow rate of 1 
mL/min) using an HPLC system equipped with an Altex mode l !lOA pump, a Rheodyne 
model 7 125 injector wi th a I 00 )..lL injec tion loop, two American Polymer Standards 10 
micron mi xed bed columns, and a Knauer differenti a l refractometer. The mol ec ular 
weights were reported versus monodi spersed polystyrene s tandards. Diffe re ntial 
scanning ca lorimeter (DSC) was measured on a Perkin -Elmer DSC -7. The results are 
given for the second heati ng using a scan rate of 20 oC/min for a ll cases. 
Monomer Synthesis 
Synthesis of 2-[3-(3,4-dihydroxyphenyl)-propionylamino]-3-phenyl-propionic 
acid methyl ester (2). To a solution of L-phenylalanine methyl ester hydrochl oride 
(1.33 g, 6.17 mmol) in CH~CI~ (30 mL) was added triethy lamine ( 1.3 mL, 9.34 mmo l) 
and the mi xture was stirred for 15 min. Then 3,4-dihydroxyhydrocinnamic acid (1. 12 g, 
6. 17 mmo l) and HOBT ( 1.08 g , 8.00 mmo l) were added and the soluti on stirred until all 
solids had di sso lved. D CC ( 1.27 g, 6 .17 mmol ) was added and the soluti on stirred for 12 
h. The organic layer was filtered, washed with 10% c itric acid (lx), water (2x), and brine 
(lx), dri ed with MgS04 and the solvent removed in vacuo. The res idue was subjected to 
co lumn chromatography (ethy l acetate e luent) to yie ld 1.58 g (75 %) of 2 as a white , 
extremely hydroscopic solid. 1H NMR (CD2CI2) 8 7. 18-7.29 (m , 3H), 6.93-6.96 (m , 2H), 
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6.74 (d, J=8 .1 H z, I H), 6.69 (d, J= 2. 1 Hz, 1H), 6.55 (dd, J=2. 1 Hz, J=8. 1 Hz, 1H), 6.04 
(bd, J=7.5 Hz, 1 H), 4.77-4.83 (m, 1 H ), 3.66 (s, 3H), 3.00-3.03 (m, 2H), 2.76 (t, J=7.5 Hz, 
2H), 2.40-2 .46 (m. 2H). 13C NMR (CD~C I ~) 8 173.83, 172.45, 144.77, 143.38 , 136.35, 
133.22, 129.76 , 129.08, 127.6 1, 120.70 , 115.94 , 11 5.84, 54 .02 , 52.9 1, 38.68, 38 .23, 
3 1.34. IR (NaCl plate): 3342,2947, 1732, 1649, 1602, 1519, 1441 , 1363, 1275, 12 18, 
I 109, 808, 746, 699 cm·1• HRMS (CI) calcd for (MHr 344.1498, found 344. 1497. 
Synthesis of ethylene glycol monoallyl ether. The compound was synthesized 
accordi ng to literature procedure~" with potassium hydroxide (1 6.8 g, 0 .3 mmol), ethylene 
g lycol (1 6.7 mL, 0 .3 mmol), and ally l bromide (26. 1 mL, 0.3 mmol) to afford 12.9 g 
(42%) of the product as a colo rless o il. 1H NMR (CDC I3) 8 5.8 1-5.94 (m, 1H), 5. 13-5.28 
(m, 2H), 3.97-4.00 (m, 2H), 3.68-3.71 (m, 2H), 3.50-3.53 (m, 2H), 2 .52 (bs, 1 H). 
Synthesis of ethylene glyco l allyl ether p-tosylate (3). Ethyle ne g lycol 
monoa ll yl e ther ( 1.7 1 g, 16 .8 mmol) and p-to lue nesul fonyl chloride (3 .20 g, 16.8 mmol) 
were di sso lved in CH2CI 2 (50 mL ), and triethylamine (3.5 mL , 25 .2 mmol) and DMAP 
(catalytic amount) were added. T he soluti on was stirred fo r 12 h be fore water was added 
and the soluti on ac id ifi ed w ith LO% c itric acid to a pH of 7. The organic layer was 
extrac ted with water (2x) fo llowed by b1ine (lx), dried over MgSO_. , and concentrated in 
vacuo to give a colorless, viscous oi l of 3 (3.90 g, 9 1% yie ld). 1H NMR (CDCI3) 8 7.8 1-
7.84 (m, 2H), 7.35-7.37 (m, 2H), 5.79-5.88 (m, 1 H), 5. 16-5.32 (m, 2H), 4 .17-4.20 (m, 
2H), 3.95-3 .98 (m, 2H), 3.63-3.66 (m, 2H), 2.46 (s, 3H ). 13C NMR (CD2C I2) 8 145.65, 
134.89, 133.20, 130 .4 1, 128.39, 11 7 .40 , 72.47 , 70.06, 67.94, 2 1.88. IR: 2868, 1598, 
1452, 1357, 11 90 , 11 77 , 1097, 10 19,920, 8 17, 777,665 cm·1• HRMS (CI) calcd for 
(M+NH_.r 274.1 1 13, found 274. 1108. 
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Synthesis of 1,2-bis-(2-allyloxy-ethoxy)-benzene (4). Compound 3 (838 mg, 
3.27 mmol), catec ho l ( 180 mg, 1.64 mmol), and anhydrous K2C03 (905 mg, 6.55 mmol) 
were dissolved in dry DMF (8 mL) and the mixture was heated to 85-90 OC for 24 h. 
Bh-c.r was added and the so lution washed with 10% NaOH (2x), water (3x), and brine 
(lx), dried over MgSO.~ and the solvent removed in vacuo. The residue was subjected to 
column chromatography (25% ethyl acetate, 75% hexanes e luent) to yield 280 mg (6 1 %) 
of 4 as a colorless o il. 'H NMR (CDCI3) <5 6 .89-<5.96 (m, 4H), 5.88-6.01 (m, 2H), 5. 17-
5.35 (m, 4H), 4 .16-4.20 (m, 4H), 4.10-4 .12 (m, 4H), 3.8 1-3 .84 (m, 4H). 13C NMR 
(CDCI3) <5 148.90, 134 .58, 121.47, 11 6.90, 114.72, 72 .12, 68.74, 68.46 . IR: 3072, 29 16, 
2864, 1592, 1503, 145 1, 1254 , 1218, 1114, 1042,927,798, 798,741 em·' . HRMS (EI) 
calcd for CMr 278. 15 18, found 278. 15 18. 
Synthesis of 2-{ 3- [3,4-bis-(2-allyloxy-ethoxy )-phenyl]-propionylamino }-3-
phenyl-propionic acid methyl ester (5). Using the same procedure as fo r 4 except with 
2 ( 1.20 g, 3.50 mmol), 3 (1.79 g, 7.00 mmol), and K2C03 ( 1.93 g, 14 .0 mmo l) in DMF 
( 17.5 mL) gave the crude product which afte r subjecting to co lumn chromatography 
(70% ethyl acetate , 30% hexanes e luent) gave 1.29 g (72%) of 5 as a white, waxy soli d. 
'H NMR (CDC I3) <5 7.2 1-7.26 (m, 3H), 6.92-6.97 (m, 2H), 6 .68-6.84 (m, 3H), 5.84-5.96 
(m, 3H), 5. 15-5.32 (m, 4H ), 4.85-4.89 (m, 1 H), 4 .06-4. 14 (m, 8H), 3.75-3.80 (m, 4H), 
3.69 (s, 3 H), 3.05 (d, 1=5.4 , 2H) , 2.8 1-2.86 (m, 2H), 2 .40-2 .47 (m, 2H ). ' 3C NMR 
(CDCI3) <5 172.48, 172. 11 , 149.6 1, 148.03, 136.26, 135.29, 134.69, 129.78, 129. 10, 
127.67 , 12 1.69, 117.63 , 11 5.65 , 72.84, 69.67, 69.48, 69.20, 53.55, 52.88, 38.89, 38.4 1, 
3 1.52. IR : 3294,293 1, 2868, 1741, 165 1, 1510, 145 1, 1433, 126 1, 12 16, 11 39, 111 6, 
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1035, 994 , 926, 808, 745, 670 cm·1• HRMS (FAB) calcd for (Mt 511.2570 , found 
5 11 .2570. 
Synthesis of triethylene glycol diallyl ether (6) . To a room temperature, stirred 
::.o(ution of allyl bromide (4 mL, 46.2 mmol) and sodium hydride ( 1.35 g, 56.3 mmol) in 
dry THF (125 mL) was added, over a period of 1 h, a solution o f triethylene glycol (3.0 
mL , 22.5 mmol ) in THF (25 mL). The reaction was a llowed to stir at room temperature 
fo r a total of 12 h. THF was removed in vacuo, and the crude product was taken up in 
ether and extracted with water 3 times. The ether layer was separated , dried over MgS04 , 
and the so lvent removed in vacuo. The crude product was purifi ed by column 
chromatograph y (ether e luent) to afford 3.52 g (70%) of 6 as a colorless oil. 1H NMR 
(CDC I3) 8 5.82-5.95 (m, 2H), 5. 13-5.28 (m, 4H), 3.98-4.01 (m, 4H), 3.56-3.66 (m, 12 H ). 
13C NMR (CDCIJ 8 134.65, 11 6 .99, 72. 12, 70.52, 69.30. IR: 3072, 2864, 1462, 1420 , 
1348 , 1291 , 1249, 1109 , 995, 9 17. HRMS (CI) calcd for (MHr 23 1.1596, found 
23 1.1 596. 
Synthesis of 1,4,7,10 tetraoxa-cyclotetradec-12-ene (7). THF (59 mL) was 
added to 6 (3 g, 13.0 mmol) and LiC I04 (6.91 g, 65.2 mmol ) and the solution stirred for 
30 min or until a ll solids had di ssolved. [Precaution should be used when handling 
perchlorate salts due to the explosive nature of these compounds; a blast shield should be 
used at all times.] D ry CH2C I2 (580 mL) was added to the flask fo llowed by a solution 
of cata lyst 1 (537 mg, 0.652 mmol) in CH2C I2 (10 mL). T he mi xture was heated to 40 OC 
fo r 90 min before cooling to room temperature , adding- 1 mL of ethyl vinyl ether and 
stirring for 30 min . The soluti on was extracted with a minimal amount of wate r to 
remove the lithium, the organic layer was dried over MgS04 , and the solvent removed in 
76 
vacuo. The residue was subjected to chromatography (ether e luent) to yie ld 7 as a brown 
liquid in 74-99% yield. 1 H NM R (CDCI3) 8 5.75-5.78 (m, 2), 4.29-4.30 (m , 4H) , 3.64-
3.72 (m, 12 H). 
Synthesis of 6, 7 ,9,12,14, 15-hexahydro-5,8, 13, 16-tetraoxa-benzocyclotetra-
decene (8). Using the same procedure as for the synthesis of 7 , treatment of 4 (238 mg, 
0.856 mmol) and LiCI0 4 (454 mg, 4.28 mmol) in dry THF (3.9 mL) and CH 2CI 2 (37 mL) 
with catalyst 1 (35.2 mg, 0 .0428 mmol) in C H2CI 2 ( 1.9 mL) formed 8 in quantitative yield 
by 1H NMR spectroscopy. Subjecting the crude product to column chromatography (1-2 
times, ether e luent) gave 50-63 % (94% cis iso mer) iso lated yields of 8 as a wh ite, 
c rystalline solid . 1H NMR (CDCI 3) 8 6.89-6.94 (m, 4H), 5.75-5.78 (m, 2H) , 4.41 -4.42 
(m, 4H), 4.15-4.18 (m, 4H), 3.86-3.88 (m, 4H). 13C NMR (CDCI 3) 8 148.99, 129.81 , 
121.58, 114.48, 70.80, 67.82, 67.34. IR: 2922, 2859, 1592, 1501 , 1451 , 1252, 1220, 
1121 , I 053, 971 , 917, 745 cm- 1• HRMS (EI ) calcd for (Mr 250.1205 , found 250. 1205. 
Synthesis of 2-(3-6, 7 ,9,12, 14,15-hexahydro-5,8,13,16-tetraoxa-benzocyclo 
tetradecen-2-yl-propionylamino)-3-phenyl-propionic acid methyl ester (9). Using the 
same procedure as for 7 except with 5 (1.56 g , 3.05 mmo l), LiCI04 ( 1.62 g, 15.3 mmol) 
in dry THF ( 13.9 mL), and dry CH2C I2 (137 mL) with catalyst 1 ( 126 mg, 0.153 mmol ) in 
CH2Cl 2 (2 mL) gave the crude product in 77% y ie ld by 
1 H NMR spectroscopy. The 
product was subjected to col umn chromatography (70% ethy l acetate, 30% hexanes 
eluent) and resubjected (ethyl acetate eluent) to yield 1.04 g (7 1% yield, 94% cis isomer, 
<5% linear diene) of 9. 1H NMR (CD2CU 8 7.20-7 .28 (m, 3 H) , 6.95-6.98 (m, 2H) , 6.70-
6.82 (m, 3H), 5.95 (bd, J=7.5 , !H), 5.65-5.76 (m, 2H), 4.77-4.83 (m, 1 H), 4.34-4.35 (m, 
4H) , 4.07-4.11 (m, 4H), 3.77-3.81 (m, 4H), 3.67 (s, 3H ), 3.02-3.05 (m, 2H), 2.80-2.85 
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(m, 2H), 2.39-2.45 (m, 2H). 13C MR (CD2C I2) 8 172.43 , 171.83, 149.65, 148.03 , 
136.72, 134.98, 130.39. 130.25 , 129.80 , 128.98 , 127.50, 121.56, 115.23, 11 5.18, 71.53 , 
7 1.26, 68.60, 68.49 , 67.94, 53.64, 52.70, 38.64, 38.3 1, 3 1.43. IR (NaCI plate): 3298 , 
3<32S, 2922,2865, 1744,1653, 1509, 145 1, 1432, 1364, 1263, 1215 , 1162, 11 33 , 1051 , 
1027 , 979, 695 cm·1• HRMS (C I) calcd for (MH r 484.2335 , found 484.2334. 
Synthesis of 2-(3-6, 7 ,9, 1 2,14,15-hexahydro-5,8,13,16-tetraoxa-benzocyclo 
tetradecen-2-yl-propionylamino)-3-phenyl-propionic acid (1 0). KOH (400 mg, 7. 14 
mmol ) was added to a so lution of 9 (950 mg, 1.97 mmol) in THF ( 14.8 mL) and 
deionized water (4.9 mL) and the reaction was stirTed for 13 h. Water was added and the 
soluti on ex tracted with CH 2C I2 ( I x). The aq ueous layer was ac idi fied with I 0% c itri c 
acid to a pH 3 and with the addition of aCI , extracted with ethe r (5x). The ether layers 
were combined. dried over MgS04 , and the solvent removed in vacuo. The residue was 
subjec ted to column chromatograph y (97% ethyl acetate, 3% acetic acid e luent), taken up 
in wate r, and re-ex trac ted (adding aCI) with ether (5x). The ether layers were 
conso lidated, dried over MgS04 • and the solvent removed in vacuo to yield 10 as a white 
solid in 75 % yie ld (694 mg). 1H NMR (CD,OD) 8 7.06-7.2 1 (m, 5H), 6.80-6.85 (m, 2H), 
6 .68-6.7 1 (m, I H), 5.70-5.72 (m, 2H), 4 .55-4 .62 (m, 1 H), 4.37-4.39 (m, 4H), 4 .07-4. 10 
(m, 4H), 3.78-3.82 (m, 4H), 3.08-3. 15 (m, 1H), 2.89-2.93 (m, I H), 2.70-2.74 (m, 2H) , 
2.38-2.44 (m, 2H). 13C MR (C D300) 8 175.73, 174.0 1, 149.53 , 147 .88, 137.88, 
135.1 7, 130. 10, 130.00. 129.50, 128.53, 126.83, 121.60, 11 5.30, 11 5. 18, 7 1.25, 70.97 , 
68.34, 68.2 1, 67.6 1, 54.90 37.98, 37.79. 3 1.43. IR (KBr pellet): 33 10, 3030,2926,2864, 
2584, 1732, 1649, 151 4, 1451 , 1426, 1265, 1228, 1161 , 1135, 1047,974, 9 12, 808, 741 , 
699 cm·1• HRMS (FAB) calcd for (MNar 492.1998 , found 492.2020. 
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Synthes is of RGD containing Monomer (15). T he H:! -Arg(Pbf)-Gly-Asp(r-
Bu):! peptide was synthes ized us in g s tandard so lu ti o n FMOC c he mi s try,':! and th en 
coupled to 10. The same procedure for 2 was fo llowed with 53 mg (0. 11 mmol) 10, 90 
mg. (0 . 13 mmol) of the peptide, 0.02 mL (0. 15 mmo l) trieth y la mine , 24 mg (0. 18 mmol ) 
HOBT, 24 mg (0. 11 mmol) DCC in 1.0 mL of C H:!CI :!, resulting in 87 mg (66% ) of 15 as 
a w hite solid. 1H MR (CO,CI, ) 8 7. 11 -7.25 (m, 5H), 6.68-6.77 (m , 3H), 6.29-6.3 1 (m, 
I H), 5.69-5.7 1 (m, 2H), 4.56-4.62 (m, 2 H), 4.24-4.3 1 (m , 5H), 4 .05-4.06 (m, 4H), 3.87-
4 .00 (m , 2H). 3.76-3.77 (m, 41-I) , 3. 16-3 .2 1 (m, 2H), 3.05-3. 11 (m , 2H) , 2.94 (s, 2H ), 
2.62-2.8 1 (m , 6 H), 2.54 (s, 3H), 2 .48 (s , 3H ), 2.05 (s, 3H), 1.64- 1.70 (m, 4H), 1.38 (2, 
18H). 1.37 (s, 6H). IR (NaCI plate): 332 1, 29 16, 1732, 1623, 1576, 1545, 1514, 1446, 
1368, 1259, 11 56, 1093 , 102 1, 798 e m·'. HRMS (FAB, D C M/NBA/NaC I) ca lcd for 
(M at 1184.5610. fo und 11 84 .5566. 
Polymer Synthesis 
General procedure for the polymerization of crown ethers. In a nitrogen-
filled dry box , a sol ution of compl ex 1 in C H:!C l:! (to give a fi na l monomer concentrati on 
o f 1.2M ) was added to the mo nomer (homo pol yme rs) o r a mi xture of mo nomers 
(copol yme rs) and the reacti on mi xture was stined at room te mpe rature fo r 5 h. The 
initial [M]/[C] was 100/1 . The polymeri zations were te rmin ated by e thyl vi nyl ether and 
the solutions stirred for an additiona l 15-30 min. The polyme rs were precipitated in to 
co ld ether. stirred for 15 min, isolated by ce ntrifugati on, washed w ith cold e ther (3x), and 
d ried under vacuum. D eviati ons from thi s literature procedure are no ted in specific cases 
below. Data not reported within the text is also reported be low. 
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Homopolymerization of 8 (12e). Typical procedure given above was fo ll owed, 
except that the initial monomer concentrati on was 0.7 M. 1H NMR (CDCI3) 8 6.90-6 .91 
(bm, 4H), 5.82-5.84 & 5.73-5.76 (trans & cis. both bm, 2H) , 4. 13-4. 17 (bm, 4H), 4.08-
4.09 ~bm. 4H), 3.77-3.8 1 (bm, 4H). IR: 3419, 2922, 2865 , 2350, 233 1, 1589, l 500, 
1440, 1251 , 121 8, 11 24, 1054, 1033,744 cm·1• 
Copolymerizations of 7 and 8 (12a-d). Typical procedure given above was 
fo llowed. For the following data, the shi fts are the same for all copol ymers, but peak 
resonances vary in intensity according to percent incorporation of the comonomers. 1H 
NMR (C D,CI,) 8 6.90 (bs), 5.79-5.84 & 5.69-5.73 (trans & cis, both bm), 4. 13-4.14 
(bm), 4.05-4 .07 (bm), 3.98-3.99 (bm), 3.76-3.79 (bm), 3.56-3.58 (bm). IR: 3474, 292 1, 
2864, 159 1, 1501 , 1452. 1354, 1253, 12 17, 1115, 1030, 977 , 930 cm·1• 
Homopolymerization of 9 (l3e). Typical procedure given above was fo llowed, 
except that a [M]/[C]=50/l was used. 1H NMR (CD2C I2) 8 7.20-7 .22 (bm, 3H), 6.95-6.97 
(bm, 2H), 6.66-6.79 (bm, 3H), 6.02 (bs, 1 H), 5.77-5.83 & 5.68-5.73 (trans & cis, both 
bm, 2H), 4.74-4.80 (bm, IH ), 3.98-4.1 3 (bm, 8H), 3.70-3.73 (bm , 4H), 3.64 (bs, 3H). 
2.99-3.02 (bm, 2H), 2.76-2. 8 1 (bm, 2H), 2.36-2.42 (bm, 2H). IR : 3294, 2922, 2859, 
174 1, 1651, 15 10 , 1451 , 1429, 1356, 126 1, 12 16, 11 34, 1116, 1030,980,745,700 cm·1• 
Copolymerizations of 7 a nd 9 (l3a-d, f). Typical procedure given above was 
followed , except that for 13f, [M]/[C]=25/l, the initi al monomer concentration was 0.8M, 
and the po lymerization proceeded for 1 week. For the fo ll owing data, shifts are the same 
for a ll copolymers, but peak resonances vary in intens ity accordin g to percent 
incorporati on of the comonomers. 1H NMR (CD2CI 2) 8 7.23-7.25 (bm), 6.97-6.99 (bm), 
6.69-6.82 (bm), 5.95 (bs), 5.77-5.84 & 5.67-5.74 (trans & cis, both bm) , 4 .76-4.82 (bm), 
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4.06-4.12 (bm), 3 .98-3.99 (bm), 3 . 75-3.76 (bm), 3.67 (bs) , 3.54-3.58 (bm), 3.03-3 .05 
(bm), 2.79-2.83 (bm) , 2.39-2.44 (bm ). IR: 3538, 3303, 2922, 2868, 1741 , 1664. 15 10 , 
145 1, 1352, 1261 , 1220, 111 6, 1026, 980, 750,700 cm·1• 
Polymers 13a-e subjected to catalyst 1. Typical procedure g iven abo ve was 
fo llowed except that 1 was reacted with po lymer ([ repeat unit]/[C]=25), the initi a l 
polymer concentration was 2 .4M (per repeat unit), and the reacti on time was 1 week. 
T he c haracte1ization was identical to that given for polymers 13a-e above. 
Copolymerizations of 7 and 10 (14). Typical procedure g iven above was 
fo ll owed except th at a [M]/[C]=50/l was used . The copol yme ri zati on with mo l % 10 in 
the feed was conducted at 35 OC. 1H NMR (CD,CI, ) 8 7.20-7.25 (bm), 7.02-7.07 (bm), 
6.68-6.83 (bm), 5.77-5.80 & 5.68-5.70 (trans & cis, both bm), 4.68-4 .78 (bm), 4 .05-4.06 
(bm), 3.98-3.99 (bm), 3.75-3.77 (bm), 3.56-3.58 (bm), 3.04-3.07 (bm), 2.79-2.83 (bm), 
2 .39-2.44 (bm) . IR : 332 1, 2864, 1732, 1654, 15 14, 145 1. 1353, 1259, 1114, 103 1, 974, 
875, 850. 744. 706 cm·1• 
Copolymerization of 7 and 15 (16). T ypica l procedure g1ve n above was 
followed except that a [M]/[C]=50/ 1 and concentrat ion of 0.9 M was used. 1H NMR 
(CD2C l2) 8 7. 12-7. 19 (bm), 6.65-6.74 (bm), 5.77-5.78 & 5.66-6.70 (trans & cis, both bm), 
4.60-4.64 (bm), 4. 18-4.22 (bm), 4 .03-4 .05 & 3.96-4.00 (cis & trans , both bm), 3.72-3.75 
(bm), 3.52-3.57 (bm), 3.06-3. 10 (bm), 2.94 (s), 2.7 1-2.75 (bm), 2.54 (s) , 2.47 (s), 2.05 (s), 
1.7 1 (bm), 1.39 (s) , 1.38 (s). 
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Chapter 4 
Synthesis of Norbornenyl Polymers With Pendent Bioactive 
Oligopeptides by Ring-Opening Metathesis Polymerization; 
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Abstract 
Synthetic norborneny l polymers substituted with ce ll adhesive sequences glycine-
argini ne-g lyc ine-aspartic acid (GRGD) and serin e-arginine-asparagine (SRN) were 
synchesized by ring-opening metathesis pol ymerizati on (ROMP) us ing newly developed 
ruthenium initi ators. Ini tia ll y, s imple r polymers with pendent g lyci ne, alanine, or 
penta(ethylene g lycol) (E05) un its attached directl y or throug h e th yl and propyl spacers 
to various norbornenyl backbones were synthesized using Ru=CHPh(Cl)iPCY:~)2 (1) as 
the initiator. The molecular weights, POI' s. polymerization times , yie lds, and g lass 
trans ition temperatures were compared for these polymers. As a res ult of this 
compari son. poly(S-norbornene-2-carboxyl) was chosen as the backbone for the more 
complex o li gopeptide containing polymers , and poly(norborne ne) homopolymers and 
copolymers with pendent E05 , GRGD, and SRN units were synthesized. It was found 
that the new ly de ve loped. more ac tive , 2 ,3-dihydro imidazo ly lidene initiators, 
Ru=CHPh(C l)2(PCy 3)(DHIMes) (2 ) and Ru=CH-CH=C(CH3)/Cl)2(PCp3)(DHIMes) (3) 
were necessa ry to synthes ize polymers contain in g more than I 0 mol % of the 
ol igopeptides . In order to a lter the presentation of the GRGD. an E05 containin g 
copolymer with a propyl spacer between the GRGD and the backbone was also made. 
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Introduction 
Considerable effort has been directed towards inc reasing the therapeutic potential 
of the cell-binding sequence Arg-G iy-Asp (RGD). 1 As was di sc ussed in C hapter 1, this 
sequence is part o f integrin-cell binding do mains of many extracellular protein s.~ One 
potent ia l way to increase the binding st re ngth of RGD-conta ining materia ls is to 
incorporate additional o li gopeptide sequences into the material s that increase the ir 
adhes ive character. The sequence Pro-His-Ser-Arg-Asn (PHSRN), that enhances integrin 
binding to RGD in the protein fibronectin ,' is a possible target. However, thi s effort has 
been limited by the lack o f methods to synthesize RGD and PHSRN containing material s 
in a controllable and reliable manner. This chapter describes an exce llent approach to the 
synthesis of copolymers substituted with RGD and the synergy peptide by ring-opening 
metathesis polymerization (ROMP) using newly developed ruthen ium catalysts. 
Previousl y, a synthetic polymer containing on ly GRGDS peptides linked to a 
poly(carboxyethylmethacrylamide) backbone has been reported and shown to have an 
increased therapeutic potentia l to cancer metastas is compared to the free peptide." 
Howeve r, thi s po lymer was synthesized by non living, radical polymerization which 
provides little contro l over the molecul ar weight and resulted in POI's between 2 and 4.6. 
A lso with thi s polymeri zation me thod, the synthes is of random or block copolymers is 
not straightforward. and copolymers containin g the syne rgy s ite PHSR N were not 
synthesized. 
Ring-opening metathesis polymerization (ROMP) provides a better a lternative for 
produci ng well -defined copolymers wi th pendent bioactive o li gopeptides. The copolymer 
composition is obtained by the feed ratio of the monomers,5 and the mo lecular weight is 
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controll ed by the initial mo nomer to catal yst rati o. Al so , ROMP of strained mono mers 
can be living, so synthesizing block copolymers may be a possibility. In addition, the 
po lymer architecture is readil y a lte red: fo r example, a spacer g roup can b e included 
bc\<.<.een the peptide and the polyme r bac kbone . Furthermore, ROMP of monomers 
substituted with amino ac ids has been de monstrated . In C hapte r 3, polye thers with 
pendent a mino ac ids were described,5 and the synthes is o f norbornen y l6 polymers w ith 
one o r two amino ac ids w ith alkyl side chains, but containing no func tionality, has been 
reported . 
ln thi s c hapte r, the synthesis o f various synthe ti c po lymers with pende nt GRGD, 
SRN , and/or penta(eth ylene o xide) (E05) units by ROMP (see C opolymer T arget) is 
described. Because deleti on studies have dete rmined that R is the important residue fo r 
PHSR func ti on,3 the syne rgy sequence was truncated to SR . Since it has been shown 
that s urfaces of oligo(e th y lene ox ide) are prote in resistant ,7 copol y me rs w ith E05 units 
were a lso made . These may be more bi ocompatiblc and w ate r solub le than po lymers 
w ith o nl y pendent pcptides. The synthesis of pol y mers containing these sequences, as 
we ll as various polyno rbornenes with pendent g lyc in es, alanines, and penta(eth y le ne 
g lycol) using cata lysts 1,8 2 ,'1 and 3 ,9 are discussed. 
1 

















Cl ,.... I 
PCp3 
3 
Mes = mesityl 
Cy = cyclohexyl 
Cp = cyclopentyl 
Monomer Synthesis. A serie of monomers w ith o ne pendent amino acid or EO, 
was synthesized in o rde r to study the ROMP of these monomers. First g lycine and 
a lanine monome rs 9, 10, 15, and 16 were prepared (Sche me I). S tarting materia l 4 is 
commerc iall y available and the exo methylene-bridged anhydride (5) was obtained by 
thermally iso merizing the commerc ially avai I ab le en do anhydride. 10 Oxa-bridged 
monomers 9 and 10 were made fo ll owing a s light ly modifi ed lite rature preparatio n 11 in 
9 % and 25% yie lds , respectively. In a similar manner, me thy lene-bridged monomers 15 
and 16 were synthesized in 59% and 5 1 o/(' yie lds, respectivel y. As has been found fo r the 
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synthesis of other oxa-bridged ami no acid monomers, the y ields for these monomers 




X= 0 (4) 






X = 0 : R = CH2COOCH3 (9 ) 
R = CH(CH3)COOCH3 (1 0) 
x = CH2: R = CH2COOCH3 (15) 
R = CH(CH3)COOCH3 (16) 
Scheme 1. Synthesis of glycine and alanine substituted norbornene imide 
monomers. 
Norbornenes substituted wi th glyc ine (19 and 20) or penta(ethy lene glycol) (21 ) 
were synthesized (Scheme 2) in somewhat better y ields compared to the imide-derived 
m onomers. Gl yc ine meth y l ester hydrochl oride was coupled to endo or exo 5-
norbornene-2-carboxy lic ac id (18) with EDC, triethylamine, and HOBT in C H 2CI 2 1n 
66% (1 9 ) and 73 % (20) y ield , respecti ve ly. The same procedure was followed to 
synthesize monomer 23 from 22 in 65% yield. The E05 monomer (21 ) was synthesized 
in 53% y ield by reacting penta(ethy lene glycol) with norbornene-exo-2-carboxylic acid 
chloride in the presence of ba e in anhydrous THF. 





R = NHCH2COOCH3 endo (19), 
exo (20) 
R = (OCH2CH2)sOH exo (21 ) 
~NHCH,COOCH, 
(23) 
Scheme 2. S y nthesis of no rbo rne ne m o nome rs w ith a pende nt g lyc ine or 
penta(ethylene g lycol). Reac tio n conditio ns: i. H-Giy-O C H 3·HC I, Et3N , EDC, and 
HOBT in CH 2CI 2 (19 , 20 , 23 ). ii . a ) O xa ly l C l and DMF in C H 2 C I2 ; b ) 
H(O C H2C H2) 50H and K2C01 in THF, re flux (21 ). 
Next, the synthe is o f monome rs with e thyl and pro py l space r g ro ups between the 
norborneny l gro up and amino acid was unde rtake n. First, 4 and 5 were heated to 50 OC 
with 2-a minoethano l fo r 12 hours in a mi xture of THF and MeOH to g ive the resultin g 
a lcoho ls 6 and 7 in 36% and 44% yie lds respecti ve ly (Sc heme 3). Then mo nomer 12 was 
prepared in 49% yie ld by mi x ing 6 and me thy l bromoacetate w ith potass ium carbo nate 
and tetrabuty l ammonium bromide in anhydro us DMF (Sche me 4). M o nomers 11 and 17 
w ith a pende nt N-a-t-Soc-alanine were made in 50% and 61 % yie ld respecti ve ly by 
coupling N-tert -butoxycarbonyi-L-alanine to 6 o r 7 usi ng DCC and a cata lytic amount of 
DMA P (Scheme 4 ). 
~0 
0 
X= 0 (4 ) 
X = CH2 (5) 
9 1 
THF/MeOH, 50 ·c 
Scheme 3. Synthesis of alcoho l precursors. 
i or ii 
X= 0 (6) 




X = 0 (6 ) 
X = CH2 (7 ) 
x = 0: R = OCCH(CH3)NH-COOC(CH3b (11 ) 
R = CH2COOCH3 (12) 
x = CH2: R = OCCH(CH3)NH-COOC(CH3b (17) 
Scheme 4. Syn thesis of mo nomers w ith e thy l spacers and g lyc ine o r a lanine amino acids. 
Reacti o n conditi ons: i . Boc-Aia-OH , DCC, and DMA P in CH~CI~ (11 , 17 ). ii . Br-
CH~COOCH3, K2C03, and Bu.~NBr in DMF (12). 
Mono mers 13 and 14 w ith propyl spacers were synthesized in decent yields from 
8 (Scheme 5). The ac id (8 ) was sy nthes ized first in 41 % y ie ld by heating 4 and 
ami nobutyric ac id in THF and MeOH at 50 OC for 12 hours. M onomer 13 was made as 
for 19 and 20 in 57 % y ie ld, and mono me r 14 in a 36% over-all yie ld by using the same 






THF/MeOH, 50 "C 




R = OH (8 ) 
R = NHCH2COOCH3 (13) 
R = (OCH2CH2)50H (14) 
Scheme 5. Synthesis of propyl spaced g lyci ne and pe nta(ethy lene g lyco l) containing 
monomers . Reacti o n condit ions: i. H -G iy-OCH3·HC I, Et, , EDC, and HOBT in 
CHcC ic (13). ii . a) Oxalyl Cl and DMF in CH2CI2 : b) H(OCHcC H2) 50H and K cCO, 
in THF, reflux (14). 
Finally, the GR(Pbf)GD(O'Bu)-OH and S(O'Bu)R(Pbf)N(Trt)-OH containing 
monomers (24. 25 , and 29 ) were sy nthes ized. 24 and 25 were made by initially 
sy nthes iz ing the peptides on a 4 -carboxy ltrity l linker resin usi ng standa rd Fmoc 
c hemis try, fo llowed by c o uplin g 5-norbornene-exo-2-carboxy lic acid to the am ino 
te rminus of the peptide . The monomer was then c leaved from the resi n unde r mildly 
ac idic conditi o ns, g iving the protec ted monomers in 76-97% and 92% yields respectively. 
In a s imi lar manner, 29 was synthe sized from 8 in 83 % yie ld. 
,-\~ Jl NTI~(O NTI:rN O OH 
f!-l_J H 0 H 0 
0 









Polymers Substituted With One Amino Acid: Synthesis and 
Characterization. Be fo re synthesiz ing polymers containing the bioactive peptides, 
poly me rs substituted w ith g lyc ines, alanines, or E05 were studied . These were prepared 
by adding a sol ution of 1 in CH2Cl2 to a so lution of monomer in CH 2C l2 to g ive an initi a l 
monomer concentrati on between 0 .5 and 0.75 M . The mixtures were stirred vigorous ly 
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for 15 minutes to 3 hours before quenching w ith ethyl viny l ether. The polymers were 
precipitated into hexanes or ether, i solated by centr i fugation , and dried under vacuum 
before characterization. Polymers wi th amino ac ids or E05 units attached directl y or 
ti'wough a spacer to the backbone were made and compared in terms of polymer yield. 
polymerizati on time, and molecu lar weight distributi on. 
First , polymers based on monomers 9 , 10 , 15 , and 16 (Scheme 1) were 
synthesized using initi ator 1 (Table 1 ).12 The monomers all reacted in 1 hour or less, 
g i ving exce llent y iel ds of polymer (82-95%). The po lymers had g lass transition 
temperatures between 147 and 158 ·c. The number-averaged mo lecular weights (M ") 
were between 17,700 and 108,000. The molecular weight distributi ons were narrow for 
poly(9) and po ly(16) (POI of I . 19 and 1.10 respectively), broader for poly(l5) ( 1.4 7), and 
bimodal for poly(10). The broad molecular weight distribution obtained for poly(15) 
may be a result of catalyst decomposi ti on w hich was detected by NMR spectroscopy 
during the course of the reaction. However, the source of the bimodal molecular weight 
distribution of poly( l 0) is unknown. Thi s persi sted regardless of the reacti on sol vent 
one of these monomers were suitable for further elaborati on to synthesize more 
complex pol ymers. Poly(10) demonstrated a bimodal molecular weight di stribution , and 
although poly(9) had a nanow, monomodal molecular weight distribut ion (1.19), the low 
yie ld of the monomer (9%) prec luded its use in the synthesis of the more complex 
po lymers . The methy lene-bridged polymers both demonstrated monomodal molecular 
weight d istribution s, and the y ields o r both monomers were good (59% and 5 1%). The 
g lyc ine linker was preferred to the alanine linker since G RGD is the native sequence in 
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fibronectin. 13 H owever, attempts to saponi fy monomer 15 in order to obtai n the 
carboxylic acid through w hich RGD cou ld be attached failed, and resulted in the 
regeneration of the anhydride. The synthesis of the g l ycine carboxy lic ac id monomer 
d i1ectl y resulted in very low yields (< 25 %). Therefore, monomer 15 was eliminated 
from the li st of candidates, and the norbornene m onomers w ere se lected for further 
studies. 
orbornen e monomers (19- 21 , 23 ) (Scheme 2) were pol y meri zed and 
characteri zed. Since monomer 19 could be made from commercial ly available starting 
material , it was synthesized and polymerized first. However , the reaction took 24 hours 
to reach 90% y ield. Thi s was not a surprising result si nce endo monomers often take 
longer to polymerize than the corresponding exo monomers. 1J Exo monomer 20 was then 
made and reacted q uick l y in 45 minutes to give a quantitative yield of polymer. The 
penta(ethy lene g lycol ) monomer, exo 21 , al so pol ymeri zed rapidly in 35 minutes. To 
determine if the polymer could be synthesized even faster, the highl y strained monomer, 
23, was subjected to ROMP. H owever, thi s monomer was too strained and polymerized 
quickl y (<5 minutes) and uncontro ll ab ly , resulting in an extremely broad molecular 











































































































































































































































































































































































































































































































































































Polymers, poly(20) and poly(21) were characterized (Table I). The M il's were 
I 0,900 ( [M]1/ [C]0 = 5011) and 4 ,6 10 ( [M] 0/[C]0 = 3511) for poly(20) and poly(21 ) 
respeclively and the mo lecu lar weight distributions were narrow ( 1.15 and 1 .1 2). The 
polymers had very different g lass transition temperatures depending on the substituent. 
The g lyc ine substituent resulted in a polymer w ith a higher T g compared to unsubstituted 
norbornene (88.0 OC vs. 3 1 °C 15). The flexible penta(ethy lenc g lycol) units resulted in a 
polymer with a lower T g (-48.9 OC). B ecause of hi gh y ields of both monomer and 
polymer, fac ile synthesis , monomodal m olecular weigh t di stributions, and fast 
polymerization times, the norbornene olefin was chosen for the synthesis of the 
monomers and polymers wi th GRGD and SRN units. 
ln an attempt to alter the presentation of the amino acids, pol ymers with ethy l (12) 
or propyl (13 -14 ) spacer groups were synthesized and charac teri zed (Table 2) 
concurrently with the norbornene monomers and polymers described above. Monomer 
12 (Scheme 4) pol ymeri zed in 2.5 hours and 13 and 14 (Scheme 5) in 30 minutes to give 
poly(l2), po ly(13), and poly(1 4 ) in exce llent y ields. Again the Tg of the polymers 
depended on the substituents. Po ly( l2) and poly(13) had g lass transitions lower than that 
of poly(9) with the g lycine directly attached to the backbone (86. 1 and 74.5 versus 147.6 
OC). Similar to poly(21). the penta(ethylene g lycol) substituent resulted in pol y( l4) 
having a low glass transition at - 29.9 OC. The M il's of poly( l2) and poly(l4) were 66,200 
and I 18,000. The molecular weight of pol y(13) could not be determined due to the low 
sol ubility of the po ly mer. Poly(l2) demonstrated a monomodal , molecular weight 
distribution of 1.3 1 while poly( l4) had a bimodal molecular weight distribution. The 
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reason for thi s bimodal mo lecular we ight di stribution is unknown; only one propagating 
spec ies was observable by 1H NMR spectroscopy. Attempts to saponify monomer 12 to 
y ie ld the carboxylic ac id functiona lity fai led; simi lar to 15, saponification resulted in the 
regeneration of the 6. 
Polymers with pendent Soc-protected alanines, po ly(l l ) and poly( l 7 ), were 
synthesized in less than 2 hours in > 99% and 95% yields respecti vel y (Table 2). The 
molecular weight di stributions were monomodal for both poly(ll ) and poly(17), and the 
mo lecular weights were s imilar (M n of 5 1,900 and 55 ,500 respec ti ve ly). The po lymers 
also had similar g lass transiti on temperatures (Tg of 96.8 and 90.3 OC respectivel y). 
Pol ymers of 11 and 17 contain an a lanine linked by the carboxy lic acid rather than 
by the amine functionality to the pol ymer backbone. For the purposes of thi s research, it 
was desired that the peptides be coupled to the polymer bac kbone thro ugh the amino 
termi nus. However, the synthesis of po ly( ll ) and po ly( l 7 ) demon strates the feasibil ity 
of attac hing peptides thro ugh either te rmini , which may be useful for other types of 
applications. For example , since the Boc protecting group may be readil y re moved with 
ac id to gene rate the po lyamines, pol y( l l) and pol y( l 7 ) may be useful in suc h 
























































































































































































































































































































































































































































































All of the prev10us pol ymeri zation s were monitored by NMR. The c he mi cal 
shifts of the cm·bene propagatin g spec ies, the presence of free phosphine, and the fina l 
trans/cis rati os (v ide infi·a) are recorded in Tables I and 2. All of the initiated carbenes 
were broad multiplets. During the polymeri zation of the oxa-bridged monomers 9 and 
11-14, onl y one propagating carbene was o bserved at ro ughly the same shift (between 
18.67 and 18.70 ppm). The meth ylene-bridged mo no me r 16 al so de mons trated one 
propagating cm·bene at 19.41 ppm. Free phosphine was not observed in any of these 
reacti ons. However, methy lene-bridged imide mo no mers 15 and 17 had two observable 
propagating species during po lymerization (at 19.48 and 18.58 ppm for 15 and 19.42 and 
19 .20 ppm fo r 17) and the norborne ne mono mers 20 and 21 de m o ns trated three 
propagating species (at 19.02, 18.94, and 18.74 ppm for 20, and 19.07 , 19.02, and 18.72 
ppm for 21 ). For these polymers, free phosphine was observed during the reaction. 
The presence o f free phosphine and two propagating species during ROMP has 
been observed in a previous study; it was de termined that the monomer was coordinating 
to the ruthenium resulting in the observati on of a monophosphine species, in addition to 
the bi sphosphine species. 16 For the above reac tions, the presence of multiple propagat ing 
spec ies corre lated to the observation of free phosphine during the reac ti on. Converse ly, 
when free phosphine was no t observed, only one propagatin g spec ies was detected. This 
suggests that the two propagating species observed for the pol ymeri zation o f 15 and 17 
may be the monophosphine and bi sphosphine species. Polyme rization o f the norbornene 
monomers resulted in three detectable propagating species. The presence o f an additional 
propagatin g spec ies may be related to the asy mmetry of the monomer. Even so, the 
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presence of free phosphine and multiple propagating species during the reaction does not 
appear to have an observable detrimental effect on the final pol ymer characte ri stics, such 
as molecular weight di stribution o r reaction time. 
Polymers With Pendent Biologically Relevant Oligopeptides: Synthesis and 
Characterization. Po lymers with pendent GRGD, SRN, and E05 were first synthesized 
using initiator 1 for 4 ho urs at room temperature in CH2Cl 2 with an initial monome r 
concentration of 0.7 M (Scheme 6). ln thi s way, monomers 21 and 24 with 10, 27, and 
50 mo l% GRGD in the feed as well as 100 mol % 24 and 100 mol % 25 were pol ymerized, 
and the protecting groups were c leaved with TFA. However, only the pol y me rizati on 
with 10 mol% GRGD in the feed (26a) gave good results (T able 3), with a hi gh over-all 
yie ld of 78% and a monomodal molecular weight di stribu tion. Po lymeri zati ons wi th 27 
to 100 mol% 24 or 100 mol % 25 in the feed resulted in extreme ly low yie lds of po lymer 
(less than 26% ) presumabl y due to catal yst decomposition. Also, the mo lecular weight 
distribution for some of these polymers was bimodal. Given these results, the more 
ac ti ve catalysts, 2 and 3 , were applied to the synthesis of these polymers . 
0 
x, y, and/or z ~R 
R = G-R(Pbf)-G-D(01Bu)-OH (24), 
S(01Bu)-R(Pbf)-N(Trt)-OH (25), 
E05 (21 ) 
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1. 1, CH2CI2, rt 
or 2 or 3 , CH2CI2/ 
MeOH, 55 ·c 
2. TFA:TIS:H20 
(95:2.5:2.5) 
R = GRGD, SRN , 
and/or E05 
Scheme 6. Synthesis of homo- and copolymers with pendent bioac tive oligopeptides. 
Polymeri zatio ns were carried o ut using initi ators 2 and 3, and the characterization 
results for the polyme rs a re given in Table 3. Onl y a few examples o f these initiators 
used in ROMP have been reported .17 However, in these examples and in ring-c los ing 
metathesis and c ross-metathes is reacti o ns, 2 and 3 were much more active than 1 both at 
room temperature and at hi gher tempe ratures.917 Also, 2 and 3 were inte r-changeable 
wi th each othe r at hi ghe r temperatures. 17 Based upo n these initial s tudies it was hoped 
that these initiators would result in hi gher yie lds of the desired pol ymers. 
Hompo ly me rs and copo ly mers of 21 , 24, and 25 were synthesized (Sc he me 6) 
usmg 2 o r 3 as an init iato r by heating the monomers in a 1: l mi xture o f C H2CI 2 and 
M eOH in an oi l bath a t 55 OC for 2 ho urs with initi a l monomer concentratio ns of 0.6 M 
(homo po lymers) or 0.7 M (copolyme rs). A mi xture of solvents was used to solubilize the 
polymers, and since the catal ysts react fas ter at e levated temperatures, the mi xtures were 
heated in sealed via ls. 18 The ho mopol ymer of 24 (26c) was synthesized using initiator 3 . 
The rest, inc ludi ng the homopol ymer of 25 (27b), were synthes ized w ith 2. Copolymers 
w ith G RGD and E05 units, 26b (49 mo l% GRGD), and w ith SRN and E05 uni ts, 27a (53 
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mo l% SRN), were syn thesized. Copolymers with both ol igopeptides, 28a (32 mol % 
GRGD, 21 mol % SR , and 47 mol % E05 ) and 28b (53 mol % GRGD and 47 mol % 
SRN), were al so made . The amou nt of the peptide monomer incorporated into the 
poi~ mer, dete1mined from the 1H NMR spectra of the purified polymers, coiTesponded to 
the amount in the feed for all of the copolymers. 
The protecting g roups of the polymers were cleaved to yield the unprotec ted 
amino acids. All of the polymers except the SRN homopo ly mer (27b) were successfully 
de protected using TFA. Poly me r 27b was not fully deprotected by thi s acid; the polymer 
prec ipitated out of the TFA solution after 10 minutes. Presumably , the more labile 
protecting groups (Pbf and Trt) were cleaved first, altering the solubility of 27b in TFA, 
resulting in the precipitation of the pol ymer before the r-buty l groups were removed. 
However, all of the protecting groups of thi s pol ymer, inc luding the !-butyl groups, were 
c leaved using HF. 
A ll of the deprotec ted po lymers were solubilized in aqueous solution. Copolymer 
26a, with 90.8 mol % penta(ethylene g lycol) units, was the on ly polymer soluble in water 
immediate ly after the deprotecti on steps. The rest of the pol ymers were solubili zed in 
wate r by stirring in 0.1 N NaOH for 10 minutes to generate the sodium salt of the 
carboxy lates and were isolated by precipitation into methanol. For copolymers 26b and 
27a, thi s procedure c leaved off many of the penta(ethy lene g lycol) units (76 % for 26b 
and 65% for 27a). H owever, it was later di scovered that these polyme rs could also be 
made wate r so luble by direct treatment with mi lde r bases such as dibasic phosphate 
buffe r (pH 8), without saponifying the penta(ethy lene g lycol) units. 
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The over-a ll yields (after polymerization, c leavage, and so lubi li zation into water) 
of the pol ymers were a ll between 59 and 92% , except for that of polymer 28b which was 
32% (Table 3). The low yie ld o f 28b was primarily due to pol ymer loss during the initial 
precipitation from the c rude reac tion so luti o n. The 1H NMR spectra of all the c rude 
reac ti o n mi xtures indicated that most of the monomers had been consumed. However, 
s ince the monomers and protected pol ymers had similar solubilities, po lymer purification 
proved to be diffic ult. Selec ti ve prec ipitation of the protected po lymers was achieved by 
precipitating into mi xtures o f solvents suc h as CH2C ij ether and MeOH/ethe r. The choice 
and relative amount of each mi xture was different depending on the poly mer. Polymer 
26a was additionall y purified by Centriprep (MWC0=3000) us ing ethano l as the 
solvent. 19 Regardless of the purification method, except fo r 28b, the yie lds were all good 
to exce llent. 
The GPC results a re g1 ven m Table 3. A s desired , the numbe r-averaged 
molecular weights were are fa irl y low between 10,700 and 18,700 , and most importantl y, 
the samples demonstrated monomodal mol ecul ar wei ght di stri butions . Copolymer 27b 
had the largest POI value ( 1.70) . Thi s was the onl y polymer to be deprotected by HF; the 
harsh deprotection conditions could have caused the molecular weight distribution to 
broaden from chain scission. A ll the other samples had low POI 's between 1.1 3- 1.32. 
Re markabl y, copolymer 28a , had a low POI of 1.2 1. Thi s result indicates that 
synthesiz ing complex copolymers with three or even more monomers is possible so th at 
drugs, for example, may a lso be incorporated into the polymers. The narrow molecular 













































































































































































































































































































































































































































































































































































































































































The T g va lues of the copo ly mers varied dependi ng on the identity and 
concentrations of the substituents. For example, copolymers 26a and 26b had T g va lues 
o\· - 30.7 ~c and 52.6 OC between that of homopolymers poly(21) at -48.9 OC and 26c at 
98.0 OC. Copolymer 27a had aT~ of 62.3 OC while homopo lymer 27b had one at 13 1.2 
OC. The trimonomer copoly mer, 28a. wi th 53 mol% total peptide had a lower T g (39.4 
OC) than ei ther of the dimonomer copo lymers 26b and 27a which contained 49 mol% and 
53 mol% peptide, respectively. The presence of the third monomer introduces extra 
disorder. In addit ion, the GRGD and SR containing copolymer, 28b, had a T g of I 04.6 
°C , w hich is c lose to that of the G RGD containing homopolymer, 26c . The SRN and 
GRGD homopolymers exhibit fairl y hi gh glass transition temperatures compared to 
unsubstituted pol ynorbornene. Perhaps hydrogen bonding or other fac tors influenced the 
glass transi tion in these cases. Po lymers containing the flex ible penta(eth y lene glycol ) 
units ex hibit lower T g's. Depending on the substituent, the physical state of the polymer 
varied widely from an oil (poly(21 )) to a powdery solid (26c, 27b, and 28b). 
Polymer Stereoisomers. The trans to cis ratios of the pol ymers synthesized in 
thi s research revealed an interesting observati on: polymers synthesized wi th 1 contained 
more trans olefins while those synthesized by 2 had a slight excess of cis olefins. The 
methylene-bridged imide polymers had trans to cis ratios f rom 5.2/l to 5.511 while the 
oxa-bridged imide polymer had ratios between 2.3/ I and 2.9/ I . T he poly(norbornene)s 
had ratios between 2.4/1 to 3.6/1. Simi larly, the GRGD containing pol y mer 26a 
synthesized wi th 1 contained more trans olefins (tran s/cis = 4.8/ I ). In contrast, the 
polymers synthesized w ith initiator 2 (26b, 27a, and 28a) exhi bi ted sli ght excesses of cis 
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o lefins (trans/cis = l/1.6- 1/1 .7, see Table 3). (Polymers 26c, 27b, and 28b were not 
soluble in CD300. and the olefin peaks of the isomers were not resolved in 0 20 .) 
To examine thi s fur ther, monomers 15, 20, and 21 were polymerized under the 
same condi tio ns w ith either 1 or 2 as the initiator. Polymetization of 15 with 1 resu lted in 
a pol ymer w ith a trans to cis ratio of 5.211 , w hil e w ith 2 the ra ti o was equal (1/1). This 
trend was more marked with monome r 20. w here 1 resulted in a polymer with a trans to 
cis ratio of 2.4/1 and 2 resulted in the reverse w ith a trans to cis ratio of 112.3. Similarly, 
for 21. initiator 1 resu lted in a pol ymer wi th a trans to cis ratio o f 3.6/1 and 2 wi th a trans 
to cis rati o of 111.7. The results obtained from pol ymers pol ymerized by 2 are unusual 
cons idering that 1 usua lly results , as evidenced in th is research, in predominantl y trans 
polymers. 
Polymers With Spacer Groups and Pendent Biologically Relevant 
Oligopeptides. T o alter the pol yme r a rc hitecture and the presentat ion of the 
o ligopeptides, it is des irab le to synthesize po lymers w ith spacer g roups between the 
peptide and the bac kbone. S ince in native fibronectin , the RGD is ex tended from the 
protein as a loop,13 it mi ght be espec ially advantageous to synthesize these polymers w ith 
a spacer between the backbone and the G RGD. As a demonstrati o n, mo nomers 14 and 
29 were polyme ri zed to form 30, a polymer w ith a propyl spacer be tween the backbone 
and RGD and E05 uni ts (Scheme 7). Initi a ll y, 30 was synthesized us ing initiator 1, but 
the pol y mer obta ined had a bimodal mo lecular weight di stribution. As a result, the more 
active initiato r, 2 , was employed instead, and a mono modal m olecular weight di stri bution 
was achieved. 
X+ y £l~o o 
)rN~R 
0 
R = R(Pbf)-G-D(0 1Bu)-OH (29) 
E05 (14) 
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1. 2 , CH2CI2/ 
MeOH, 55 ·c 
2. TFA:TIS:H20 
(95:2.5:2.5) 
R = RGD or 
E05 (30) 
Scheme 7. Synthesis of a pol ymer wi th propy l spacers and pendent RGDs. 
Polymer 30 was synthesized as prev ious ly described using 2 as the initi ator with a 
[M]0/ [C]0 = 1011 (Sc he me 7). The yie ld was approximately 90% by 1H MR 
spec tra copy. The polymer was deprotected with TFA and rendered so luble in water by 
first di ssolving in pH 8 phosphate bu ffe r (which did not saponify any of the E05 units), 
then precipitating into methanol. The wate r so lubility of thi s po ly mer was dependent on 
the molecul ar weight: when hi ghe r mo nome r to cata lyst ra ti os were used ([M]0/[C]0 = 
50/ I ) the po lymer did not di sso lve even when subjected to stron g base. The amount of 
29 incorporated into the polymer (30 mol %) was s li ghtl y hi gher than the amount in the 
feed (20 mo l%) . The M" obta ined in aqueous buffer was fa irl y hi gh, at 11 5 ,000, and the 
POl was narrow ( 1. 14 ). The Tg of the pol ymer was 70.2 OC. Similar to other polymers 
synthesized with 2 , the trans to cis rati o was 1/1 .2. Thi s work is readily extended to the 
synthesis o f o the r homopolymers and copo lymers, and demonstrates that by using the 
more active initi ators, biopo lymers with diffe rent arch itectures can be synthesized . 
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Summary 
orbomenyl polymer wi th pendent g lycines, alanines. penta(ethylene glycol)s, 
or bioactive peptides GRGD a nd SR attached directl y o r thro ugh spacers were 
synthesized. The ruthenium bisphosphine in itiator 1 successfull y po lymeri zed monomers 
with g lyc ines, alanines, and pcnta(ethylene g lycol)s: copolymers with < 10 mol % GRGD 
were also prepared w ith thi s initi ator. However, the synthesis of pol y mers with hi gher 
co ncentrations of the bioactive pe ptides req uired the use of the more ac ti ve 2,3-
dihydro imidazoly lidene initiators 2 and 3 . The work described in thi s chapter 
de mo nstrates that with the advent o f c atalysts 2 and 3 , ROMP is a viable method to 
produce pol ymers substituted with complex peptidic structures in a controllable manner. 
Po lymers with potential b ioactivity, substituted with several di ffe rent bioacti ve peptides, 
arc now accessible . 
Experimenta l 
Materials. 5- o rbornene acid-endo-2-carboxy lic acid (endo 18) was purchased 
from Aldrich. 5-Norbornene acid-exo-2-carboxyli c acid (exo 18/ 0 and acid chloride 21 as 
well as 5 10 were synthesized accordi ng to lite rature procedures. 2-A minoethano l and all 
o ther solvents were purchased from EM sc ience. Glyci ne methy l ester hydrochloride and 
alanine meth yl ester hydroc hloride were purc hased from Sigma. Penta(ethy lene g lycol) 
was purchased from Aldri ch and dried over 4 A molec ular sieves (Li nde). The peptides 
were synthesized by the Beckman Institute Biopolymers Synthesis Laboratory (California 
In stitute of Tec hnol ogy) using reagents purchased from Novabiochem. Centriprep flasks 
were purchased from Millipo re. Methylene chlo ride used in the polymerization reactions 
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was dried over CaH2, degassed, and vacuum transfen·ed before use. All other chemicals 
were purchased from Aldrich and used as received. 
Techniques. All operations were carried out under a dry nitrogen or argon 
atmosphere. Dry box operations were performed in a nitroge n-filled Vacuum 
Atmospheres dry box. Column chromatography was performed using silica gel 60 (230-
400 mesh) from EM sc ience . 1H NMR spectra were recorded on a General Electric QE-
300 (300. 1 MHz) spectrometer, a JEOL GX-400 (399.65 MHz) spectrometer, or a Varian 
U nityPlus 600 (600.203 MHz) spectrometer as indicated. 13C NMR (75.49 MHz) spectra 
were recorded on a General Electric QE-300 spectrometer. Chemical shifts are reported 
downfie ld from tetramethyl s ilane (TMS). 31P NMR spectra were recorded on a JEOL 
GX-400 (161.85 MHz) spectrometer refe renced to an ex ternal 85 % H 3P04 standard. 
Infrared spectroscopy was performed on a Perkin Elmer Paragon 1000 FT-fR 
spectrometer using a thin fi lm of sample cast on a NaCl plate or a KBr pellet as indicated. 
Optical rotations were recorded on a Jasco P- 1010 digital polarimeter at 589 nm. High-
reso lution mass spectra were provided by the Southern California Mass Spectrometry 
Facility (Univers ity of California, Riverside). Ge l permeation chromatographs with 
CH2Cl 2 as the e luent (flow rate of 1 mL/min) were obtained using an HPLC system 
equipped with an Altex model 110A pump, a Rheodyne model 7 125 injector with a 100 
J.AL injection loop , two American Pol ymer Standards 10 micron mixed bed columns, a 
Knauer differential refractometer, and poly(styrene) as the calibration standard. Aqueous 
GPC (0.1 M Na2HP04 dibasic buffer) or DMF GPC (both with a flow rate of 1 mL!min) 
were conduc ted usi ng an HPLC system equipped with a Waters 5 15 HPLC pump, a 
Rheodyne model 7725 injector with a 200 )..tL injection loop, a Waters 2487 Dual A 
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absorbance detector. a Waters 24 10 refractometer, two TSK columns (TAS K 3000PW, 
TSK 5000PW) and pol y(e thylene ox ide) or pol y(styrene) as the calibrat ion standard as 
indicated. Differential scannin g ca lorimetry was measured on a Perki n-Elmer DSC-7 for 
Tg·s above 25 OC and on a Perkin-Elmer Pyris 1 for Tg's below 25 OC. The results are 
given for the second heating using a scan rate of 10 OC/min . The HPLC resu lts were 
obtained on a Bec kman 126 Solvent Module HPLC equipped with a 166 UV Detector 
and an Altech 18-LL column using a H~O/CH3CN solvent system (7% CH3CN for 6 min , 
7-90% CH~C over 38 min , and 90% C H3C for 8 min). 
Monomer Synthesis 
4-Hydroxymethyl-1 O-oxa-4-aza-tricyclo[S.2.l.02·6]dec-8-ene-exo-3,5-dione ( 6). 
Prepared as for the 7 (vide i1~{ra) with 6. 10 g (36.80 mmol ) 4 and 2.22 mL (36.80 mmol) 
of 2-ami noethanol in THF/MeOH (30 mL, Ill ) resulting in 2.78 g (36%) of 6 as a white 
crystalline solid. 1H MR (0~0. 500 MHz) 5 6.48 (2H , s), 5. 17 (2H, s), 3.56 (2H, t, J = 
4.5) , 3 .50 (2 H, t, J = 4.5) , 2.99 (2 H, s). 13C NMR (D 20 , 300 Ml-lz) b 179.32, 136.28, 
80.83, 58. 12, 47.31 , 40.87. IR (KBr pellet): 3475,300 1,2969,293 1,2894, 1766, 1688, 
1438, 1407, 1386, 1335 , 13 16 , 1268 , 12 19, 11 69, 11 55 , 1099, 1054, 10 14,956,938,9 15, 
878, 849, 8 10, 773, 723 , 704, 653, 597 e m· '. HRMS (DCJ/ H 3) ca lcd for (M I-l t 
2 10.0766 found 210.0763. 
4-Hydroxymethyl-4-aza-tricyclo[S.2.1.02.6]dec-8-ene-exo-3,5-dione (7) . 2-
Aminoethanol (0.74 mL, 12.20 mmol) was added to a solution of 5 (2.00 g, 12.20 mmol) 
in THF/MeOH (1/ 1, 30 mL) and the mi xture was heated to 50 oc for 12 h. After cooling 
to room te mperature , the so lvent was removed in vacuo and the product was 
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recrystallized from MeOH/hex (2/1) to afford 1.11 g (44% ) of 7 as white c rys tal s. 1H 
NMR (CDCI3, 300 MH z) 8 6.26-6.32 (2 H, m) , 3.77-3.82 (2H, m), 3.69-3.74 (2H, m), 
3.30 (2H, s), 2.73 (2H, s), 2.18 ( I H , bs), 1.53 ( I H, d , J = 8.7) , 1.35 ( I H. d, J = 8.7). 13C 
NMR (CDCI 3, 300 MHz) 8 178.65, 137.70, 60.02 , 47.78 , 45.14, 42.68, 4!.15. IR (NaCJ 
plate) : 3506,2984. 2954,2885, 1758, 1689. 1423 , 1403 , 134 1, 1329, 11 66, 1152, 1063, 
989 , 935 , 900. 881, 856. 767, 733, 649 c m·1• HRMS (DCIINH3) ca lcd for (MHt 
208.0974, found 208.0969. 
4-(Exo-3,5-dioxo-1 O-oxa-4-aza-tricyclo[5.2.l.02·6]dec-8-en-4-y I)-butyric acid 
(8). Same procedure as for the synthesis of the 7 was followed with 3.00 g ( 18.00 mmol ) 
o f 4 and 1.86 g ( 18.00 mmol) 4-aminobutyric acid in THF/MeOH (36 mL, I : 1). The 
crude product was subjected to column chromatograph y (EtOAc w ith 3% AcOH) to give 
1.83 g (4 1 %) of 8 as a white solid. 1H NMR (CDCI 3, 300 MHz) 8 6.51 (2 H. s), 5.26 (2H, 
s), 3.56 (2H, t. J = 6.9 Hz). 2.85 (2H, s), 2.34 (2H, t, J = 7.5 Hz), 1.90 (2H , t, J = 7.2 Hz). 
I.'C MR (CDCI ,, 300 MHz) 8 176.01. 168.60, 136.51 , 80 .95, 47.40, 37.96, 30.81, 22.59. 
TR ( aC I plate): 3480.6. 2977.1. 2677.2 , 1770.9, 1696.0, 1562. 1, 1396.1 , 1165.8, 1096. 1, 
I 0 15.0, 9 14.1 , 87 1.2, 849.8, 807 .0, 721.3, 65 1.6. 603.4 cm·1• HRMS (0Cl/NH3) calcd for 
(MH t 252.0872 found 252.0878. 
Exo-(3,5-dioxo-1 O-oxa-4-aza-tricyclo[5.2.l.02 •6 ] d ec -8-en -4- y I)-acetic ac id 
methyl ester (9). The same procedure as for 15 was followed (vide in{ra) with 1.42 g 
(8.53 mmol ) of 4 , 1.07 g (8.53 mmol) g lycine methyl es ter hydrochloride, and 3.50 mL 
(25.16 mmol) of tri e th y lamine in CH~CI ~ (43 mL) to yie ld 0.17 g (9%) of 9 as a white 
solid. 1H NMR (CDCI 3, 300 MHz) 8 6.54 (2H, m), 5.3 1 (2 H, s), 4.24 (2 H, s), 3.76 (3 H, 
s), 2.97 (2 H, s). 13C MR (CDCI3 , 300 MHz) 8 175.85, 167 .62, 137.09, 8 1.45, 53.02, 
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48.22, 39.92. IR (NaCI plate): 3 100, 3029, 3011 , 2992, 2958, 1747, 1707, 1423 , 1373 , 
1326, 1267, 1221 , 1180, 11 54. 11 02 , 108 1, 101 4 , 983,951 , 9 15, 874, 848, 806, 7 13, 656, 
6 19, 593 em·'. HRMS (DCIIN HJ calcd for (MHt 238.0716, found 238.0704. 
Exo-2-( 3,5-d ioxo-1 0-oxa-4-aza-tricyclo[ 5.2.1.02·6]dec-8-en-4-y \)-propionic acid 
methyl ester (10). Compound 10 was synthesized according to lite rature procedure " in 
25% yie ld. 'H NMR (CDC13, 500 MHz) 8 6 .53 (2 H, s) , 5 .29 (2 H, s) , 4.74 (IH, q , J = 7.4 
Hz), 3.73 (3H , s), 2.84-2.92 (2H, m) , 1.54 (3H, d , J = 7.5). 
2-tert-Butoxycarbonylamino-propionic acid exo-3,5-dioxo-10-oxa-4-aza-
tricyclo[5.2.l.02·6]dec-8-en-4-ylmethyl ester (11). The same procedure as for 17 (vide 
infra) was followed with 0.50 g (2.39 mmol) of 6 , 0.45 g (2.39 mmol) of N-tert-
butoxycarbonyi-L-alanine, 0.49 g (2.39 mmol) of l ,3-dicyclohexylcarbodiimide (DCC), 
and 0.04 g (0 .36 mmol) of 4-(dimethylamino)pyridine (DMAP) in 20 mL CH 2CI2 . The 
product was puri fied by recrysta ll ization from MeOH/hex (2/1) to yie ld 0.46 mg (50%) of 
11 as white crystals. 1 H NMR (CDCI3, 500 MHz) 8 6 .51 (2H , s), 5.27 (2H, s), 5.02 (IH, 
bs), 4.30 (2H, t, J = 5.3 Hz), 4.23-4.29 (1 H , m), 3.73-3.8 1 (2H, m), 2.86-2.89 (2H, m), 
1.42 (9H, s), 1.34 (3H, d , J = 7.2 Hz). 13C NM R (CDCI3 , 300 MHz) 8 175.9 1, 172.76, 
154.97, 136.44, 80.79, 61. 17, 49.06, 47.38, 47.36, 37.63, 28.23, 18.25. IR (NaCI plate): 
3356.0 , 2967.3, 2936.6, 1742.0, 1701.1 , 15 11.8, 1455.6, 1430.0, 1394.2, 1363.5, 1332.8 , 
1251.0, 1158.9 , 1066.8 , 1020.8 , 886.0, 855.4, 7 13.9, 647.4. [cx] D25 = -10.6. HRMS 
(DCIINH1) calcd for (MHt 38 1.1 662 found 38 1.1 645. 
(Exo -3,5-d ioxo-1 0-oxa-4-aza-tricyclo[5.2.1.02·6]dec-8-en -4-ylmethoxy )-acetic 
acid methyl ester (12). Methyl bromoacetate (1.8 1 mL, 19 .1 2 mmol) was added to a 
so lution of the 6 ( 1.00 g , 4.78 mmol) , potassiu m carbonate (0.80 g. 5.76 mmol), and 
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tetrabutylammo ni um bromide (0 .02 g, 0 .06 mmol ) in anhydrous DMF (20 mL). T he 
so lution was stirred at room temperature for 12 h. CHCI , (100 mL) was added, and the 
organic layer was successively washed with H20 (twice) and 5% HBraq· T he aqueous 
iayers were combined and washed with CH 2Cl2 (three times) . T he organic layers were 
poo led, dried over MgSO.~ , and the solvent was removed in vacuo. The crude product 
was recrysta ll ized from a mi xture or EtOAc and ether (4: 1) to give 0 .66 g (49%) of 12 as 
a white soli d. 1H NMR (CDCI,, 300 MHz) 8 6.5 1 (2H , s), 5.27 (2H, s), 4.62 (2H, s), 4.34 
(2H, t, J = 5.4 Hz) , 3.8 1 (2H, t. J = 4.5 Hz), 3.78 (3H , s), 2.89 (2H, s). 1' C NMR (CDCI 3, 
300 MHz) 8 175.87, 167 .66, 154.36, 136.44, 80 .8 1, 63.35, 52.27, 47.39, 37.46. IR (NaCI 
p late): 3009.3, 2966.4, 1754.9, 170 1. 3, 1428.2, 1396. 1, 1337. 1, 1288.9 , 12 14.0, 11 49.7, 
I 122.9, 102 1.2, 9 19.4, 876.6, 849.8, 785.5, 72 1.3, 646.3 , 592.7 cm·1• 
[ 4- (Exo-3,5-d ioxo-1 O-oxa-4-aza-tricyclo[5.2.1.02'6]dec-8-en-4-yl)-
butyrylamino]-acetic acid methyl ester (13). Same procedure as fo r 19 was fo llowed 
(vide infi·a) with 2.21 mL (15.89 mmo l) tr iet hy lamine, 0 .65 g (4.77 mmol ) 1-
hydroxybcnzotriazo le (HOBT) , 0.6 1 g (3. 18 mmol) 1-[3-(d imethylamine)propy l]-3-
e thylcarbod ii mide hydrochloride (EDC) , 0.40 g (3. 19 mmo l) g lycine methyl ester 
hydroch lo ride , a nd 0.80 g (3 .1 8 mmol) of 8 in 64 mL CH2Cl2 . T he crude product was 
subjected to column chromatography (EtOAc) to give 0.58 g (57%) of 13 as a white 
solid. 1H MR (CDCI3 , 300 MHz) 8 6.53 (2 H, s), 5.28 (2 H, s), 4.05 (2H , d, J = 5.1 Hz), 
3.76 (3 H, s), 3.62 (2H, t, J = 6.3 Hz), 2.86 (2H, s), 2. 19 (2H , t, J = 6.9 Hz), 1.97 (2H, t, J 
= 6.3 Hz). 1'C NMR (CD 2Cl 2 , 300 MHz) 177.09, 172.47, 136.98 , 8 1.56, 54.68, 52.64, 
47.99, 4 1.66, 38.42, 33.39, 24.22. IR (NaCI plate): 3563.8, 3292.9, 3084.6, 2949.2 , 
1750.7 , 1698.6 , 1547.6 , 1433.0, 140 1.8. 1370.5, 1282.0, 1214.3 , 11 62.2, 102 1.6 , 9 17.4, 
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875.0, 849.7, 802.9, 719.5, 651.8 . 589.3 , 500.8 cm·1• HRMS (EI ) calcd for (MHr 
323. 1243 found 323.1241. 
4-(Exo-3,5-dioxo-10-oxa-4-aza-tricyclo[5.2.l.Ou']dec-8-en-4-yl)-butyric acid 2-
\2- ~2 - [2-(2-hyd roxy-ethoxy )-ethoxy ]-ethoxy )-ethoxy )-ethyl ester (14). The acid 
ch loride of 8 was generated in situ using 0.70 g (2.78 mmo l) of 8, 0 .53 mL (6.12 mmol) 
oxaly l chl oride , and a cata lyti c amoun t of DMF in CH 2Cl2 following a li terature 
procedu re. 2 1 To a solution of the c rude ac id chloride in anh ydrous THF (45 mL), 
penta(ethy lene glyco l) (0.66 g , 2.78 mmol) and potassium carbonate ( 1.3 1 g, 9.47 mmol) 
were added. The mixture was heated to reflux and stin·ed for 12 h. After cooling to room 
temperature , CH 2Cl2 (50 mL) was added, and the o rganic layer was washed with HP 
(three times). The organic layer was dried over MgSO.~, and the solvent was removed in 
vacuo. The crude product was subjected to column chromatography (EtOAc/MeOH, 4/ I) 
to give 0.48 g (36%) of 14 as a yel low oil. 1H NMR (CDC I3 , 300 MHz) 8 6.5 1 (2 H, s), 
5 .24 (2H, s) , 4.2 1 (2H, t, J = 4.8 Hz), 3.64-3.66 (18H , m), 3.53 (2H , t, 1=6.9 Hz), 2.84 
(2H, s), 2.32 (2H , t , 1=7.5 Hz), 1.88 (2H, t, 1=7. 1 Hz). 13C NMR (CD2C l2, 300 MHz) 8 
176.80, 173.0 1, 136.99, 8 1.50, 73.04, 7 1.01 , 70.96, 70.79, 69.53, 64. 14, 62.09, 47.96, 
38.34, 3 1.49, 23.27. IR (NaCI plate): 4015 .1, 3479.7, 2878.7 , 1947.7 , 1767.4, 1734.6, 
1696.4, 1636.3 , 1439.6, 1401.4, 1352.2, 1100.9, 1019.0, 953.4, 876.9 , 7 18.5, 647.5, 587.4 
cm·1 • HRMS (DCI/ H ,) calcd for (MNHY 489.2448 found 489.2460. 
Exo-(3,5-dioxo-4-aza-tricyclo[5.2.1.02•6]dec-8-en-4-yl)-acetic acid methyl ester 
(15). A literature procedure11 was followed except that CH2C l2 was used as the solvent 
to g ive 15 in 59% yie ld as a wh ite solid. 1H NMR (CDCI 3 , 300 MHz) 8 6.29-6.30 (2H, 
11 6 
m), 4.22 (2H , s), 3.73 (3H, s), 3.30-3.32 (2 H, m). 2.75 (2H, d, J = 1.5 Hz), 1.70 (1 H. d, J 
= 9.9 Hz), 1.52 ( I H, d. J = 9.9 Hz). 
Exo-2-(3,5-d ioxo-4-aza-tricyclo[5.2.1.02·6]dec-8-en-4-y 1)-propionic acid me thy I 
ester (16). Compound 16 was synthesized according to lite rature procedure' ' in 51 % 
yie ld. 1 H MR (CDC13 , 300 MHz) 8 6.27-6 .28 (2H, m), 4 .75 ( I H, q, J = 7.5 Hz), 3.70 
(3 H, s), 3 .27-3 .28 (2H, m), 2.69-2.70 (2H, m), 1.53 (3H, d , J = 7.2 Hz), 1.50-1.54 (2H, 
m ). 
2-te rt- B u tox y ca rbo n y lam i no-propionic acid exo-3,5-dioxo-4-aza-
lricyclo[5.2.l.02·6]dec-8-en-4-ylmethyl ester (17). 7 (0 .30 g, 1.45 mmol) , N- (re rt-
butoxycarbonyl)-L-alanine (0.27 g, 1.45 mmol), DCC (0.30 g, 1.45 mmol), and DMAP 
(0.03 g, 0 .22 mmol) were st in·ed in C H2Cl2 ( 18 mL) for 12 h. T he solution was fil tered 
and the solvent removed in vac11o. The residue was subjected to column chromatography 
twi ce (EtOAc, fol lowed by EtOAc/hex, 8/2) to give 0.33 g (6 1% yie ld) of 17 as a sticky 
so lid . ' H MR (CD3Cl , 500 MHz) 8 6.29 (2H, s), 4.99 (1 H, bs), 4. 11 -4 .32 (3 H, bm). 
3.75-3.79 (2H, m), 3.29 (2H. d , J = 10. 1 Hz), 2.7 1 (2H, s), 1.52-1.54 ( lH, m), 1.43 (9H. 
s), 1.35 (3 H, d, J = 7.2 Hz), 1.27- 1. 29 ( I H, m). 13C NMR (CDCI3 , 300 MHz) 8 177.89, 
173.33 , 155 .33, 137.79, 79.87 , 6 1.69, 49 .33, 47.83, 45.22 , 42.73, 37.49, 28.3 1, 18.39. IR 
(NaCl plate): 3366.2, 2977.5 , 2936.6, 1747. 1, 1696.0, 1506.7 , 1450.4, 1389. 1, 1363.5 , 
1327.7, 125 1.0 , 11 64.0 , 1061.7 , 990. 1, 775.3, 7 19.0, 642.3 em·' . [a]D23 = - 19.0. HRMS 
(DC!/ H3) calcd for (M Ht 379.1 869 found 379. 187 1. 
[(Bicyclo[2.2.1]hept-5-ene-endo-2-carbonyl)-amino]-acetic acid methyl ester 
(19). T rie th ylamine ( 1.41 mL, 10 .1 4 mmol) and glycine methyl ester hydrochloride (0.64 
g, 5.06 mmol) were added to a solution of endo 18 (0.70 g , 5.06 mmol) in CH2C l2 (75 
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mL) . HOBT (1.03 g, 7.62 mmol) was added, and the solution was stirred until all solids 
had dissolved. Then a solution of EDC (0.97 mg, 5.06 mmol) and triethy lamine ( 1.4 1 
mL, 10.14 mmol ) in CH2C I2 (25 mL) was added and the mi xture was stirred for 24 h. 
The organic layer was washed successively with 10% ci tric acid, H20 , sat. NaHC03 , and 
brine, dried over Mg$04 , and the solvent removed in vacuo. The c rude product was 
subjected to column chromatography (ether) resulting in 0.70 g (66% yield, II % exo) of 
19 as a white so lid. 1H NMR (CD2CI 2, 300 MHz) 8 6. 17-6. 19 (lH, m) , 5.94-5.97 ( 1H, 
m) , 3.92 (2H, d , J = 5.7 Hz), 3.70 (3H , s), 3. 14 (1 H, bs), 2.87-2.92 (2H, m), 1.85-1.93 
(lH, m), 1.28- 1.43 (3H, m). 13C NMR (CD 2CI2 , 300 MHz) 8 174.62, 17 1.16 , 138.03 , 
132.73, 52.58, 50.39, 46.77 , 44.80, 43.26, 41.46, 29 .84. lR (NaCI plate): same as for 20 
(vide infra). 
[(Bicyclo[2.2.1 ]hept-5-ene-exo-2-carbonyl)-amino ]-acetic acid methyl ester 
(20). The same procedure as for 19 was followed wi th 1.40 mL ( 10.06 mmol) 
triethy lamine, 0.54 g (4.30 mmol) g lyci ne methyl ester hydrochl o ride, 0.57 g (4. 10 
mmol ) exo 18, 0.83 g (6. 14 mmol ) HOBT, and 0.79 g (4. 10 mmo l) EDC in 40 mL of 
CH2CI2 resulting in 0 .63 g (73 %) of 20 as an off-white so lid. 'H NMR (CDCI3, 400 
MHz) 8 6. 10-6. 13 (2H, m) , 6.01 (1 H , bs), 4.05 (2H, dd, J = 4.8 Hz, 17.9 Hz), 3.75 (3H, 
s) , 2.96 (lH, s), 2.9 1 (lH, s), 2 .06-2.08 ( 1H, m), 1.90- 1.95 (lH, m), 1.67 (lH, d, J = 8.0 
Hz), 1.34 (2H, d , J = 9.2). 13C NM R (CD,CL, 300 MHz) 8 175.92, 170.97, 138.48, 
136.25, 52.43, 47.48 , 46.45 , 44.49, 41.94, 41.42, 30.59. IR (NaCI plate): 33 15. 1, 3059.3, 
2957. 1, 2865.0, 1747.1 , 1644.8 , 1532.3, 1440.2, 1404.4, 1368.6, 1327.7, 1204.9, 1097 .5, 
1046.4, 1010.6, 898.0, 852.0, 790.6, 7 19.0 em·'. HRMS (EI) calcd for (Mt 209. 1052 
fou nd 209. 1048. 
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B icyclo [2.2.1] hept-5-ene-exo-2-ca rboxylic acid 2- (2-(2-[2-(2-hyd roxy-ethoxy )-
ethoxy]-ethoxy)-ethoxy)-ethyl ester (21). 5-Norbornene ac id-exo-2-carboxylic acid 
chloride (1.20 g, 7.67 mmol ) was added dropwi se to a stirred mixture of penta(ethylene 
g?ycol) (2. 79 mL, 13.20 mmol ) and potassium carbonate (3.70 g, 26.80 mmol ) in THF 
( 160 mL). The reaction was heated to reflux and sti lTed for 12 h, cooled, and the solvent 
removed in vacuo. H,O was added and the mi xture was neutralized with 10% citric acid. 
The aq ueous layer was washed with CH2CI2 (3 times) , the o rganic layers were then 
consolidated, dried over MgS04 and the solvent was removed in vacuo. The residue was 
subjected to column chromatography (EtOAc/MeOH, 911) to g ive 1.4 g (53%) of 21 as a 
co lorless oil. 1H NMR (CDCI3, 300 MHz) 0 6.07-6.14 (2H, m), 4.23 (2H, t, J = 4.8), 
3.58-3.73 (18H, m), 3.03 (lH, s), 2.90 (lH. s), 2.60 (lH, bs), 2.22-2.27 (lH, m), 1.88-
1.94 (lH, m), 1.51 ( I H, d, J = 8.4Hz), 1.32- 1.38 (2H, m). 13C NMR (CDCI3 , 300 MHz) o 
176.01 , 137.87, 135.53 , 72.34, 70.38, 70.12, 69.02 , 63.29 , 61.45 , 46.47 , 46.09 , 42.83 , 
41.43, 30.15. IR (NaCI plate): 3455 .7, 2936.8 , 2864.2 , 1721.2, 1451.4, 1342.5, 1332.1 , 
1280.2, 1254.3, 1228.9 , 1171.2, 1109.0 , 1051.9, 942.9 , 859.9 , 7 19.8 cm-1 • HRMS 
(DCI/NH3) calcd for (MHr 359.2070 found 359.2082. 
[ (T ricyclo [ 4.2.1.0 2•5 ] non-7 -ene-exo -3-ca rbonyl)-amino ]-acetic acid methy I 
ester (23). Same procedure as for 19 was followed w ith 0.97 mL (6.98 mmol) 
triethylamine, 0.44 g (3.49 mmol) g lyc ine meth yl ester hydrochloride, 0 .57 g (3.49 
mmol) 22, 0.71 g (5.22 mmol ) HOST, and 0.67 g (3.49 mmol ) EDC in 30 mL CH2CI2. 
The c rude produc t was subjected to column chromatography (ethe r) to provide 0.53 g 
(65 %) of 23 as a white so lid. 1H NMR (CDCI 3, 300 MHz) 0 5.90-5.98 (2H, m) , 4.04 
(2H, d , J = 5.1 Hz), 3.74 (3 H, s), 2.7 1 (1H, s), 2.65 (IH, s), 2.3 1-2.36(2H , m), 2.14 (IH, t, 
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J = 7.2 Hz), 1.99 ( lH, t, J = 7.8 Hz), 1. 54- 1.66 (2 H, m), 1.32 (lH, d, J = 9.3 Hz). ' 3C 
MR (CDCI3, 300 MHz) 8 175 .68, 170.59, 135.75, 134.39 , 52.22, 43.97 , 43.85, 41.16, 
40.35, 40.28, 38.70, 34. 12 , 23.68. JR ( aCI plate): 3287.8, 3062.8 , 2966.4, 2355 .9 , 
\7 54 .9, 164 7.8 , 1540.7 , 1433.6, 1369.3 , 1203.3, 1048.0, 989.0 , 699.9, 507.1 em·' . 
HRMS (DEI) calcd for (M+) 235. 1208 found 235. 120 1. 
Norbornene G-R(Pbf)-G-D(O'Bu)-OH monomer (24). H" -G-R(Pbf)-G-
D(O'Bu)-resin (0.50 mmol peptide, 4-carboxytrityl lin ker Novasync· resin ) was placed in 
a fla sk containing a frit and stopcock. The resin was swell ed in 17 mL of DMF for 15 
min and then rinsed with DMF ( I x 10 mL). In a vial , 0 .28 g (2.00 mmo l) of exo 18, 
0.76 g (2.00 mmol ) of 2-(/ H -ben z otri azo le-1 -y l )- 1, I ,3 ,3- te tramethy I uron i urn 
hexaflurophosphate (HBTU), and 0 .27 g (2.00 mmo l) of HOBT in 17 mL of DMF were 
agitated until all solids had d i o lved. N,N-dii sopropy lethylamine (OlEA) was added 
(0.70 mL, 4.00 mmol ) and the solution was agitated and added to the resin . itrogen was 
ge ntl y bubbled through the mi xture for 2 h. The solution was removed, and the resin was 
then rinsed wi th DMF (5 x 10 mL), CHoClo (5 x 10 mL), and MeOH (5 x lO mL) and 
dried fo r 24 hat 30 millito tT. In a vial , 33 mL of aceti c acid, CH~CI ~, and MeOH (5:4: 1) 
were added to the dry resin and the vial was periodicall y swirled for 1.5-2 h. The 
solution was filtered to remove the resin , added to an excess of hex, and the solvent was 
removed in vacuo. The procedure was repeated to remove a ll of the acetic ac id. The 
product was freeze-dri ed from benzene to give 24 in 76-97% yie ld as an off-white solid. 
HPLC: sing le peak at 21.94 min . ' H NMR (CD~CI 2 , 600 MHz) 8 7 .89 (lH, bs), 7.50 (lH, 
b), 7.42 ( 1H, bs), 7.06 ( lH, bs), 6.2 1 (2H , bs), 6.03 ( IH, s), 5.99 ( IH, s), 4 .65 ( lH, bs) , 
4.38 ( 1 H, bs), 3.96 (lH, bs) , 3.87 (2 H, bs), 3.75 (lH, bs), 3. 13 (2H, bs), 2.88 (2H, s), 2.83 
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(I I--I, s), 2.78 (l H, s), 2.71 (2H, bs), 2.46 (3H, s), 2.40 (3H, s), 2.07 (lH, bs), 1.99 (3H, s), 
1.80 (I H, bs), 1.72-1.75 (lH, m) , 1.63 (1H, bs), 1.48-1.52 (3H, m), 1.35 (6H, s), 1.29 
(9H, s), 1.17-1.22 (2H, m) . NOESY cross peaks (CD 2Cl 2 , 600 MHz) 8 7.89 (G2N11 ) , 4.38 
(Ra) ; 7.50 (DNII) , 3.96 (G2,...) , 3.75 (G2a); 7.42 (RN11 ) , 3.87 (G 1a); 7.06 (G 1 ~"H) , 2.07 
(norbornene). TOCSY cross peaks (CD 2Cl2 , 600 MHz) 8 norbornene: 6.03 , 5.99, 2.83, 
2.78 , 2.07 , 1.72-1.75 , 1.48- 1.52, 1.17-1.22; Gl: 7.06, 3 .87; R: 7.42, 4.38, 3.13, 1.80, 
1.63 , 1.48-1.52; Pbf group: 2.88, 2.46, 2.40, 1.99; G2: 7.89 , 3.96, 375; D: 7 .50, 4.65, 
2.71. 13C NMR (CD,Cl,, 300 MHz) 8 178.0 1, 173.79, 173.58 , 171.27, 170.64, 170.44, 
159.11 , 156.99 , 138.60. 138.33, 136.42, 132.84, 132.64, 128.64, 125.19, 117.82, 86.87, 
8 1.96, 71.73, 70.68 , 70.28, 69.07 , 66.95, 49.77, 47.54, 46.52, 44.31, 43.43, 41.96, 37.59, 
30.77, 28.66, 28.12, 25.68, 19.48, 18. 15, 12.57 . IR (NaCI plate): 3445.2, 3310.3, 3050.9, 
2967.9, 2936.7, 1726.4, 1638.2, 1544.8 , 1456.6, 1368.4, 1291.5, 1245.2, 1152.8, 1101.4, 
I 029.5 , 956 . 1, 899.6 , 848.2 , 807. 1, 786.6, 704.4, 668.4 , 560.5 cm· 1 • HRMS 
(DCM/NBA/NaCI) calcd for (MNar 854.3735 found 854.3707. 
Norbornene S(O'Bu)-R(Pbf)-N(Trt)-OH Monomer (25). The same procedure 
as for 24 was fo llowed with H2 N-S(O'Bu)-R(Pbf)-N(Trt)-resin (0.75 mmol, 4-
carboxytrity llinker Novasyn® resin), 0.47 g (3.00 mmol) of exo 18, 1.14 g (3.00 mmol) 
of HBTU, 0.41 g (3 .00 mmol) of HOBT, and 1.00 mL (6.00 mmol ) of DIEA in 19 mL of 
DMF to yield 0.72 g (92%) of 25 as a fluffy , white so li d. HPLC: single peak at 28.86 
min. 1H NMR (CD2CI2 , 600 MHz) 8 7.54 (IH, bs), 7.38 (IH, bs) , 7.07-7.13 (15H , m), 
6.46 ( II--I , bs), 6.01-6.03 (3 H, m), 5.84 (lH, bs) , 4.65 (1H, bs), 4.52 (lH, bs), 4.37 (lH, 
bs), 3.62 (1 H, bs), 3 .37 (lH, bm) , 3. 15 (lH, bs), 2.92-2.95 (2H , bm), 2.87 (2H, s) , 2.75-
2.79 (3H, bm), 2.43 (3H, s), 2.37 (3H, s), 2.02 ( 1H, bs), 1.98 (3H, s), 1.73- 1.79 (2H, bm), 
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1. 50- 1.54 (2H, bm) , 1.42 (2H , bm), 1.37 (6H , s) , 1.1 8- 1.26 (2H. bm) , 1.07 (9H, s). 
TOCSY cross peaks (C02Cl:! , 600 MHz) 8 norbornene: 6.03 , 6.0 1, 2.79 , 2.02, 1.78 , 1.52, 
1.22; Ser: 7.54, 4.65 , 2.96, 2.75 ; Arg: 7.38, 5.84, 4.52, 3. 15, 2.92 , 1.79, 1.5 1, 1.42; Pbf: 
2.87 , 2.43, 2.37, 1.98; Asn: 7.07, 6.46, 4.37, 3.62, 3.37. 13C NMR (CDC\3 , 300 MHz) 8 
176.40, 176.26, 173.98, 173. 16, 172.7 1, 170.27 , 170. 14 , 144.14, 138.53, 138.24, 137.99, 
136. 14, 135.85, 132.73, 132.36, 128.68, 127.78, 126.85 , 124.44 , 117.46, 86.25 , 73.99, 
70.95, 70.53 , 6 1.84, 53.53 , 52.02 , 49.89, 47.40, 46.92, 46.32, 46.2 1, 44.41 , 43.30, 41.57, 
39.40, 37.85 , 30.83, 30.29, 29.7 1, 28.57, 27.3 1, 25.00, 19.28 , 17 .97, 12.4 1. IR (NaCl 
plate); 3434.9, 333 1.1 , 306 1.3, 2967.9, 2926.4, 2874.5 , 1726.4, 1643.0, 1550.0, 1492.9, 
1446.2 , 1394.3 , 1368.4, 1332. 1, 1254.2, 11 92.0, 1155.6 , 1098 .6 , 103 1.1 , 994.8 , 953.3 , 
90 1.4 , 854.7, 802. 8, 756. l , 699.0 , 667 .9 , 636.0 , 621. 1, 569.3 c m· 1 • HRMS 
(DCM/NBA/NaC l) calcd for (MNat I 068.488 1 found 1068.4873. 
R(Pbf)-G-D(0 1Bu)-OH Monomer (29). The same procedure as for 24 was 
followed with H2N-R(Pbf)-G-0(0
1Bu)-resin (0.25 mmol, 4-carboxytrity l linker Novasyn@. 
resin), 0.25 g (1.00 mmol) 8, 0 .38 g (1.00 mmol ) HBTU, 0. 14 g ( 1.00 mmol ) HOBT, and 
0.35 ml (2.00 mmo l) OlEA in 8 mL DMF to yield 0.1 8 g (83%) of 29 as a white solid. 
HPLC: single peak at 21.90 min. 1H NMR (CD 2Cl2, 600 MHz) 8 7.97 ( I H, bs), 7.6 1 (I H, 
bs), 7. 19 (IH , bs), 6.37 (5H, bs), 5.10 (2H, s), 4.63 ( 1H, bs), 4.29 ( 1H, bs), 3.93 ( IH, bs), 
3.72 (lH, bs) , 3.39 (2H, bs) , 3. 16 (2H, bs), 2.87 (2H, s), 2.75 (2H, bs) , 2.68-2.72 (2H , 
bm), 2.46 (3H , s) , 2 .39 (3 H, s), 2. 18 (2H, bs), 1.98 (3H , s), 1.86 (2H, bs), 1.73 ( I H, bs), 
1.58 ( 1H, bs), 1.50 (2 H, bs), 1.36 (6H, s), 1.33 (9H, s). TOCSY cross peaks (CD 2C I2 , 600 
MHz) 8 norbornene: 6.37 , 5.10, 3.39, 2. 18, 1.86. 1.73 ; R: 7. 19, 6.37, 4.29, 3. 16, 1.86, 
1.58, 1.50; Pbf group: 2.87 , 2.46, 2.39, 1.98, 1.36; G : 7.97, 3.93, 3.72; D : 7.6 1, 4.63 , 
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2.68-2.72. 13C NMR (CD,CI,, 300 MH z) 8 177.50, 174.09, 170.68, 170.60, 159.0 1, 
157 .04, 138.52, 136.79, 133.1 3, 132.55 , 128.636, 125.17, 117.77, 86.85, 81.75, 81.28, 
72.75, 70.47 , 69.94, 6 1.44, 50.12, 47.90, 43.42 , 38.12, 37.74, 32.33, 29.07, 28.66, 28. 14, 
~5.76, 23 .47, 19.43, 18.14, 12.55, 1.11. IR (NaCI plate): 3435.3, 3331.5, 2968.3 , 2926.8, 
2522.0, 1695.5, 1653.9, 1545.0, 1446.4, 1404.9, 1368.6, 1254.4, 1155.8, 1098.8, 1020.9, 
917.2. 875.6, 849.7, 803.0, 730.4, 657.7, 569.5 cm·1• HRMS (DCM/NBA/NaCI) calcd 
for (MHr 888.3813 found 888.3778. 
Polymer Synthesis 
General Synthesis for Polymers with Pendent a lanine, glycine, or E05• In a 
nitrogen-fi lled dry box, a solution of 1 in CH2Cl2 was added to a solution of monomer 
CH2CI2 (or CD 2CI 2 for NMR reactions) to give an initial monomer concentration of 0.7-
0.75 M. The initial [M]0/ [C]0 was I 0011. The reaction mixture was stirred at room 
temperature for 15 min to 3 h before quenching with ethyl vinyl ether and stirring for an 
additional 15-30 min. The polymers were precipitated into ether or hex, stirred for 15 
min , and subjected to centrifugation. The solvent was removed and the solids dried unde r 
vacuum. The polymers were all white to tan powders, except for Poly( l4) and Poly(21) 
which were viscous oils. Deviations from this literature procedure are noted in specific 
cases below. (Data not reported within the text is also reported be low.) 
Poly(9). 1H NMR (CDCI 3 , 300 MHz) 8 6.06, 5.79 (trans & cis, 2H, bs), 4.91-
4.97, 4.44-4.53 (cis & Tran s, 2H, bm), 4.20 (trans & cis, 2H, bs), 3.74 (trans & c is, 3H, 
s), 3.40 (trans & cis, 2H, bs). 13C NMR (CDC! ,, 300 MHz) 8 174.77, 167.05, 130.94, 
130.71 , 80.74, 53.32, 52.84, 52.34, 39.37. IR (NaCI plate): 3662.0, 3468.5 , 2998.0, 
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2957.1 , 2854.8 , 1782.9. 1752.2, 1711.3, 14 19.8, 1368.6, 1322.6, 1220.3, 11 69.1 , 1020.8, 
974.8 , 9 18.5, 734.4 cm·1• 
Poly(lO). The solvent was either CH~C I ~ or benzene. 1H NMR (CD~Cl ~, 300 
MHz) 0 6.08, 5.83 (trans & cis, 2H, bs), 4 .87-4.97, 4 .74-4.76 (cis & trwzs , lH, bm), 4.48 
(trans & c is, 2H, bs) , 3.7 1, 3 .70 (tran s & cis, 3H , s), 3.37 (trans & cis, 2H, bs), 1.57 
(trans & cis, 3H, bd. J = 7.5 Hz). 
Poly(ll). 1H NMR (CD:2C I2, 400 MHz) 8 6.06, 5.78 (trans & cis , 2H, bs), 5.25, 
5.16 (c is & trans, 1H, bs), 4.91-5 .00, 4.47 (cis & trans, 2H , bm, bs), 4.29 (trans & cis, 
2H, bs), 4. 15-4.19 (trans & c is, lH, bm), 3.75 (trans & c is , 2H, bs), 3.35 (trans & cis, 
2H, bs), 1.38 (tran s & c is , 9H, s), 1.30 (trans & c is , 3H, bd, J = 7.3 Hz) . 13C NMR 
(CDCI 3 , 300 MHz) 8 175.42, 173.22, 155.08, 130.99, 130 .89, 80.63, 79.83, 61.41 , 53.30, 
52.28, 49. 12, 38.20, 28.3 1, 18. 12. IR (NaC I plate): 3528 .3, 3372.6, 2967.9, 2936.8, 
2874.5, 1778.3, 1742.0. 1705.7, 151 3.7, 145 1.4, 1425.5 , 1394.3 , 1363.2 , 1332. 1, 1249.1, 
1160.8, 111 9.3, 1067.5 , 1025.9, 9 11.8, 730.2 cm·1• 
Poly(12). [M]0 was 0.6 M. 
1H NMR (CD2CI2, 300 MHz) 8 6.06, 5.79 (trans & 
cis. 2H, bs), 4.92 , 4.47 (c is· & trans, 2H, bs), 4.60 (trans & cis , 2H , s), 4 .32 (Trans & cis, 
2H, bs), 3.80 (trans & cis, 2H, bs), 3.73 (trans & c is, 3H, s), 3.38 (trans & c is . 2H, bs) . 
1.1C NMR (COcC I ~ , 300 MHz) 8 176.04 , 175.91 , 168.38 , 155. 15, 13 1.78, 13 1.49, 131.38, 
8 1.36 , 8 1.30, 8 1.24, 77.8 1, 65.24, 64.07 , 54.76, 54.40, 52.92, 38.30 . IR (NaCI plate): 
4202.5, 363 1.2, 3537.9, 3468.0 , 30 13.2, 2954.9, 2850.0, 1754.6, 1707.9, 1433.9, 1393.1 ' 
1119. 1, 1031.7, 973.4, 9 15. 1, 850.9, 78 1.0 , 705.2, 676.0, 629.4, 565.3 cm·1 • 
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Poly(13). [M]0 was 0.5 M. 
1H NMR (C0 2CI2, 400 MHz) 8 7.03 (trm1s & cis, IH, 
bs), 6 .03 , 5.79 (trans & cis, 2H, bs), 4.96, 4.48 (trans & cis , 2H, bs), 3.93 (trans & cis . 
2H, bs), 3.66 (t rans & cis. 3H. s) , 3.47 (trans & cis , 2H, bs), 3 .37 (trans & c is, 2H, bs), 
2.23 (trans & cis, 2H, bs), 1.85 (trans & cis, 2H, bs). 13C NMR (CD 2Cl2, 300 MHz) 8 
176.0 1, 173.21 , 172.91 , 135.87, 135.54, 135.24, 82.46, 8 1.56, 81.26, 55.10, 52.57, 48 .23 , 
41.77 , 41.55 , 39. 16, 38 .49, 34.69, 34.21 , 25.21. IR (NaCI plate): 3578.3, 3330.0, 308 1.6, 
2947.1 , 2854.0, 1749.2, 1702.7, 1666.5, 1542.3 , 1433.6, 1397.4, 1366.4, 12 11.2, 11 59.4, 
111 8.0, 1030.1 , 973.2, 916.3, 771.4, 704. 1, 564.4 cm-1• 
Poly(14). [M]0 was 0.55 M. 
1H NMR (CD 2CI2, 400 MHz) 8 6.05 , 5.79 (trans & 
cis, 2H, bs), 4.96, 4.45 (cis & trans, 2H, bs), 4.17 (trans & cis, 2H, bs), 3.5 1-3 .62 (trans 
& cis, 20H, bm), 3.33 (trans & cis, 2H, bs), 2.33 (trans & cis, 2H, bs), 1.86 (trans & cis, 
2H, bs). 13C NMR (CD 2Cl2 , 300 MHz) 8 176.33 , 176.22, 173.03, 13 1.60, 8 1.37, 73. 16, 
70.95, 70.9 1, 70.70, 69.50, 64.20, 61.98 , 54.81 , 52.9 1, 38.67 , 3 1.79, 31.75, 23.94. IR 
(NaCI plate): 4016.0, 349 1.3, 2908.3, 1947.0, 1777 .9 , 17 13.8, 1638.0, 1439.8, 833.4, 
769.3 , 734.3 , 705 .2, 670.2 , 576.9, 512.8 cm·1• 
Poly(lS). 1H NMR (CD 2C l2, 300 MHz) 8 5.74, 5.53 (trans & c is, 2H, bs), 4.17 
(trans & c is, 2H, bs), 3.72, 3.7 1 (trans & c is, 3H , s), 3 .45 , 3.09 (c is & trans, 2H, bs), 
2.84 , 2.76 (cis & trans, 2H, bs), 2 .13-2 .2 1 (trans & cis , IH, bm), 1.61- 1.76 (trans & cis, 
IH, bm). 13C NMR (CDCI1, 300 MHz) 8 177.47, 167.32, 13 1.89, 131.76, 52.67, 51.04, 
50.93, 45.87 , 45.73, 41.9 1, 41.07, 39.06. IR (NaCI plate): 2994.4, 2954.0, 2853.7 , 
1779.4, 175 1.4 , 1704.5, 141 3.6, 1366.7 , 1324.5, 1216.6, 11 69.7 , 972.7, 916.4 , 766.3 , 
733 .5, 6!6.2 cm·1• 
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Poly(l6). 1H MR (CD2CI2, 300 MHz) 8 5.74-5.78, 5.57-5.59 (t rans & cis , 2H, 
br m), 4.76 (trans & cis, I H, br q , J = 7.5 Hz), 3.74 , 3.7 1 (trans & cis, 3H, s), 3. 19-3.25, 
3.07-3.14 (cis & trans, 2H, br m), 2.76 (trans & cis, 2H, br s), 2. 10-2.22 (trans & cis, 1 H, 
br m), 1.82- 1.90, 1.60-1.75 (cis & trans, IH, br m), 1.55 (trans & cis , 3H , d , J = 7.2 Hz). 
J:'C NMR (CDCI3 , 300 MHz) 8 177.43 , 177.23, 169.70, 133.40, 132.01 , 13 1.77 , 52.75, 
52.28, 50.77, 47.7 1, 45.78 , 45.65 , 41.93 , 41. 84 , 40.87, 14.23 , 14 .02. IR (NaCI plate) : 
3003.8, 2947.5, 2863 . 1, 1774.8, 1742.0 , 1704 .5, 1451.2, 1390.2, 1357.3, 13 10.4, 1230.7, 
1197.9, 111 8. 1, 1071.2, 972.7, 9 11.7, 785. 1, 733.5, 625.6 cm·1• 
Poly(17). 1H MR (CDCI 3, 300 MHz) 8 5.73, 5.49 (trans & cis, 2H, bs), 5. 17, 
5.07 (cis & trans, 1 H, bs), 4.22-4.28 (trans & cis, 3H, bm), 3.70 (trans & cis, 2H, bm). 
2.96-3.05 (t rans & cis, 2H, bm), 3.23, 2.70 (c is & trans, 2H. bs), 2.05-2.27 (trans & cis, 
I H, bm), 1.55- 1.67 (trans & cis , 1H, bm), 1.40 (trans & cis, 9H, s), 1.32 (trans & cis, 3H, 
d, J = 7.2 Hz). 13C NMR (CDCI 3 , 300 MHz) 8 177.9 1, 173.09, 155.04, 13 1.87 , 13 1.75 , 
79.77 , 6 1.65 , 51.65, 50. 78, 49. 12, 47.55 , 45.59, 42 .19, 40.79, 37.73, 28 .32, 18.27. IR 
(NaCI plate): 3439.0, 3364.9, 2973 .2, 2930.9, 2867.4, 1766.8, 1745 .6, 1703.3, 1512.7, 
1449.2, 1422.7 , 1391.0, 1364.5, 1332.8, 1248.1 , 1163.4, 111 5.7, 1068. 1, 1020.5 , 972.8 , 
9 14.6, 729.4 cm·1• 
Poly(19). The reacti on time was 26 h. 1H NMR (CD2C I2_ 300 MHz) 8 5.40-5.59 
(trans & cis, 2H, bm). 3.89-4.02 (trans & c is, 2H, bm), 3.74 (trans & cis, 3H, s), 2.66 
(trans & cis, 2H, bs), 2.48 (trans & cis, 1 H , bs), 1.57- 1.98 (rrans & cis, 2H, bm), l.lO-
1.45 (trans & c is , 2H, bm). 13C NMR (CD2Cl2 , 300 MHz) and IR (NaCI plate): same as 
for Po ly(20) (vide i1~{ra). 
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Poly(20). 1H NMR (CDCI,, 400 MHz) 8 6.40, 6.03 (cis & trans, 1 H, bs), 5. 18-
5.55 (trans & cis, 2H, bm) , 3.88-4.08 (trans & cis , 2H , bm), 3.72 (trans & cis, 3H, s), 
3.0 1, 2.65 (c is & trans , 2H, bs), 2.47, 2.38 (c is & trans IH, bs), 2. 17 (trans & cis, 1H, 
bs), 1.94, 1.84 (cis & trans, 1H, bs), 1.57- 1.61 (trans & cis, 1 H, bm), 1.1 5- 1.20 (trans & 
cis, IH, bm). 13C MR (CD,Cl,, 300 MHz) 8 176.12, 175 .49, 171.97, 17 1.16, 170.79, 
135.54, 134.96, 133.87, 133.04, 13 1.78 , 128.77, 52.46, 5 1.76, 5 1.1 7, 50.86, 49.43, 48.30, 
43.62 , 42.99 , 42 .36, 4 1.48, 37.75 , 37.55 , 37.01 , 36.73, 36.36, 36. 15 . IR (NaCl plate): 
3300.0, 3082.1 , 2947.2, 2843.4, 1752.4, 1648.6, 1534.4, 1437.7, 1404.7, 1363.2, 1259.4, 
1202.4, 1181.6, 103 1.1 , 968.9, 844.3, 797.6, 750.9, 704.2 cm·1• 
J>oly(21). [M]0 was 0 .5 M. 
1H NMR (CD1CI1 , 400 MHz) 8 5.33-5.40, 5.1 8-5 .25 
(trans & cis, 2H, bm), 4. 11 -4 .19 (trans & cis, 2H, bm), 3.5 1-3.64 (trans & cis, 18H, bm), 
2.69-3.07 (cis & trans, 2H. bm), 2.5 1-2.58 (trans & cis , I H, bm), 1.78-2.40 (trans & cis. 
2H, bm), 1.48- 1.66 (trans & cis, I H. bm), 1.1 3- 1.22 (trans & cis, I H, bm). 13C MR 
(C DCI 3, 300 MHz) 8 175.74, 134.36, 133.4 1, 132.50, 13 1.92, 13 1.06, 128.38, 125.88, 
72.53 , 70.42, 70.15 , 69 .07 , 63.28, 6 1.52. 49.92, 49.25, 47.30, 42.83 , 41.85, 40.90, 36.91 , 
36.82. 1R (NaCl plate): 3445.3, 2936.8, 2874.5 , 1726.4, 145 1.4, 1347.6, 1285.4, 1249.1 , 
11 7 1.2, 1114.2, 968.9, 942.9, 875.5 , 854.7 cm·1• 
Poly(23). [M]0 was 0.6 M. 
1 H NMR (CD 2CI2, 300 MHz) 8 6.43-6.8 1 (trans & 
cis, I H, bs) , 5.08, 5.3 1 (trans & cis, 2H. bs), 3.93 (trans & cis, 2H, bs), 3.67 (trans & cis, 
3H, bs), 2.76 (trans & cis, 2H, bs), 2.36-2 .60 (trans & cis , 2H, bm), 2.09 (trans & cis, 
I H, bs), 1.82 (trans & cis , I H. bs), 1.1 5- 1.43 (trans & cis , 3H , bm). 13C NMR (CD 2CI1 , 
300 MHz) 8 176. 10, 175.98, 17 1.19, 17 1.10, 133.66, 133.34, 132.58, 54.50, 52.66, 42.98, 
44.27 , 4 1.70, 35. 14, 32. 11 , 28.23, 28.27, 25.76, 23. 19, 14.42. IR ( aC l plate): 330 1.9 , 
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3073.5 , 2921.2, 2856.0. 1753.7, 1650.4, 1536.2, 1438.3, 1405.7, 1373. 1, 12 10.0, 11 88.2, 
I 035.9, 1003.3, 965.3, 845.6. 704.3, 67 1.6 cm·1 • 
General Polymerization Procedure for RGD, SRN, and E05 Containing 
Polymers. Method 1: ln a nitrogen-fil led dry box , a soluti on o f 1 in CH2C\2 was added 
to a solution of monomer in C H2C\ 2 to g ive an initial m o no mer concentration of 0.70 M . 
The initial [M]0/[C]0 was I 0/1 (homopo ly me rs) or 20/1 (copo lyme rs). The reaction 
mixture was stined at room te mperature fo r 4 h be fo re que nching w ith e thyl vinyl ether 
and stilTing for an additional 15-30 min before isolatio n. 
Method 2: In a nitrogen-fi ll ed dry box , a solutio n of 2 or 3 in C H 2C I2 was added 
to a soluti on of monomer in MeOH ( I : I C H 2CI 2:Me0H) in a dram to g ive an initial 
m onomer concentratio n of 0.6 M (po lymers conta in ing RGD/S RN o nl y) or 0.7 M 
(polymers containing E05). The dram was sealed and removed from the box. Within I 0 
min. the dram was placed in an oi l bath at 55 ·c and the solutio n was stined for 2 h. The 
initial [M]0/ [C]0 was 10/J (polym e rs containing RGD and/or SR o nl y) or 20/1 
(pol y me rs conta ining E05 ). The polymerization mixtures were coo led to room 
temperature, diluted , and ethyl vin yl e ther was added. T he soluti o ns were stined for an 
addi ti o nal 15-30 min before isolation. 
The po lym ers were precipitated into e ther (26a), e ther/CH 2C\2 ( 1/3) (26b, 27b, 
28a), ethe r/CH 2C\ 2 (1/1 ) (27a), e the r/ MeOH (113) (28b), or MeOH (26c). The polymers 
were subjec ted to centri fugat ion, the so lvent was removed and the solids dried unde r 
vac uum. The po lymers were th en c harac te ri zed by 1 H MR spectroscopy and 
deprotected. 
128 
General Deprotection Procedure. For all po lymers, except 27b, the fo ll owing 
procedure was unde rtaken . A so luti o n of TFA, trii sopropy ls il ane (TIS ), and H~O 
(95/2.5/2.5) was added to the dried polymers to make a fin a l concentrati on of 20 mL/g 
polymer. The mi x tures were stirred for 2-7 h be fo re precipitating into cold ether. The 
po ly mers were subjected to centrifugati on , the solvent was re mo ved , and the so lids 
washed with cold e the r (2 x 5 mL) be fo re drying under vac uum. Po ly mer 27b was 
subjected fo r I h to 9.5 mL of condensed HF a nd 0.5 mL o f p-c reso l in the proper 
containment apparatus. The HF was removed in vacuo and the solid was washed with 
e the r before drying under vacuum. 
Solubilization in Water. The pol ymers (except fo r 26a and 30) were subjected 
to a minimum amount of 0 . 1 N NaOH for 10 min . Po lymer 26a was a lready soluble in 
water, and po lymer 30 was subjected to pH 8 phosphate buffer fo r 10 min . The po lymers 
were then precipitated into MeOH , subjected to centrifugati o n, and dri ed under vacuum 
to yie ld the fina l po lymers as tan powders (26c, 27b, 28b), g lassy solids (26b, 27a, 28a), 
and a stiff ge l (26a). 
Specific Methods and Data. Data not reported in the text is reported be low. 1H 
NMR copo lymer spectrum is the additi on o f the two homopo lymer spectra. Al l peaks are 
broad . Charac te ri zati on, except fo r GPC , of 26b and 27a was performed prio r to 
treatme nt with base. 
26a. Meth od 1 was fo ll owed . Additi ona l purificati o n was achi eved before 
de pro tecti o n by so lubili zi ng the po lyme r in e than o l and subjec tin g the so lutio n to 
centri fugati on us ing a Centriprep fl as k (MWC0=3000). The re moval of the mo no mer 
was monitored by HPLC. T he e thanol was removed in vacuo, and the po lymer was dried 
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under vacuum. 1H MR (CD,OD, 400 MH z): 8 5.4 1-5.48, 5.23-5 .30, 4.74-4.79, 4.5 1-
4 .55, 4.37-4.4 1, 4.19-4.22 , 3.91 -3.94, 3.79-3.82, 3.54-3.69. 3.20-3.23 , 3.0 1-3. 17, 2.94-
3.06, 2.86, 2.60-2.73, 1.95-2.05, 1.66- 1.73 , 1.1 8- 1.28. TR (KBr pellet): 3420.9, 2929.7 , 
288 1.6, 1781.2, 1728.2, 1665.6, 163 1.9, 1554.9, 1545.2, 1453.7, 138 1.5, 1352.6, 125 1.5, 
1203.4, 11 74.5 , 1097.4, 967.4, 948.2, 885.6 , 803.7 , 697.8, 582.3 , 514.8 cm·1• 
26b. Method 2 was followed . Characterization is iden ti ca l to 26a except the 
peaks vary in intensity. 
26c. Method 2 was followed except that 3 was the init iato r. 1H MR (D,O, 400 
MHz) 8 5.20-5.48 (trans & cis, 2H, bm), 4.37 (trans & cis, 1H, bs), 3.76-3 .99, 3 .60-3.67 
(trans & cis , 4H, bm), 3. 17 (trans & cis, 2H, bs), 2.84-3.02. 2.57-2.65 (cis & trans, 5H, 
bm), 1.63-2.0 1, 1.15- 1.42 (trans & cis, 8H , bm). IR (KBr pe llet): 3320.7, 2936.8 , 
1664.1, 1534.4, 1399.5, 1300.9, 1249.0, 11 34.9, 1025.9, 968.8 , 865. 1, 750.9, 683.5 , 62 1.2 
27a. Method 2 was fo ll owed. 1H MR (CD30D, 400 MHz): 8 5.38-5.49, 5.21-
5.3 1. 4.71-4.78 , 4.52-4 .54, 4.44-4.49, 4. 18-4.25. 3.79-3.8 1, 3 .63-3 .69, 3.56-3.58, 2.97-
3 .26 , 2 .53-2.82, 1.1 9-2.09 , 1.64- 1.77, 1.16- 1.28. IR (KBr pe lle t): 3468 .6, 2954.9 , 
2872.7, 1763.4, 1732.5, 1696.6, 1450.0, 1383.2, 130 1.0, 1259.9, 12 18.8, 11 72.6 , 11 05.8 , 
1033.9, 900.3 , 746.2, 699.9, 643.4, 602.3, 56 1.2 cm·1• 
27b. Method 2 was followed. 1H MR (D 20, 400 MHz) 8 5.24-5.49 (tran s & 
cis, 2H. bm), 4.34-4.50 (trans & cis, 2H, bm), 3.79 (tran s & cis , 2 H, bs), 3 . 15 (trans & 
cis, 2H , bs), 2.54-2 .76 (trans & cis, 5H, bm), 1.1 8- 1.96 (trans & cis , 8H, bm). IR (K.Br 
pe llet) : 335 1.9, 2926.4, 2864.2 , 1653.8, 1524. 1, 1389.2, 1306.1, 1249. 1, 11 97.2 , 1150.5 , 
I 083.0, 89 1.0 , 750.9, 600.5 , 553.8 em·'. 
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28a. Me thod 2 was fo ll owed. ' H NMR (CD300, 400 MH z): 8 5.39-5.48, 5.21-
5.3 1, 4.75-4.80, 4.52-4.54, 4.44-4.49, 4.37-4.4 1' 4.2 1' 3.94, 3.80-3.83, 3 .63-3.72, 3.57, 
2.99-3.26 , 2.87, 2.53-2.82 , 1.90-2.09, 1.62- 1.78 , 1.1 5- 1.27. IR (KB r pe llet): 3460.6, 
2952.0, 2870.6, 1733.4, 1646.9, 1586.0, 1580.8, 1453 .6 , 1387.5, 1362. 1, 1290.8, 1189.1 , 
1036.5, 899.2, 746.6, 700.8, 644 .9, 604.2, 558.4 em·'. 
28b. Method 2 was fo llowed. 'H NMR (CD300, 400 MHz): 8 5.26-5.48, 4.33-
4.48, 3.80-3.98, 3. 17 , 2.86-3.02, 2.56-2.77, 1.56-2.05, 1.1 2- 1.29. IR (KB r pe llet): 
3476.4, 2947.2, 2864.2, 1767.9, 1705.7 , 1643.4, 1596.7, 1575.9, 145 1.4, 1378 .8, 1295.8 , 
1254.2, 1238.7, 11 29.7, 1020.8 , 90 1.4, 839.2, 745.8, 699. 1, 642.0 , 600.5 , 599.0 em·' . 
30. Method 2 was fol lowed. 'H NMR (0 20, 400 MHz) 8 6.06, 5.79 (t rans & cis, 
4H, bs), 4.96, 4.46 (cis & trans, 4H, bs) , 4. 18 (t rans & cis, 4 H, bs), 3.55-3.64 (trans & 
cis , 20H, bm), 3.34 (t rans & cis, 4H, bs), 2.89 (trans & cis, 2H, bs), 2.35 (trans & cis, 
4H, bs), 1.98 (trans & cis, 2H, bs), 1.87 (trans & cis, 4H, bs). IR (KBr pe llet): 3428.8, 
2905.9, 246 1.7, 1802.4, 1702.3, 1384.6, 1372.0 , 11 68.8, 1076.8, 946.7, 856.6, 548.44, 
5 15.7cm·' . 
Polymer Stereoisomers 
Using Initiator 1. T he polymeri zations of monomers 15, 20, and 21 with initiator 
1 are described above. 
Using Initiator 2. Monomers 15, 20, and 21 were polymeri zed with ini tiator 2 
under identical condit ions as with 1 , except that the mi xtures were heated in a sealed 
dram in a 55 OC oil bath during polymerization. T he trans to cis rati os were determined 
13 1 
from the 1H NMR spectra by integrating the peaks corresponding to the o lefinic pro tons 
of the trans and cis po lymers. 
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Chapter 5 
Inhibition of Cell Adhesion to Fibronectin by 
Oligopeptide Substituted Polynorbornenes 
135 
Abstract 
Po lynorborne nes substituted with peptide sequences from the RGD-co ntain ing 
integrin ce ll b inding domain of fibronectin are pote nt inhibitors of human dermal 
fibroblast ce ll adhesion to fibronec tin. R ing-opening metathes is polymerization (ROMP) 
us ing Ru=CHPh(C l)2(PCy,)(DH IMes) (1) as an initiato r produced polyme rs substituted 
with G RGDS and PHSRN peptide sequences. The inhibitory activity was quantified for 
these polymers and compared to the free peptides. A homopolymer substituted wi th 
GRGDS was significantl y more acti ve than the free GRGDS peptide (IC50 of 0.18 ± 0.07 
and 1.08 ± 0.5 mM respectively). and the po lymer containing both GRGDS and PHSRN 
was the most potent inhibitor (IC50 o f 0.03 ± 0.007 mM). These results demonstrate the 
applicability of ROMP to the synthesis of hi ghl y acti ve inhibitors of cell ular-extracellul ar 
matrix protein interactions. 
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Introduction 
Soluble peptides containing the arg inine-glycine-as parti c acid (RGD) sequence 
a re kn o wn to duplic ate o r inhibit the ce ll-binding o f the ex trace llular m atri x pro te in 
fibronec tin .1 As a result , thi s sequence has been targeted to pro vide treatments fo r 
di seases such as cancer." Ho wever, as di scussed in C hapte r I , because RGD pe ptides 
have low affinities and sho rt hal f- li ves in vivo, the the ra pe utic use of thi s peptide has 
been limited .3 As a resul t , muc h effort has been directed tow ards the synthes is of ROD-
conta ining m ate ri a ls and mimics that would have inc reased therapeuti c po te nti a ls 
compared to the free peptides . .~ One feas ible w ay is to substitute RGD-conta ining 
m ateri a ls w ith oli gopeptides th at enh ance the ce llular adhesio n stren g th o f the RGD 
seque nce. 
In C hapte r 4 . an exce llent method to synthesize copo lyme r substituted w ith RGD 
and o the r o ligopeptides by ring-opening me tathesis po lymerizati o n (ROMP) us ing the 
newly developed initiator 1 was described . Specificall y, hom opo lymers w ith GRGD and 
copo lyme rs containing GRGD and SR , the truncated sy ne rgy d o m ain to RGD in 
fibro nec tin , were made.5 Thi s c hapte r describes the synthes is o f ho mopol ymers and a 
copo lymer substituted with the mo re ac ti ve fo rms o f the peptides contained in the 
integrin cell binding do m ain of fi bro nectin , GRGDS and PHSR .1b.c. lo The po lymer 
substituted w ith GRGES, an inac tive peptide, was a lso made as a contro l. ' b.c The ability 
of these materi a ls to inhibit human de rma l fibro blast (HDF) cell adhesio n to fibronectin 
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Monomer and Polymer Synthesis and Characterization . Norbornene 
monomers substituted w ith o ligopeptides were synthes ized by solid-phase peptide 
che mistry . 5-Norbornene-exo-2-carboxylic acid was coupled to the amino terminus of 
peptides attached to a 4-carboxyl trityl linker res in using HBTU, HOBT and DlEA in 
DMF. The monomers were then c leaved from the resin using mildl y acidic conditions to 
give the protected monomers. All of the monomers were soluble in organic solvents. In 
thi s way, norbornenes substituted with the protected integrin binding seque nce, 
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GR(Pbf)GD(O'Bu)S(O'Bu)-OH (2), synergy seq uence PH(Trt)S(Trt )R(Pbf)N(Trt)-OH 
(3), and inactive seq uence GR(Pbf)GE(O'Bu)S(O'Bu)-OH (4) were synthesized in 9 L %, 
97%. and 47% yield respectively. While 2 and 3 were >95 % pure after cleavage from the 
resin, 4 contained an impurity whi ch persis ted in the final compound. 
0 
x or y ~R 
2 , 3, or 4 
1 . 1 , CH2CI2/ 
MeOH, 55 ·c 
2. TFA:TIS:H20 
(95:2.5:2.5) or HF: 
p-cresol (95:5) R 
R = GRGDS (5), PHSRN (6), 
GRGES (7) , or GRGDS 
and PHSRN (8) 
Scheme 1. Synthesis of homo- and copolymers wi th pendent bioactive o ligopeptides. 
Hompolymers of 2-4 and a copolymer of 2 and 3 were synthesized by ROMP 
us ing 16 as an initiato r (Scheme 1). The monomers were heated in a sealed vial in a L: I 
mixture of CH,CI , and MeOH in an oil bath at 55 OC for 2 hours. The initi a l monomer 
concentration was 0.6 M and the ini ti al monomer to catalyst ratio was I OIL. Res idual 
monomers were removed during isolati on by prec ipitati on into mixtures of CH2C I2 and 
ether. The protecting groups were then c leaved us ing either TFA or, for polymers 
containing PHSR , HF to yield the unprotected peptides. The polymers were stirred in 
0.1 N NaO H for 10 minutes to generate the sodium carboxylates. After isola tion , the 
polymers were then ri gorous ly purified by repeated centrifugation through a membrane 
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(MWC0=3000) followed by lyophili zation resulting in the products as spongy, tan-
colored materials. 
In thi s manner, polynorbomene homopol ymers substituted with GRGDS (5), 
PHSRN (6), and GRGES (7) were synthesized. The copolymer containing GRGDS and 
PHSRN (8) was also prepared. The over-a ll yields (Table 1) for the GRGDS and 
GRGES containing polymers were excellent (91 % and 84% respecti vely). The yields of 
the polymers containing PHSRN we re somewhat reduced (40% for 6 and 64% for 8 ). 
Thi s could be due to the rapid degradation of 1 in the presence of thi s peptide .7 The 
percent of GRGDS incorpo rated into the copoly mer was 49% (determined from the 'H 
NMR spectrum) which cotTesponded to the amount in the feed (50%). 
Table 1. Polymers substituted with oligopeptides.a 
Peptide %x in %x in % yield M0 (x1 0
3)c PDI 
feed polymerb overall 
GRGDS 100% 100% 91 % 12.0 1.37 
PHSRN 100% 100% 40% ns ns 
GRGDS/PHSRN 50/50% 49/51 % 64% 9.14 1.30 
GRGES 100% 100% 84% 11 .5 hs 
aGeneral reaction conditions: CH2CI2 :MeOH (1: 1) as the solvent, 55 ' C for 2 hrs. in 
sealed vial , M/C=1 0/1, [M]o = 0.6 M. bCalculated from 1 H NMR spectra. coetermined 
by GPC, pH 8 .0 phosphate buffer eluent, poly( ethylene oxide) standards. ns =not 
soluble in water. hs = high molecular weight shoulder. 
Pol ymers 5 , 7 , and 8 were readil y soluble in water and phosphate buffered saline 
(PBS). Unfortunately , the homopolymer substituted wi th PHSRN was not comple te ly 
soluble in aqueous solutio ns. The number-average molecular weights (Mn) dete rmined 
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by G PC (compared to po ly( ethy lene g lycol ) standards) were be tween 9, l 00 and 12,000. 
The polydispersity indexes (POI' ) were narrow for 5 and 8 ( 1.37 and 1.30 respectively). 
T he G PC trace of 7 exhi bi ted a s li ght hi gh mo lecul ar we ight shoulde r. As mentioned 
above, the monome r 4 conta ined an impurity whic h cou ld have caused the observed 
mo lecular weight di stribution. 
Inhibitory Activity of Polynorbornenes Substituted With Oligopeptides. It 
was origin ally hypothesized tha t po lymers substituted wi th many G RGDS peptides along 
the backbone would exhibit stronger cell -adhesive affiniti es tha n the free peptide due to 
mul t iva lent inte rac ti o ns provided by the pol ymer scaffo ld.8·9 A lso, s ince PHS R N 
e nh ances cell binding to the RGD peptide in fibron ectin ,10 it was predi c ted that a 
copo lymer substituted with both G RGDS and PHSRN may exhibit hi gher activities than 
mate ri a ls conta ining only G RG DS. T o in vestigate thi s , the ability of the po lymers and 
peptides to inh ibit HDF cell adhesion to fibronectin was de te rmined , fo ll owing a known 
procedure .1b Bri efly, no rma l HDF neonata l ce ll s were added to human plasma 
fibro nec ti n coated we ll s containing a certa in concentrati on of the po lymer and inc ubated 
at 37 OC for 1 hour. The ce ll s were fixed with methano l, and the number of cell s adopting 
a norma l, well -spread mo rpho logy was estimated by counting a number o f rando ml y 
se lected fie lds viewed by phase cont rast mic roscopy. T he percent cell attachment was 
determined by com paring the experimenta l wells to contro l wells incuba ted with PBS 
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Figure 1. Inhibition of normal HDF cell attachment to fibronectin by the polymers and 
free peptides. The HDF cells (35,000 cells/mL) were incubated in hu man plasma 
fibronectin coated wells at 37 "C for 60 min in the presence of increasing concentrations 
of soluble peptides or peptide substituted polymers. Adherent cells were fi xed and 
counted by viewing a minimum of 6 randomly selected fields per well. Each point 
represents the average of 3 wells. 
The inhibitory effects of polymers 5, 7,and 8 and peptides GRGDS, GRG ES, and 
PHSRN are compared in H gure 1. As expected , G RGDS and GRGDS-containing 
142 
polymers 5 and 8 have an inhibi tory effect. The inactive peptide GRGES'b.c as well as 
PHSRN, which i s known to be inactive unless covalently bound in the vicini ty of the 
RGD containing peptide, 10 have no effect. 
The control polymer substituted with GRGES, 7, did not inhibit HDF adhesion to 
fibronectin. Cells spread normally and effectively in the presence of this peptide, as 
observed by phase contrast microscopy . This indicates that the polymer backbone is 
nontoxic to the cells and the inhibitory effect observed for polymers 5 and 8 is due solely 
to the peptides substituted along the backbone. I n addition, the percent cell attachment 
level s of f for both 5 and 6 rather than continuing to decline, providing further indication 
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Figure 2. IC50 values for the GRGDS containing materials. Polymer concentrations 
are reported as the concentration of the GRGDS repeat unit. * Within a 95% 
confidence level, this value is statistically different from the other two. 
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The inhibitory act ivity was quantified for GRGDS and 5 and 8 . The IC50 values, 
or concentration of GRGDS necessary to inhibit 50% o f the cell s fro m attaching, are 
represented in Figure 2. For GRGDS , an IC50 of 1.08 ± 0.5 mM was obtained, which is 
wi thin the lite rature ran ges obtained for thi s peptide. '"·c Pol ymer 5 has a lower IC50 of 
0. 18 ± 0.07 mM, and 8 is the most ac tive with an IC 50 of 0 .0 28 ± 0 .007 mM. These 
values are all stati sticall y different (p < 0.04 between each value). 
Both GRGDS-conta ining po lymers inhibited HDF adhesion to fibronectin at 
lower concentrati ons than did the free peptide. Thi s indicates that multi valent peptide-
integrin interac tions provided by the po ly mer scaffold may be important. Similar 
behavior has been observed for po lypeptides containing man y RGD repeats9b and a 
syntheti c polymer substituted with RGD peptides synthesized by radical chemistry.9" 
Po lymer 8 w ith GRGDS and PHSR li gands is the most potent substrate studied. 
The pol ymer backbone prov ides the covalent linkage necessary to obta in the PHSR -
induced e nhancement of RG D adhesive acti vi ty. 10 In fib ronectin , PHSRN is 30-40 A 
away and on the same face of the pro te in as RGD. 11 One integrin can easil y span this 
di stance. The above results indicate that the polymer backbo ne also provides the correct 
o rientati on and spatial separation of these ligands to effect a n en hancement of GRGDS 
binding to the fibrobl ast cellul ar integrins . 
Summary 
These results hi ghli ght the applicability of ROMP to the synthesis of po lymers for 
the inhibiti on o f cell adhesion . Homopo lymers and copo lymers a re readily synthes ized 
containing complex o ligopeptide substituents such as G RG DS and PHSRN . Multi valent 
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interactions provided by the polymer scaffold enhance the inhibitory activity of the 
GRGDS containing polymers towards HDF cell adhesion to fibronectin. A copolymer 
wi th pendent GRGDS and PHSRN peptides is a potent inhibitor of ce ll binding, 
demonstrating that ROMP provides acces to synthetic materials that can inhibit the 
activity of proteins suc h as fibronectin. Such material s may be used to modulate 
physiological ly important integrin-extracellular matrix protein interactions and may be 
useful as drugs for di sease re lated applications such as tumor therapy . 
Experimental 
Materials. 5-Norbornene-exo-2-carboxy lic acid was synthesized according to a 
literature procedure. 12 All peptide coupling agents were purchased from ovabiochem. 
Centriprep flasks were purchased from Millipore. The peptides were synthesized and 
purified by the Beckman In sti tute Biopolymers Synthes is Laboratory (Cali fo rnia Institute 
of Technology). Meth ylene c hloride used in the polymeri zation reactions was dried over 
CaH2, degassed, and vacuum transferred before use. All other chemicals were purchased 
from A ldri ch and used as received. Dulbecco's modified eagle medium (OMEM) and a ll 
ste ril e cell c ulture reagents were purchased from GIBCO and used as received. The 
sterile flasks and 24-well plates coated with human plasma fibronectin were purchased 
from Becton Dickinson Labware. A ll other sterile culture materials were purchased from 
Falcon. The normal human dermal fibroblast (HDF) cell s isolated from neonatal foreskin 
tissue of a sing le male donor were obtained from Clonetics. 
Techniques. All operations were carried out under a dry nitrogen or argon 
atmosphere. Dry box operations were performed tn a nitrogen-filled Vacuum 
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Atmospheres dry box. 1H MR spectra were recorded on a JEOL GX-400 (399.65 MHz) 
spectrometer, or a Varian Uni tyPlus 600 (600.203 MHz) spectrometer as indicated. 
13C NMR (75 .49 MH z) spectra were recorded on a General Electric QE-300 
spectrometer. Chemical shifts are reported downfield from tetramethylsilane (TMS ). 
Infrared spectroscopy was performed on a Perkin E lme r Parago n 1000 FT-IR 
spectrometer using a film cast on a NaCI plate or a KBr pel le t as indicated. High-
resolution mass spectra were provided by the Southern California Mass Spectrometry 
Facili ty (University of California, Riverside). Aqueous gel permeation chromatograph y 
(GPC) were conducted using an HPLC system equipped w ith a Waters 515 HPLC pump, 
a Rheodyne model 7725 injector with a 200 J.!L injec tion loop , a Waters 2487 Dual A 
absorbance detector, a W aters 24 10 refractome ter, and two TSK columns (TASK 
3000PW, TSK 5000PW). The e lue nt was 0. 1 M Na2HPOJ dibasic buffer, the flow rate 
was I mL/min , and pol y(ethy le ne ox ide)s were used as the ca libration standard. The 
HPLC results were obtained on a Beckman 126 Solvent Module HPLC equipped with a 
166 UV Detector and an Altech 18-LL column using a H 20/CH3CN solvent system (7% 
CH3CN for 6 min , 7-90% CH3CN over 38 min , and 90% C H3CN for 8 min). Amino acid 
analysis was performed by the Beckman Researc h Institute in the Di vision of 
Immunology (City of Hope). All cell manipulations were performed in a sterile vertica l 
laminar flow hood. Phase contrast mic roscopy was performed on an inverted ikon 
Eclipse TE300 microscope wi th 200x magnification. 
Norbornene GR(Pbf)GD(t-Bu)S(tBu)-OH Monomer (2). H 2N-G-R(Pbf)-G-
D(O'Bu)-S(O'Bu)-resin (0.75 mmol peptide, 4-carboxytrityl linker Novasyn® resin) was 
placed in a flask containing a frit and stopcock. The resin was swelled in 20 mL of DMF 
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for 15 min and then rinsed w ith DMF (1 x I 0 mL). In a via l, 0.14 g ( 1.0 I mmo l) of 5-
norbornene-exo-2-carbox y li c aci d, 0.38 g ( 1.00 mmo l) of 2-(JH -benzotri azole- 1-yl)-
1, I ,3,3-tetramethy luronium hexafl urophosphate (HBTU), and 0.14 g ( 1.04 mmo l) of 1-
hydroxybenzotriazole (HOBT) in 6.60 mL o f DMF were agitated until a ll solids had 
di ssolved. N,N-diisopropylethylamine (DIEA) was added (0.35 mL, 2.01 mmo l) and the 
sol ution was agitated and added to the resin . Nitrogen was gentl y bubbled through the 
mixture for 2 h. The solution was removed, and the resin was then rinsed w ith DMF (5 x 
10 mL), CH 2Cl 2 (5 x 10 mL), and MeOH (5 x 10 mL) and dried for 24 h at 30 millitorr. 
In a via l, 33 mL of acetic ac id, CH 2C l2 , and MeOH (5 :4: 1) were added to the dry resin 
and the vial was pe ri odicall y swirled fo r 1.5-2 h. The soluti on was filtered to remove the 
resin , added to an excess of hex, and the solvent was removed in vacuo. The procedure 
was repeated to remove a ll of the acetic ac id. T he product was freeze-dried from benzene 
to g ive 0.73 g (9 1%) of 2 as an off-white solid. HPLC: s ingle peak at 2 1.1 3 min. 1H 
NMR (CD 2Cl2, 600 MHz) 8 8.09 ( 1H, bs, G
2N11), 7 .58 (lH, bs , D N11 ), 7 .49 (lH, bs, RN11), 
7.41 (lH, bs, S :-.: 11), 7.23 ( 1H, bs, G
1r-; 11), 6.27 (lH, bs, Rg), 6.02 ( IH, s, Norolcflr,), 5.98 (LH, 
S, Noroldin) , 4.67 (1H, bm, Da), 4.43 (1H, bm, Sa), 4.32 (lH, bm, Ra), 3.88 (2H, bm, G2a + 
G 1a), 3.77 ( 1 H, bm, G 1a) , 3.67 (l H , bm, Sp), 3.54 ( 1 H, bm, SrJ, 3.1 2 ( 1H, bm, Ru.), 2.87 
(2H, s , R (Pbf)c112) , 2.82 (1 H , s , Nor), 2.77 (LH, s, Nor), 2.73 (lH, bm, Dp), 2.66 (lH, bm, 
0 13) , 2.45 (3 H, s, R(Pbf)c11 3) , 2.38 (3 H, s , R(Pbf)013 ) , 2 .08 ( 1H, bs, Nor0 1c0 ), 1.98 (3H, s, 
R(Pbf)c113), 1.80 (LH, bm, R), 1.72 (l H, bm, Nor), 1.61 (LH, bm, R), 1.50 (3H , bm, R + 
Nor), 1.36 (6H , S, R(Pbf)CIDtfurar,) , L.33 (9H , S, D,8J, 1.19 (2H , bm, Norbrictgc), 1.07 (9H, S, 
S,8 u). NOESY cross peaks (CD 2Cl2, 600 MHz) 8 8.09 (G2r-;11), 4.32 (R,J; 7 .58 (DN11 ) , 3.88 
(G2a), 3.77 (G2a); 7.49 (RN11 ) , 3.88 (G 1a): 7.4 1 (S r-;11 ), 4.67 (Da); 7 .23 (G 1N11), 2.08 
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(Norc11c0 ) . TOCSY cross peaks (CD2Cl2, 600 MHz) 8 norbornene: 6.02, 5.98, 2.82, 2.77, 
2.08, 1.72, 1.50, 1.1 9; Gl: 7.23, 3.88; R: 7 .49, 4 .32. 3. 12, 1.80, 1.6 1, 1.50; G2: 8.09, 
3.88, 377; 0 : 7.58 , 4 .67, 2.73 , 2.66; S: 7 .41 , 4.43, 3.67, 3.54. 13C NMR (CD2Cl", 300 
MHz) 8 177.74 , 173.32, 172.69, 17 1.15, 17 1.01 , 158.92, 156.83, 138.26, 136.29, 132.52, 
128.50, 125.08, 11 7.70, 86.79, 82.09, 74. 13, 70.78, 61.69, 53.39, 53.0 8, 50.37, 47.65 , 
46.57, 44.39, 43.76, 42.06, 40.87, 37.84, 30.85, 29.48, 28.74, 28.2 1, 27.93 , 27.5 1, 25.94, 
19.54, 18.25, 12.66. IR (NaCl plate): 3320.7, 3061.2, 2967.8, 2926.3, 2864 .1, 1726.4, 
1653.7, 1544.8 , 1456.6, 1363.2, 1249.0 , 11 55.6, 1098 .5, 953.3, 849.5 , 808.0, 709.4, 
667 .9, 564. 1 em· '. HRMS (DCM/NBA/PPG) ca lcd fo r (MHt 975 .486 1, fo und 
975.4876. 
Norbornene P-H(Trt)-S(Trt)-R(Pbf)-N(Trt)-01-1 Monomer (3). T he same procedure 
as fo r 2 was fo llowed with H,N-P-H(Trt)-S(Trt)-R(Pbf)-N(Trt)-resin (0.75 mmol, 4-
carboxytrityl linker Novasyn <S resin) , 0. 14 g (1.01 mmol) of norbornene-exo-2-carboxylic 
acid, 0.38 g ( 1.00 mmol) of HBTU, 0. 14 g ( 1.04 mmo l) of HOBT, and 0.35 mL (2.01 
mmol) of DIEA in 6.25 mL DMF to yie ld 1.24 g (97.3%) of 3 as a flu ffy white soli d. 
H PLC: si ngle peak at 38 .85 min . 1H NMR (CD2Cl2, 600 MHz) 8 8.29 (bs) , 7 .59-7.38 
(bm), 6.89-7.29 (bm with maxi ma at 6.89, 7.04, 7. 13, 7.22, 7 .28, 7.29), 6.63 (bm), 5.98 
(s), 5.84 (bm), 5.73 (bm), 4.45 (bm), 4.30 (bm), 4. 13 (bm), 3.47-3.36 (bm), 2.93-2.65 
(bm, wi th maxima at 2.65, 2.76, 2.84, 2.93), 2.34-2.43 (bm w ith maxima at 2.34, 2.40), 
2. 10 (bm), 1.98 (s), 1.93 (bm), 1.76 (bm), 1.63 (bm), 1.54 (bm), 1.34 (s), 1.22 (bm) , 0.95 
(bm). ''C NMR (CD2Cl2 , 300 MHz) 8 174.74, 172.87, 17 1.27, 170.0 1, 158 .49, 156.70, 
144.5 1, 143.85 , 14 1.86, 138.36, 136. 19, 135.9 1, 132.32, 129.90, 128.49, 128 .06, 127.32, 
127. 11 , 126.92, 124.62 , 120.3 1, 11 7.34, 87.20, 86.49, 70.66 , 63 .49 , 6 1.24, 54.93 , 5 1.09, 
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47.78 , 46.95, 46.24, 45 .79, 43 .07 , 42.76, 41.98, 30.8 1, 30.06, 28.70, 25.35, 21.26, 19 .51 , 
18.20, 12.68. JR (NaCI plate): 33 17.7, 3054.7, 2970.5, 2917.9 , 1669.8, 1622.5, 1548.8, 
149 1.0, 1443.6, 1417.3, 1264.8, 1096.4, 738.7, 696.6 , 659.6 . HRMS (MALDI) calcd for 
(MNar 1708.7737, found 1708.7739. 
Norbornene G-R(Pbf)-G-E(O'Bu)-S(O'Bu)-OH (4). The same procedure as for 
2 was fo ll owed with G-R(Pbf)-G-E(O'Bu)-S(O'Bu)-resin (0.25 mmol, 4-carboxytrity l 
linker Novasyn® resin), 0. 14 g (1.01 mmol) of 5-norbomene-exo-2-carboxyli c acid, 0 .38 
g ( 1.00 mmol) of HBTU, 0. 14 g (1.04 mmol ) of HOBT, and 0.35 mL (2.01 mmol ) of 
DIEA in 6.60 mL DMF to yie ld 0 .11 g (46.1 %) of 4 (plus an impurity detected in the 'H 
NMR spectrum) as a whi te solid. HPLC: sing le peak at 24.35 min. 'H NMR (CD2C l2, 
600 MHz) 8 8.07 ( lH , bs) , 7.62-7.53 (3 H, bm), 7.23 (lH, bs), 6.28-6.23 (2H, bm), 6 .02 
( 1H , s), 5.99 ( IH, s) , 4.75 ( 1H, bm), 4.42 (lH, bm), 4.28 ( IH, bm), 3.86 (3H, bm), 3 .68 
(lH, bm), 3.56 ( 1H, bm), 3. 12 ( 1H, bm), 2.86 (2H , s), 2.82 ( 1H, s), 2.77 (lH, s), 2.46 
(3H, s), 2.39 (3H, s), 2.36 (lH, bm) , 2.30 ( I H , bm), 2.08 ( 1H, bs), 1.98 (3H , s), 1.93 (2H, 
bm), 1.80 ( IH, bm), 1.73 (lH, bm), 1.6 1 (lH, bm), 1.50 (3H , bm), 1.36 (6H, s), 1.33 (9H, 
s), 1.19 (2H, bm), 1.06 (9H , s). IR (NaCI plate): 3444.0 , 3286.2, 2970.6, 1727.7, 1627.8, 
1543.6, 1448 .9 , 1364.7, 1249.0 , 1154.3, 1096.4 , 733.4, 665 .0, 570.3 . HRMS 
(DCM/NBA/PPG) calcd for (MHr 989.5018, found 989.5018. 
General Polymerization Procedure. In a nitrogen-filled dry box, a so lution of 1 
in CH 2C l2 was added to a sol ution of monomer in MeOH (1: I CH2C I2:Me0H) in a dram 
to give an initial monomer concentrati on of 0.6 M. The dram was sealed and removed 
from the box . Within 10 min , the dram was placed in an oi l bath at 55 OC and the 
soluti on was stirred for 2 h. The ini tial monomer to cata lys t ratios were 10/ 1. The 
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polymerization mixtures were cooled to room temperature, diluted , and ethyl viny l ether 
was added. The solutions were stirred for an additional 15-30 min before isolation by 
precipitat ion into CH 2C l2 :ether (3: 1 for 5 -7 , I : I for 8 ). The pol ymers were subjected to 
centrifugation , the solvent was removed , and the solids dri ed under vacuum . 
General Deprotection Procedure. For 5 and 7 , a so luti on of TFA , 
triisopropyls ilane (TIS), and H 20 (95/2.5/2.5) was added to the dried pol ymers to make a 
fi na l concentration of 20 mUg po lymer. The mi xtures were s tirred for 2.5 h before 
precipitating into co ld ethe r. The pol ymers were subjected to centrifugation, the solvent 
was removed, and the solids washed with co ld e ther (2 x 5 mL) before dry ing under 
vacuum. 6 and 8 were subjected for 1 h to 10 mL of condensed HF and 0.5 mL of p-
cresol in the proper containment apparatus. The HF was removed in vacuo and the solid 
was washed w ith ethe r before dryi ng under vacuum 
Purification. The po ly mers were subj ected to a minimum amount of 0.1 N 
NaOH for 10 min , prec ipitated into MeOH, isolated by centrifugation , and dried under 
vac uum . Deioni zed, doubl y di stilled wate r was added to the po lymers and the pol ymers 
purifi ed by centrifugati o n through a membrane us ing Centiprep tubes with a mo lecul a r 
weight cut off (MWCO) of 3 ,000. Thi s procedure was repeated a minimum of 5 times 
fo r each pol ymer. The polymer so lutions were then subjected to centri fugation, the 
solution decanted to remove any insoluble partic ulate mate rial , and lyophili zed . The 
resulting pol ymers were all spongy, tan materia ls and were kept at -30 OC until use. 
T he pol ymers were c haracte ri zed and the data not reported in the text is reported 
below. The 'H NMR copo ly mer spectrum is the addition of the two homo po lymer 
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spec tra. All peaks are broad, and un less otherwise stated , are the composite of the trans 
and cis polymer proton peaks. 
GRGDS Homopolymer (5). 'H NMR (D:P . 600 MHz): 8 7.41 (bm, NH), 7.36 
(bm, NH), 7 .29 (bm, NH) 5.24-5.45 (2H, bm), 4.68 (bm, Da), 4.36 (lH), 4.26 (lH, bm), 
3.94-4.02 (3H, bm), 3.84 (3H, bm), 3.20 (2H), 2.94 & 2.71 (cis & trans, 2H, bm), 2.65 
(2H , bm), 1.90-1.97 (2H, bm), 1. 76 (lH, bm), 1.64 (4H, bm), 1.23 (2H , bm). IR (KBr 
pe ll et): 3363.1, 2933.3, 1638.7, 1528.6 , 1397.6, 1240.4, 1114.6 , 1036.0, 967.9 , 925.9, 
6 11.5 em·' . AAA expected (found): Asp 1.00 ( 1.03), Ser 1.00 (0.90), G ly 2.00 ( 1.96), 
Arg 1.00 ( 1.11) residue/mol. 
GRGES Homopolymer (7). 'H NMR (D20, 600 MHz): 8 7.43 (bm, NH ), 7.37 
(bm, NH), 7.29 (bm, NH) 5.29-5.46 (2H, bm), 4.38 (2H, bm) , 4 .27 (lH) , 3.92-3.98 (3H, 
bm) , 3.85 (3H, bm), 3.20 (2 H, bm), 2.98 & 2.60-2.69 (c is & trans, 2H, bm), 2.27 (2H, 
bm) , 2.13 (1 H, bm), 1.94 (4H, bm), 1.76 (lH, bm) , 1.64 (3H , bm) , 1.23 (2H, bm). fR 
(KBr pe llet): 3323.8, 2936.0, 1655 .7, 1540.4, 1451.3, 139 8.9 , 1241.7, 1115.9, 1042.5 , 
979.7, 848.6, 670.5. 539.5 e m·' . AAA expected (found): Ser 1.00 ( 1.04), Glu 1.00 
( 1.09), Gly 2.00 (2. 15), Arg 1.00 (0.72) residue/mol. 
GRGDS/PHSRN Copolymer (8). 'H NMR (D20 , 600 MHz): 8 7.70, 7.3 1, 6.98 , 
5.42, 4.48 , 4.37-4.40, 4.27 , 3.97, 3.86, 3 .1 8, 2.76, 2.71 , 2.66, 2. 18, 1.91 , 1.75, 1.64, 1.28. 
IR (KBr pellet): 3342.1 , 2933.3, 1596.7 , 1444.8 , 1387. 1, 13 13.7, 1245.6, 1046.5, 983.6, 
925.9, 6 16.7 em·' . AAA expected (found): Asp+ Asn 2.00 (2.04), Ser 2.00 (1.73), Pro 
1.0 (1 .07), Gly 2.00 (2.24), Hi s 1.0 (0.97), Arg 2.00 (1.94) residue/mol. 
Cell Maintenance. HDF cell s were maintained in DMEM supplemented with 
10% feta l bovine serum, 400 U/mL penici llin , and 400 mg/mL streptomyc in in an 
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incubator at 37 OC and 4 .9% CO~ . Subc ulturing was accompli shed by rins ing the cell s 
wi th HEPES buffered sa line sol ution (HBSS), enzymatically re mov ing the cell s from the 
surface w ith trypsin , and neutrali z ing the tryps in with supplemented DMEM. The 
number of viable ce lls was assessed us ing a hemacytomete r with trypan blue, and the 
cel ls were dispensed into 25 or 75 em" flasks at a density of 3500 cell s/em". 
Sample Prepa ration. Samples were weighed o n a microbalance and solubili zed 
in phosphate buffered saline (PBS) to a concentration 4x the desi red final concentration. 
The pH of the soluti ons were determined and adjusted to -7.4 as necessary. Phosphate 
buffered saline (PBS) a lone was used in the control wells. The samples were filte r 
(0.2 J-lm) steril ized before use. 
Competitive Inhibition Assay. T o 24-well plates coated with human plasma, 
fibronectin was added I 00 f-ll o f the polymer or peptide solution . HDF cells of passage 4-
7 were harves ted with trypsin as described above and resuspended to 35,000 cell s/mL in 
unmodified DMEM. Cell suspensions were allowed to recover for at least 15 min before 
adding 300 f-ll to each well. The cells were evenly dispersed by gent le rocking of the 
plate before inc ubati on fo r 60 min at 37 OC and 4.9% CO". The attac hed cells were fixed 
with methanol after remova l of the sample soluti o ns and washing with deionized H"O. 
The ce ll s were observed by phase contrast microscopy and counted in a minimum of 6 
random ly selected fields per well. The percent maximum cell attachment is the average 
number of cell s pe r view divided by the average numbe r obtai ned for the contro l 
multiplied by 100. The IC50 is the concentration where 50% of the maximum possible 
cells are attached. 
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Chapter 6 
Purification Technique for the Removal of Ruthenium from 
Olefin Metathesis Reaction Productst 
!55 
Abstract 
Ri ng-c los in g metat hes is ( RC M ) pro duc t s of reac ti o n s util iz in g 
RuCI ~(=CHPh)(PCYJh (1 ) as a cata lys t were successfull y purified of unwanted 
ru theni um U S In g a wa te r -so lubl e coo rdin a tin g ph os phin e , 
tris(hydroxymethyl)phosphine, P(CH~OHh Severa l simple and e ffi c ie nt purification 
procedures were compared fo r the isola ti on o f the produc t of the RC M of di e thy l 
dia ll y lmalonate. The effecti veness o f thi s procedure was a lso de monstrated for the 
i alation or an unsaturated ana log of 12-crown-4 ethe r. 
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Introduction 
M etal complexes are uti li zed in many organic transformati ons, including small 
molecule and po ly mer synthesis. 1 H owever , remova l o f the metal complex after 
completi on o f the reacti on can pose a serious problem during product purifi cati on, 
especiall y on an industrial scale. Thi residual metal can be problemati c in subsequent 
transformations, as well as for storage and use of the materi al. Specificall y, as descri bed 
in Chapter I , ruthenium catal ys ts such as benzy lidene ruthenium complex 1,2 are 
common ly utilized in o lefin metathesis reactions such as RCM . cross metathesis, or r ing-
opening metathesis polymeri zati on (ROMP). 3 H owever, it can prove very di f fi cult to 
remove the highl y-colored ruthenium complexes from the products of these reacti ons, 
and the res idual ruthenium can cause problems such as o lefin i someri zation during 
d istill ati on o f the product , decompositi on over time, and increased toxi c ity of the f inal 
materi al. In thi s chapter , a method i s described to allev iate these problems by using a 







Tri s(hydroxymeth y l)phosphine (2 ) i s a water soluble and moderately air stable 
phosphine.'
1 
Because of these properties, there have been an increasing number of rep011s 
on th e use o f 2 as a l igand for water-so luble transiti on metal complexes used as 
cata l ysts~.s and for applicati ons in medi cinal chemistry. 6 Recentl y , two ruthenium 
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complexes of 2 (See Figure I) have been described.7 In these cases the phosphine readi ly 
coordinates to the ruthenium resulting in complexes that are soluble in water. These 
studies prompted the in vesti gations into the use of 2 for the removal of residual 
ruthenium from olefin metathesis reaction products as described in thi s chapter. 
+ 
Higham, eta/. * OC ...--Ru- P(CH20 Hb 
Driel3en- l-lolscher, eta/. 
Figure 1. Water-soluble ruthenium complexes containing tri s(hydroxymethyl )-
phosph ine. 
Results and Discussion 
The RCM of diethyl diallylmalonate by ruthenium complex 1 and purifica tion of 
the product using 2 was undertaken as shown in Scheme I . It was observed that when the 
crude product was added to a solution of 28 and triethy lamine9 in methy lene chloride, the 
solution turned from a black/brown color to pale ye llow wi thin five minutes, indicating 
that 2 was coordinating to the ruthenium. Upon the addition of water, the yellow color 
moved into the aqueous phase leav ing the methy lene chloride phase colorless. 1H NMR 
spectra copic studi es indicated that all of the product remained in the methy lene chloride 
phase and all of the phosphine moved to the aqueous phase (Figure 2). 
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2. H20 extraction 
(crude) (pu rified) 








l · ' ' 
I I 
I I i' 
Figure 2. 1H NMR spectra fo r the RC M of di e thy l di a ll y lmal o nate : A) C H 2C I2 layer 
containing o nly the product. 3 ,3-die thy leste r-pe nte ne. B ) H 20 layer conta ining both 
the phosphine 2 and trie thy lamine. 
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T o quantify thi s observati on a series of pUiification experiments were undertaken 
and the results given in Table I. The amount of ruthenium in a 5 mg sample of the RCM 
product was determined by inductive-coupled p lasma mass spectrometry (ICP-MS). All 
purification methods achieved a more than tenfold decrease in the amount of ruthenium 
remain ing in the sample compared to the crude sample (entry I ). The results were similar 
w hether 86 equivalents (entry :2) or 378 equ i valents (en try 3) of 2 were used followed by 
a single aqueous wash. The amount of ruthenium in the product could be decreased by 
adding 86 equi valents of 2 fo llowed by 3 aqueous washes (entry 4 ) o r adding 2 to the 
m eth y lene chloride layer three times. fo llowed by an aqueo us wash each time (entry 5). 
B ecause 2 is polar and i s known to graft onto silica ge l,10 a purification invo l ving stirring 
a soluti on of the product, 2 , and tri eth y lamine in meth y lene chloride w ith an excess of 
sili ca gel (entry 6) was attempted. Thi s method gave the best result and the amount of 
re idual ruthenium in the sample w as reduced to I Jlg in 5 mg or product. 









86 eq. 2 , 1 H20 wash 
378 eq . 2 , 1 H20 wash 
86 eq. 2 , 3 H20 washes 
86 eq. 2 , 1 H20 wash, repeated 3 times 
86 eq. 2 , stir with silica gel , filter 
Ruthenium 
(~g/5 mg product) 
74.6 + 0.8 
5.72 + 0.07 
5.84 + 0.07 
3.35 + 0.07 
3.56 + 0.07 
1.03 + 0.04 
aNumber of eq. of 2 based on added 1. In each case, 2 eq. Et3N to 2 was used. 
G i ven th at in the above experiments the same results were obtained by adding 86 
equi valents or greater of 2 , nex t we studied the minimum amount o f 2 that would be 
160 
neces ary to draw ruthenium into the aqueous phase. A senes of experiments was 
undertaken to determine the net IC P-MS intensity of ruthenium 101 in the aqueous phase 
after adding a certain number of equ ivale nts of 2 to the methylene chlo ride layer followed 
by o ne aqueous wash. There was a steep ri se in the ne t intens ity and thus amount of 
rut he nium in the aqueous phase between 1 and 10 equi va le nts o f 2 , follo wed by a 
leve ling off of in te ns ity (Figu re 3). It appears that at least 10 eq ui valents of 2 is 
necessary to effic ie ntly extract the ruthenium into the H,O layer fro m the methylene 












0 10 20 30 
[2]/[Ru] 
40 50 
Figure 3. Ruthenium ICP-M S signa l from aqueous phase versus equi valents of 2. 
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distillation 
trace amt. of Ru 
3 4 
Scheme 2. Di stillati on o f 3 results in an isomeri zation of the a ll y l e the r to a viny l 
e ther to fo rm 4. Spec ies 4 reac ts w ith c atal yst 1 to fom1 a ruthe nium species inert to 
metathesis. 
With thi s informati o n , the me thodo logy was ex te nded to anothe r exampl e. As 
di scussed in C ha pte r 3, the RC M of bi sall y l tri ethy le ne g lycol w ith 1 y ie lds crown e the r 3 
w hic h can be po lym erized by RO MP to fo rm a po lyethe r . 11 However, w hen the 
purificati on o f 3 w as atte m pted by dist ill a ti on , 2 -5% of the cyc lic viny l e the r 4 formed 
(Scheme 2). Thi s spec ies reacts irreversi bl y w ith 1 to fo rm RuC 12(=C HOR)(PCy3) 2 • 
wh ich i inactive fo r o lefin me tathes is reacti o ns. Whe n 4 is present in soluti o n , the 
RO MP of 3 is inhibited . However, w he n 3 was pre treated w ith 2 a nd puri fied w ith a 
s ing le aqueous wash, the rutheniu m concentrati o n was reduced fro m 80 to 8.8 !lg per 
5 mg 3 as de termined by ICP-M S . In thi s case, a te n fo ld decrease in the ruthen ium 
concent rati o n was s ign ific ant enough to inhi b it the detrimenta l isomerizati on d ur ing 
d is ti ll ation , thus e liminati ng the need for a mo re time-consuming purification of 3 . 
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Summary 
This c hapte r describes the removal of ruthe niu m from RCM reaction products, 
fac ilitated by the use of water-so luble phosphine 2 during the iso lation process. An 
aqueous extrac tion o r silica gel purifi catio n may be used . fn the case of an aq ueous 
extraction, 10 equi valents of 2 to ruthenium is adeq uate to move the ruthenium to the 
H~O phase. This method can be extended to the purification of other RC M products, 
such as unsaturated c rown ethers. 
Experimental 
Materials. Tri s(hydroxymethyl)phosphine was purchased from Strem and used 
as received . Die thy l diallylmalonate and the ruthenium standard were purchased from 
Aldrich. The crown e ther substrate was synthesized as described in Chapter 2. 11 Water 
used to make the 1CP-MS samples was purifie d through a nanopure column after 
disti ll atio n. Methylene chloride (CH"C l2) was ri gorous ly degassed and passed through 
purification columns. 12 Triethy lamine and a ll other solvents were purc hased from EM 
Sc ience and used as received . 
Techniques. 1H NMR (399.65 MHz) spectra were taken on a JEOL GX-400 
spectro meter. 1H chemical shifts are reported down fie ld from tetramethy ls il ane (TMS). 
Inductive-coupled mass spectrometry data was obta ined on an Elan SOOOA using a 180 s 
rinse time fo llowed by a 120 s wash delay. 
General RCM procedure. To a solut ion of diethy l dia ll ylma lonate (0. 10 mL, 
0.4 1 mmol) in CH 2CI2 (19 mL) was added a solution of 1 (17 mg, 0.02 mmol) in CH2C l2 
(2 mL). T he mi xture was stilTed for 2 h at room temperature, e thy l vi nyl ether ( - 0 .1 mL) 
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was added , and the mi xture sti rred fo r an additiona l 30 min. The so lvent and e thyl viny l 
ether were evaporated to give the c rude 3,3-d ie thyleste r-pente ne product. 1H N MR 8 
5.59 (s, 2H), 4. 14 (q , 2H , J=7.2 Hz), 2 .96 (s, 2 H), 1.2 1 (t , 3H, J=7 .7 Hz). 
Typical purification procedure. A typical puri ficati on procedure is as fo ll ows: 
3,3-Diethy leste r-pentene ( I 00 mg, 0.47 mmo l) in meth yle ne ch lo ride (0 .5 mL) was added 
to a so lution of 2 (29 mg, 2.36 mmol) and triethylamine (66 11g, 4.72 mmo l) in methylene 
chloride (1.5 mL) and stirTed fo r 10 min . W ate r (-2 mL) was added and the biphasic 
so lution vigorous ly sti rred for 15 min . The aq ueous layer was sepa rated a nd the 
methy lene chlo ride removed in vacuo to isolate the produc t as a ye llow o il. 
General quantification by ICP-MS. Samples of approximate ly 5 mg were 
precisely weig hed on a mi c roba lance, di gested overni ght w ith concentrated nitric acid, 
and d iluted to l % ni tric acid . The samples were fi lte red th rough 2 11m filters to remove 
any particulate ma tte r. T he samples were each measured 10 times by IC P-MS , and the 
intens ities were obta ined for ruthe nium isotopes 99, I 0 I , and I 02. The intensity of pure 
I% n itric ac id was subtrac ted from the sample intensi ti es to give the ne t in tens iti es. To 
determine the ac w a / conce ntrati on o f ruthenium in the sam ples , the ne t intensiti es were 
compared to the ne t intensiti es obtained for the ruthenium standards. The standards were 
obtained by diluting a ruthenium standard of 980 !lglmL Ruin 5 w t. % HC I with l % nitric 
ac id to get 2 .04 , 1.49 , 0 .98, 0.47 , 0. 1, 0.05 , a nd 0 .01 !lglmL Ru standards where each 
samp le contained less than 0.0 1 wt. % HC I. The numbers g iven indi cate the average 
amount of ruthenium obtained for the th ree isotopes measured . 
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